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Cardiac output (CO) defines the blood flow arriving from the heart to the 
different organs in the body and it is thus a primary determinant of global O2 
transport. Cardiac output has traditionally been measured using invasive 
methods, whose risk sometimes exceeds the advantages of a cardiac output 
monitoring. 
In this context, the minimization of risk in new noninvasive technologies 
for CO monitoring could translate into major advantages for clinicians, 
hospitals and patients: ease of usage and availability, reduced recovery time, 
and improved patient outcome. Impedance Cardiography (ICG) is a 
promising noninvasive technology for cardiac output monitoring but available 
information on the ICG signals is more scare than other physiological signals 
such as the electrocardiogram (ECG). 
The present Doctoral Thesis contributes to the development of signal 
treatment techniques for the ICG in order to create an innovative 
hemodynamic monitor. 
First, an extensive literature review is provided regarding the basics of the 
clinical background in which cardiac output monitoring is used and 
concerning the state of the art of cardiac output monitors on the market. This 
Doctoral Thesis has produced a considerable amount of clinical data which is 
also explained in detail. These clinical data are also useful to complement the 
theoretical explanation of patient indices such as heart rate variability, blood 
flow and blood pressure. In addition, a new method to create synthetic 
biomedical signals with known time-frequency characteristics is introduced. 
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One of the first analysis in this Doctoral Thesis studies the time difference 
between peak points of the heart beats in the ECG and the ICG: the RC 
segment. This RC segment is a measure of the time delay between electrical 
and mechanical activity of the heart. The relationship of the RC segment with 
blood pressure and heart interval is analyzed. The concordance of beat 
durations of both the electrocardiogram and the impedance cardiogram is one 
of the key results to develop new artefact detection algorithms and the RC 
could also have an impact in describing the hemodynamics of a patient. 
Time-frequency distributions (TFDs) are also used to characterize how the 
frequency content in impedance cardiography signals change with time. Since 
TFDs are calculated using concrete kernels, a new method to select the best 
kernel by using synthetic signals is presented. Optimized TFDs of ICG signals 
are then calculated to extract several features which are used to discriminate 
between different anesthesia states in patients undergoing surgery. 
TFD-derived features are also used to describe the whole surgical 
operations. Relationships between TFD-derived features are analyzed and 
prediction models for cardiac output are designed. These prediction models 
prove that the TFD-derived features are related to the patients’ cardiac output. 
Finally, a validation study for the qCO monitor is presented. The qCO 
monitor has been designed using some of the techniques which are 
consequence of this Doctoral Thesis. The main outputs of this work have 
been protected with a patent which has already been filed. 
As a conclusion, this Doctoral Thesis has produced a considerable amount 
of clinical data and a variety of analysis and processing techniques of 
impedance cardiography signals which have been included into commercial 


















La despesa cardíaca defineix el fluix de sang que arriba des del cor als 
distints òrgans del cos i és, per tant, un determinant primari del transport 
global d’oxigen. La despesa cardíaca s’ha mesurat tradicionalment emprant 
mètodes invasius, els riscs dels quals en ocasions excedeixen els avantatges de 
la monitorització de la despesa cardíaca. 
En aquest context, la minimització del risc de la monitorització de la 
despesa cardíaca en noves tecnologies no invasives podria traduir-se en més 
avantatges per a metges, hospitals i pacients: facilitat d’ús i disponibilitat de 
l’equipament, temps de recuperació dels pacients i millors resultats en el 
pacients. La cardiografia d’impedància (ICG per les seues sigles en anglés) és 
una tecnologia prometedora i no invasiva per a la monitorització de la despesa 
cardíaca però la informació disponible sobre els senyals d’ICG és més aviat 
escassa en comparació amb altres senyals fisiològics com l’electrocardiograma 
(ECG). 
La present Tesi Doctoral contribueix al desenvolupament de tècniques de 
tractament del de senyal d’ICG per així crear un monitor hemodinàmic 
innovador. 
En primer lloc, es proporciona una extensa revisió bibliogràfica sobre els 
aspectes bàsics del context clínic en què la monitorització de la despesa 
cardíaca s’utilitza principalment, així com sobre l’estat de l’art dels monitors 
de despesa cardíaca que existeixen al mercat. Aquesta Tesi Doctoral ha produït 
una considerable quantitat de dades clíniques que també s’expliquen en detall. 
Aquestes dades clíniques també són útils per a complementar les explicacions 
teòriques dels índexs de pacient de variabilitat cardíaca i de fluix i pressió 
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sanguínia. A més a més, es presenta un nou mètode de creació de senyals 
sintètics biomèdics amb característiques de temps-freqüència conegudes. 
Una de les primeres anàlisis d’aquesta Tesis Doctoral estudia la diferència 
temporal entre els pics dels batecs cardíacs de l’ECG i de l’ICG: el segment 
RC. Aquest segment RC és una mesura del retard temporal entre l’activitat 
elèctrica i mecànica del cor. S’analitza la relació del segment RC amb la pressió 
arterial i l’interval cardíac. La concordança entre la duració dels batecs de 
l’ECG i de l’ICG és un dels resultats clau per a desenvolupar nous algoritmes 
de detecció d’artefactes i el segment RC també podria ser rellevant per a la 
descripció de l’hemodinàmica dels pacients. 
Les distribucions de temps-freqüència (TFD, per les seues sigles en anglés) 
s’utilitzen per a caracteritzar com el contingut dels senyals de cardiografia 
d’impedància canvia amb el temps. Atès que les TFDs han de calcular-se 
emprant nuclis (kernels, en anglés) concrets, es presenta un nou mètode per a 
seleccionar el millor nucli mitjançant la utilització de senyals sintètiques. Les 
TFDs d’ICG optimitzades es calculen per extraure distintes característiques 
que són emprades per discriminar entre diferents estats d’anestèsia en pacients 
sotmesos a processos quirúrgics. 
Les característiques derivades de les distribucions de temps-freqüència 
també són utilitzades per descriure les operacions quirúrgiques durant tota la 
seua extensió temporal. La relació entre eixes característiques són analitzades 
i es proposen distints models de predicció per a la despesa cardíaca. Aquests 
models de predicció demostren que les característiques derivades de les 
distribucions de temps-freqüència de senyals d’ICG estan relacionades amb la 
despesa cardíaca dels pacients. 
Darrerament, es presenta un estudi de validació del monitor qCO. Aquest 
monitor ha sigut dissenyat utilitzant alguna de les tècniques que són 
conseqüència d’aquesta Tesi Doctoral. Les principals conclusions d’aquest 
treball han sigut protegides amb una patent que ja ha sigut registrada. 
Així doncs, aquesta Tesi Doctoral ha produït una considerable quantitat de 
dades clíniques i una varietat de tècniques de processat i anàlisi de senyals de 














El gasto cardíaco (GC) define el flujo de sangre que llega desde el corazón 
a los distintos órganos del cuerpo y es, por tanto, un determinante primario 
del transporte global de oxígeno. Se ha medido tradicionalmente usando 
métodos invasivos cuyos riesgos excedían en ocasiones las ventajas de su 
monitorización. 
En este contexto, la minimización del riesgo de la monitorización del gasto 
cardíaco en nuevas tecnologías no invasivas podría traducirse en mayores 
ventajas para médicos, hospitales y pacientes: facilidad de uso, disponibilidad 
del equipamiento y menor tiempo de recuperación y mejores resultados en el 
paciente. La impedancio-cardiografía o cardiografía de impedancia (ICG) es 
una prometedora tecnología no invasiva para la monitorización del gasto 
cardíaco. Sin embargo, la información disponible sobre las señales de ICG es 
más escasa que otras señales fisiológicas como el electrocardiograma (ECG). 
La presente Tesis Doctoral contribuye al desarrollo de técnicas de 
tratamiento de señal de ICG para así crear un monitor hemodinámico 
innovador. 
En primer lugar, se proporciona una extensa revisión bibliográfica sobre 
los aspectos básicos del contexto clínico en el que se utiliza la monitorización 
del gasto cardíaco así como sobre el estado del arte de los monitores de gasto 
cardíaco que existen en el mercado. Esta Tesis Doctoral ha producido una 
considerable cantidad de datos clínicos que también se explican en detalle. 
Dichos datos clínicos también son útiles para complementar las explicaciones 
teóricas de los índices de paciente de variabilidad cardíaca  y el flujo y la 
presión sanguíneos. Además, se presenta un nuevo método de creación de 




Uno de los primeros análisis de esta Tesis Doctoral estudia la diferencia 
temporal entre los picos de los latidos cardíacos del ECG y del ICG: el 
segmento RC. Este segmento RC es una medida del retardo temporal entre la 
actividad eléctrica y mecánica del corazón. Se analiza la relación del segmento 
RC con la presión arterial y el intervalo cardíaco. La concordancia entre la 
duración de los latidos del ECG y del ICG es uno de los resultados claves para 
desarrollar nuevos algoritmos de detección de artefactos y el segmento RC 
también podría ser relevante en la descripción de la hemodinámica de los 
pacientes. 
Las distribuciones de tiempo-frecuencia (TFD, por sus siglas en inglés) se 
utilizan para caracterizar cómo el contenido de las señales de impedancia 
cardiográfica cambia con el tiempo. Dado que las TFDs deben calcularse 
usando núcleos (kernels, en inglés) concretos, se presenta un nuevo método 
para seleccionar el mejor núcleo mediante el uso de señales sintéticas. Las 
TFDs de ICG optimizadas se calculan para extraer distintas características que 
son usadas para discriminar entre los diferentes estados de anestesia en 
pacientes sometidos a procesos quirúrgicos. 
Las características derivadas de las distribuciones de tiempo-frecuencia 
también son utilizadas para describir las operaciones quirúrgicas durante toda 
su extensión temporal. La relación entre dichas características son analizadas 
y se proponen distintos modelos de predicción para el gasto cardíaco. Estos 
modelos de predicción demuestran que las características derivadas de las 
distribuciones tiempo-frecuencia de señales de ICG están relacionadas con el 
gasto cardíaco de los pacientes. 
Finalmente, se presenta un estudio de validación del monitor qCO, 
diseñado con alguna de las técnicas que son consecuencia de esta Tesis 
Doctoral. Las principales conclusiones de este trabajo han sido protegidas con 
una patente que ya ha sido registrada. 
Como conclusión, esta Tesis Doctoral ha producido una considerable 
cantidad de datos clínicos y una variedad de técnicas de procesado y análisis 
de señales de cardiografía de impedancia que han sido incluidas en dispositivos 
médicos ya disponibles comercialmente. 
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This introductory chapter aims to give an initial overview of the topics 
addressed in the present Doctoral Thesis. The basic problem on which this 
research focuses is explained. Furthermore, the specific objectives to 
accomplish with this study are defined. Finally, the framework where this 
thesis was developed is provided as a guide for the reader. 
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1.1 Introduction 
This chapter is divided into three main parts. The first part will state the 
problem this work concentrates on. Thanks to the analysis of the initial 
problem, concrete objectives are therefore established as a guideline for the 
Doctoral Thesis. The special framework in which the Doctoral Thesis has 
been developed is explained in detail. Finally, the outline of the present 
document is also provided at the end of this Chapter. 
1.2 Problem Statement 
Cardiac output (CO) is a primary determinant of global O2 transport from 
the heart to the body. It defines the blood flow arriving to the different organs 
in the body. As a consequence, determination of CO is essential in any 
advanced hemodynamic monitoring system in perioperative and intensive 
care medicine. 
Traditionally, CO has been measured using invasive methods such as the 
intracardiac catheterization. The risk involved in such invasive methods posed 
a burden on the standardization of this measurement since clinicians needed 
to evaluate the balance between the risk and the advantages of the CO 
measurement. 
Today, there is a continuous search for methods of CO measurement 
which are less invasive than its predecessors in order to minimize risk. Such 
risk minimization in new noninvasive technologies for CO monitoring could 
translate into major advantages for clinicians, hospitals and patients: ease of 
usage and availability, reduced recovery time, and improved patient outcome. 
New technologies are nowadays available for noninvasive CO 
monitoring but further research is required to improve the different options 
for noninvasive continuous CO with regard to signal acquisition, signal 
processing, and clinical applicability. 
Impedance Cardiography (ICG) is a promising solution for noninvasive 
continuous CO monitoring. The technique to calculate the CO using the ICG 
was first proposed by Kubicek in 1966 but due to the state of the art, it did 
not further devolved [1]. The latest advances in biomedical signal processing 
allow us to further explore this technique, which is the main topic of this 
Doctoral Thesis. There exists a vast bibliography about electrocardiogram 
(ECG) but information on ICG is scarce. In this Doctoral Thesis, the 
impedance cardiography signal has been studied and characterized using time-
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frequency distributions (TFDs) and Recurrence Plots (RPs). The relationship 
between TFD-derived and RP-derived features and the hemodynamic state of 
patients has been studied. Finally, some of the resulting algorithms have also 
been implemented and validated in the new noninvasive CO monitor qCO by 
Quantium Medical. 
1.3 Objectives 
The ideal CO monitor should be reliable, continuous, noninvasive, 
operator-independent and cost-effective and should have a fast response beat-
to-beat time [2]. Impedance cardiography is a technique which can definitely 
fulfill all those requirements but the technology is still under development. 
Main issues arise when trying to find the exact parameters to extract from the 
ICG curve but, mostly, the most important problems are associated with high 
levels of noise and artifacts which appear due to the movement of the patient. 
The main final contribution of this Doctoral Thesis is the development 
of signal treatment techniques for the thoracic bioimpedance signals in 
order to create an innovative hemodynamic monitor. The development 
of this Doctoral Thesis under the framework of the Industrial PhD program 
by the Catalan government has reinforced the availability of resources and the 
practical focus which all the developed signal treatment techniques must fulfill 
in order to be applicable to marketable real-time medical devices. 
Specific objectives of the present Doctoral Thesis are: 
- Research on the available technologies for CO measurement: there is 
a vast amount of literature regarding CO measurement, which has 
historically been an invasive technique. Today, a large number of 
methodologies have appeared promising to be noninvasive and this 
Doctoral Thesis provides a compilation of several research works as 
a background for innovation. 
- Evaluation of the relation between CO and anesthesia: the qCO 
monitor is used to record the CO of patients undergoing anesthesia 
and statistical tests have been conducted in order to quantify the 
effect of anesthesia on CO and other hemodynamic indices. 
- Time-frequency distributions of impedance signals: the complexity 
and variability of ICG signals in both frequency and time domains 
imposed the need to apply time-frequency analysis. Several time-
frequency distributions have been applied to bioimpedance signals: 
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Wigner-Ville, Choi-Williams, Beta Distribution, etc. TFD-derived 
features applied to bioimpedance signals have been extracted with the 
best-performance TFD kernels. 
- Relation between hemodynamic indices and TFD-derived features: 
several studies have been executed in order to investigate whether 
TFD-derived features of impedance signals relate to the 
hemodynamic state of the patient. The relation between 
hemodynamic indices and features derived from Recurrence Plots 
has also been investigated. 
- Statistical comparison between the qCO monitor and other CO 
monitors: in order to check the performance of the algorithms 
developed in this Doctoral Thesis. 
- Publication of a Patent: according to the contractual agreement 
between Universitat Politècnica de Catalunya and Quantium Medical, 
the advancements developed during this Doctoral Thesis must be 
protected. Thus, in order to ensure the rights of the company and to 
foster the society of knowledge, a patent has been submitted with the 
algorithms implemented in the commercial qCO monitor and will be 
owned by Quantium Medical, as agreed with the university. The 
patent will comprise all the processing techniques used to improve 
the calculation of hemodynamic indices. 
1.4 Thesis Framework and Outline 
Quantium Medical specializes in the design and development of 
noninvasive patient monitoring methods and applications in the field of 
anesthesia. Since 2016, Quantium Medical is a Fresenius Kabi company, a 
global healthcare company that specializes in medicines and technologies for 
infusion, transfusion and clinical nutrition. Quantium Medical reinforces 
Fresenius Kabi products by providing monitoring technology for infusion and 
transfusion technology. There has also been a long, fruitful collaboration 
between Quantium Medical and the Automatic Control Department 
(Enginyeria de Sistemes, Automàtica i Informàtica Industrial, ESAII) and 
Biomedical Engineering Research Centre (CREB), both belonging to the 
Universitat Politècnica de Catalunya.  
ESAII and Quantium Medical have led this Doctoral Thesis within the 
framework of the Industrial PhD program of the regional Catalan 
Government (Generalitat de Catalunya, DI-2014). This program aims to 
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contribute to the competitiveness and internationalization of the Catalan 
industrial fabric, retain talent and place doctoral students where they can 
develop research and innovation projects. 
The synergy of both entities under the patronage of the Catalan 
Government has provided a vast amount of resources for this Doctoral Thesis. 
On the one hand, Quantium Medical’s knowledge on the biomedical market 
needs and former experience in anesthesia monitoring have ensured access to 
a large amount of proprietary databases, contacts and know-how. On the 
other hand, the experience of ESAII in biomedical signal processing has been 
a key to success for this project. 
The main techniques developed within this Doctoral Thesis relate to 
template searching, time-frequency characterization for ICG signals, and 
statistical methods for the calculation of CO using the ICG signals. Several of 
these techniques have been implemented and validated onto a new device 
which measures CO in a noninvasive, continuous way. 
1.5 Outline 
After the introduction to the problems analyzed and the main objectives 
of this Doctoral Thesis, Chapter 2 explains all necessary aspects regarding the 
medical and technical background. An introduction to Impedance 
Cardiography and Electrocardiography is also included in the first part of the 
second chapter. It then includes details of the state of the art regarding medical 
devices for CO monitoring. Nowadays, there are several technologies in the 
market which differ in the degree of invasiveness. Nevertheless, more invasive 
technologies imply a higher risk which is not always worth to take and 
therefore, noninvasive technologies are being developed. Impedance 
Cardiography is a promising technology which can combine the 
characteristics required by clinicians for noninvasive CO monitors. Methods 
of validation of CO monitor are also included at the end of this chapter. 
Chapter 3 introduces the databases which have been developed during 
this Doctoral Thesis. The synergies between the private company and the 
public university supervising this Doctoral Thesis have produced numerous 
opportunities for data collection. Finally, this chapter also explains a new 
procedure to create synthetic biomedical signals with known time-frequency 
characteristics. These synthetic database will also be used in subsequent 
chapters. 
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Chapter 4 describes the relationship between heart rate variability, blood 
flow and blood pressure during anesthesia. Anesthesia procedures are one of 
the situations where CO monitors are most useful. Anesthetic drugs exert an 
influence on heart rate variability, blood flow and blood pressure which are 
analyzed in this chapter in order to complement, from a statistical point of 
view, the explanations offered in chapter 2 regarding the medical background. 
Chapter 5 introduces the RC segment as the time difference between 
characteristic points in the electrocardiogram and the impedance cardiogram. 
This RC segment is a measure of the time delay between the electrical and 
mechanical activity of the heart. The RC segment is statistically described in 
different situations and its relationship with blood pressure and heart interval 
is analyzed. The concordance of beat durations of both the electrocardiogram 
and the impedance cardiogram is key to develop new artefact detection 
algorithms and the RC could also have an impact in describing the state of a 
patient. 
Chapter 6 explains time-frequency distributions as a methodology to 
analyze how the frequency content in impedance cardiography signals change 
with time. Since time-frequency distributions are calculated using concrete 
kernels, this chapter focuses on selecting the best kernel by using the synthetic 
signals created in Chapter 3. 
Chapter 7 explores different features derived from the time-frequency 
distributions analyzed in the previous chapter. These features are used to 
discriminate between awakeness and anesthesia states in patients undergoing 
surgery. 
Chapter 8 extends the work in the previous chapter by analyzing the 
behavior of features derived from the time-frequency distributions during the 
whole process of surgical operations. In addition, features from Recurrent 
Plots – a methodology to analyze periodicities in non-stationary signals – are 
also included in the analysis. Relationships between all the presented features 
with hemodynamic parameters and depth of anesthesia are studied. Prediction 
models for CO trained with the before-mentioned features are also created. 
Chapter 9 presents a validation of the CO monitor which has been 
developed during this Doctoral Thesis. The qCO monitor is compared with 
the LiDCOrapid monitor and results on agreement between both methods 
are explained. Finally, the main conclusions of this Doctoral Thesis are 


















This chapter introduces the clinical and technical background for the 
understanding of this Doctoral Thesis. It starts with the physiological aspects 
which justify the analysis of the electrocardiogram (ECG) and impedance 
cardiogram (ICG) signal, which are also explained in detail. Important 
information is also provided regarding blood flow management, monitoring 
during anesthesia, and the variety of cardiac output monitoring technologies. 
Finally, the main validation techniques for cardiac output monitoring are 
explained.  
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2.1 Introduction 
The first part of the present chapter deals with general concepts on 
physiology and hemodynamics: the heart, the circulatory system and its 
nervous connections regulating both blood pressure and blood flow. ECG 
and ICG signals are also detailed. Anesthesia settings are explained with a 
special focus on how important flow monitoring is for patient safety. 
The second major part of this chapter explains the available medical 
device technology. Finally, the design and validation of new medical devices 
is described. 
2.2 Hemodynamics 
Hemodynamics is the study of the blood pumped by the heart across the 
circulatory system. The main components which we need to analyze to 
understand hemodynamics are the heart, as the central part of the circulatory 
system, and the nervous innervation. All these components interact to change 
blood pressure and blood flow, which are central topics in anesthesia 
management. 
2.2.1 The Heart and the Circulatory System 
The heart is a biological pump which supplies the blood flow through the 
blood vessels of the circulatory system. It does so by adjusting the required 
pressure and amount of blood [3]. 
This muscular organ is composed of four chambers (Figure 2.1), two 
superior or atria and two inferior or ventricles. Blood enters the right atrium 
and passes through the right ventricle, which pumps the blood to the lungs 
for oxygenation. The oxygenated blood returns to the heart via the pulmonary 
veins which enter the left atrium. From there, blood flows to the left ventricle. 
The latter is in charge of pumping the blood into the aorta which distributes 
the oxygenated blood through the circulatory system. This pathway is 
described in Figure 2.1. 
The circulatory or cardiovascular system collects the blood pumped by 
the aorta and permits its circulation in order to transport nutrients, oxygen, 
carbon dioxide, etc. Adequate blood circulation is a necessary condition for 
adequate supply of oxygen to all tissues. 
Hemodynamics is concerned with the mechanical and physiological 
properties which control blood pressure and blood flow through the body. 
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Hemodynamic monitoring is the observation of hemodynamic parameters 
over time, such as blood pressure, heart rate or CO. 
 
Figure 2.1 Diagram of the human heart showing the four cardiac chambers, valves, 
arteries and veins (Creative Commons) 
2.2.2 Vagal and Sympathetic Innervation 
The autonomic nervous system is the primary neural mediator of 
physiological responses to internal and external stimuli. It is composed of 2 
branches: the sympathetic nervous system, which ultimately innervates blood 
vessels and the heart, and the parasympathetic (vagal) nervous system, which 
also innervates the heart [4]. 
Sympathetic stimulation of the heart increases the rate of sinoatrial node 
diastolic depolarization, heart rate, atrioventricular conduction velocity 
(positive dromotropy), and heart contractility in the atrial and ventricular 
muscles (increasing the capability of the heart to pump larger volumes of 
blood). Parasympathetic stimulation of the heart has some opposite effects: it 
decreases the rate of diastolic depolarization, heart rate, and the 
atrioventricular conduction velocity.  Sympathetic and parasympathetic 
effects on heart function are mediated by beta-adrenoceptors and muscarinic 
receptors, respectively. One of the most important functions of nervous 
control of the circulation is its capability to cause rapid increases in arterial 
pressure and heart rate, beginning and accomplishing the circulatory 
adaptation within seconds [4]. 
 
2 Background 10 
 
2.2.3 Blood Flow 
Cardiac output is defined as the volume of blood ejected from the heart 
every minute [5]. At rest the normal adult CO is approximately 5–6 L/min 
and the normal cardiac index (CI) is 2.6–3.2 L/min/m2. CO is the product of 
stroke volume (SV) and heart rate (HR). Stroke volume is the volume of blood 
pumped from the left ventricle of the heart per beat and is determined by the 
volume of blood in the ventricles at the end of the diastole (end diastole 
volume or EDV), the impedance to blood flow in arteries (total peripheral 
resistance or TPR) and the strength of ventricular contraction or contractility. 
The typical value of stroke volume is 70 mL and its normal range varies from 
55 to 100 mL. The three major determinants of stroke volume, and thus CO, 
are preload, afterload, and contractility. Preload and contractility are directly 
correlated to stroke volume while afterload is inversely correlated. 
CO = SV · HR (L/min) (1) 
 
Cardiac index (CI) is a parameter which relates the CO from the left 
ventricle to the body surface area (BSA) and it is calculated using (2). The unit 
of measurement is liters per minute per square meter and the BSA is the 
measured or calculated surface area of a human body. It can be approximated 
by several methods and the most widely used is the Du Bois formula reported 




 (L/min/m2) (2) 
 
BSA = 0.007184 · W0.425 · H0.725(m2) (3) 
where W(kg) and H(cm) are the patient’s weight and height, respectively. 
Similar to the cardiac index, the stroke volume index (SVI) relates the 










 (mL/beat/m2) (4) 
Stroke volume variation (SVV) is a natural phenomenon in which the 
stroke volume falls during inspiration and increases during expiration because 
of the changes in intra-thoracic pressure during ventilation. SVV represents 
11 Chapter 2 
 
 
the variation (as a percentage) of SV during the ventilation cycle and is 
traditionally calculated according to Equation (5). 




Currently, there is no consensus on the use of SVV in patients with 
spontaneous ventilation. However, literature supports its usage when patients 
are mechanically ventilated. Normal SVV values are less than 10-15% [6]. 
2.3 ECG Signals 
The electrocardiogram (ECG) is one of the most widely used biomedical 
signals in medical practice since it is a noninvasive measure and can be easily 
acquired. As Figure 2.2, the ECG signal is composed by several waves: a P 
wave, a QRS complex (formed by three waves Q, R, and S), a T wave, and 
occasionally a U wave. The QRS complex is the reference point for ECG 
applications because it is the most prominent wave in the cardiac cycle. 
 
Figure 2.2 A pair of cardiac beats with the P and T waves and the QRS complex. 
The RR segment is the distance between two consecutive R peaks  
The ECG signal may be affected by several sources of noise and 
interferences, which can significantly alter the morphology of the signal, 
producing errors in the measurement systems. The most common noise or 
interferences are: (a). baseline wandering due to for example respiration signal 
or movements of patient; (b). electromyographic (EMG) noise; (c). 50/60 Hz 
power line interference; (d). electrosurgical instruments interferences [7].  
From the QRS detection standpoint, noise might also have physiological 
origins, i.e., tall P or T waves, ectopic beats, etc. These noises or interferences 
cause extreme values in the inter-beat interval time series which are seen in 
form of false positive (FP, non-existent QRS complex is detected as true) or 
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However, a normal-to-normal (NN) time series, i.e., a clear R-R time series 
(free of artifacts or ectopic beats), is crucial for a proper heart rate variability 
analysis [8] which is an important part of the qCO monitor. 
Furthermore, the detection of characteristic points in the impedance 
cardiogram might also depend on the position of the R peak in the ECG. 
Thus, any algorithm implemented for the QRS complex identification has to 
be able to reject or to at least attenuate the adverse effects of such noise 
sources. 
2.4 ICG Signals 
Impedance cardiography is the study of cardiac function determined 
from measurements of the electrical impedance of the thorax [9]. Typically, 
the impedance is measured at around 50 kHz using currents of around 1 mA 
rms, which ensures no physiological effects. Four electrodes are situated on 
the patient: two on the neck and two on the lower end of the thorax. The 
outer electrodes supply the current and the inner electrodes are used for 
voltage pick-up. 
As shown in Figure 2.3, during systole, the impedance Z decreases which 
fosters the assumption that the blood volume in the region measured has 
increased. On the ICG waveform, the letters represent labels to indicate 
cardiac activity: A. atrial activity, B. synchronous wave with first heart sound, 
C. largest decrease in impedance during systole, X. aortic wave closure, Y. 
pulmonary valve closure and O. largest decrease in impedance during diastole. 
The CC segment is the heart period in the ICG.  
 
Figure 2.3 Typical impedance waveforms from the thorax of a human subject: (A) 
impedance wave Z; (B) ICG signal with all characteristic points; (C) ECG signal 
with R peaks, RR heart period and RC segment (distance between R peaks in the 
ECG and C peaks in the ICG) 
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In Figure 2.3, the ECG is also included to show the RR segment, the 
heart period in the ECG, and the RC segment which is the difference between 
the C peak in the ICG and the R peak in the ECG. The RC segment will be 
further explained in Chapter 5. 
2.5 Anesthesia in the Operating Room 
2.5.1 Introduction 
Anesthesia aims at three objectives: hypnosis, analgesia, and muscle 
relaxation. This is achieved by the use of intravenous or inhalational 
anesthetics. The most common hypnotic, inhaled drugs are nitrous oxide, 
sevoflurane and desflurane while barbiturates, benzodiazepines, ketamine, 
and propofol are some of the main intravenous anesthetic drugs [10]. 
Analgesia refers to the avoidance of pain in the patient. Some of the most 
common analgesics are fentanyl, remifentanil and alfentanil. These drugs 
cancel the sensation of pain, resulting in a sedation state and a respiratory 
depression. As a consequence of decreased alveolar ventilation, the pressure 
of CO2 in blood increases, whereas arterial pH and the pressure of O2 in blood 
decreases. The degree of depression not only depends on the dose but also 
on the route of administration and speed of access to the central nervous 
system [10]. 
During anesthesia, remifentanil is known to cause hypotension and 
bradycardia either by parasympathetic activation or by other negative 
chronotropic effects [11]–[14]. Remifentanil also decreases sympathetic action 
[15]. Propofol during anesthesia reduces parasympathetic tone to a lesser 
degree than sympathetic tone [16]–[24]. The combination of remifentanil and 
propofol could therefore imply a maintained or slightly reduced vagal tone 
and a reduced sympathetic tone. 
Neuromuscular blocking agents (NMBA) are used to facilitate operations 
which require muscular tissues to be relaxed such as endotracheal intubation. 
NMBAs can be depolarizing and non-depolarizing. Non-depolarizing 
muscular relaxants (NMR) such as pancuronium, vecuronium, coruronium, 
atracurium, cisatracurium and mivacurium prevent the depolarization from 
happening so that the muscle action potentials are not propagated  [10]. 
Not a single drug produces all the effects required during a surgery. 
Therefore, combinations of different drugs are used. Over-dosages or under-
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dosages are to be avoided during anesthesia procedures and therefore 
different methods are used to monitor the degree of anesthesia and analgesia. 
Several technologies have been developed during the last years. 
In this Doctoral Thesis, the Conox® monitor (Quantium Medical, 
Barcelona) has been used during the registration of several databases to 
investigate the relationship between ICG characteristics and the patient’s 
depth of anesthesia. The Conox monitor includes a depth-of-anesthesia index, 
qCON, which ranges from 0 to 99. This index can be divided into four 
different patient states: awakeness (qCON > 80), sedation (qCON ∈ [60, 80]), 
general anesthesia (qCON ∈ [40, 60]) and deep anesthesia (qCON < 40). 
2.5.2 Importance of Flow Monitoring in the Operating 
Room 
Oxygen is constantly required to maintain aerobic metabolism in human 
tissues. Low cardiac output and/or inadequate oxygen transportation in the 
blood can impair this oxygen supply. When this impairment is severe, the 
body tissues slowly revert to anaerobic metabolism, producing toxic metabolic 
breakdown products, such as lactic acid. Therefore, maintenance of cardiac 
output above the minimum threshold for aerobic metabolism is necessary for 
the health and survival of body tissues [25]. 
Critical illness or major surgery are two situations when a systemic 
inflammatory response syndrome might occur. This syndrome causes an 
increased demand of oxygen which results in compensation mechanism to 
meet such demand. Failure to increase cardiac output can lead to tissue 
hypoxia and an eventual organ dysfunction. Therefore, monitoring of cardiac 
output is vital in these situations. In fact, researchers have reported that low 
cardiac output in critically ill patients may be related to increased morbidity 
and mortality [25]. 
In patients with insufficient tissue perfusion, fluid resuscitation is often 
the first option. Nevertheless, only 50% of hemodynamically unstable patients 
have been reported to be volume responsive [26]. Volume responsiveness is 
the situation when an increase in patients’ fluids corresponds to an increase in 
stroke volume. Fluid resuscitation aims to increase the stroke volume and 
therefore in unresponsive patients this therapy is not beneficial at all. 
Therefore, fluid challenges also require monitoring blood flow. 
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2.5.3 Fluid Management 
During an operation, the classical approach to fluid management used to 
be based on the prediction of the amount of fluids needed during the surgery 
based on the duration and severity of the particular operation. Fluids were 
therefore empirically replaced based on these calculations. 
Nowadays, fluid management is based on the concept of goal-directed 
therapy (GDT). Fluid management strategies based on stroke volume 
optimization are extremely well-validated approaches that have shown to 
reduce patient morbidity [27]–[30]. 
During surgery, hypovolemia (decreased blood volume) and 
hypervolemia (excessive body fluid) represent a severe risk for patients and 
either situation is related to higher perioperative morbidity risk [31]. 
Hypovolemic situations are related to tissue hypoxia, organ failure, 
tachycardia, hypotension, renal failure, etc. Hypervolemic situations are 
related to volume overload, poor oxygenation, organ failure, peripheral edema, 
respiratory failure, poor wound healing, etc. In Figure 2.4, discontinuous line 
B represents a division between patients who are hypovolemic and 
hipervolemic. Discontinuous line C represents the limits over which the risk 
associated to the hypovolemic and the hypervolemic situations increases 
dramatically. 
 
Figure 2.4 Lines of risk in fluid management during surgery [31]: discontinuous 
line B separates hypovolemic and hypervolemic patients and discontinuous line C 
represents the limit of excessive patient risk. Patients should be loaded with fluids 
so that the morbidity risk is minimized 
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In fluid management strategies, the ideal approach should be able to 
define the nadir of the curve in Figure 2.4 in a tight manner [31] in order to 
maintain the patient in such state. However, this requires individualized 
measurements since the volume required to achieve this may vary dramatically 
between patients even in the same standard of care [32]. However, this nadir 
point can be analyzed by the Frank-Starling law. This law represents the 
relationship of the stroke volume and the end diastolic volume or the venous 
return and the right atrial pressure (RAP). 
 
Figure 2.5 Frank-Starling law of the heart. As preload increases, cardiac output 
increases and venous return decreases and there is an operating point which makes 
cardiac output equal venous return 
The red curves in Figure 2.5 represent the relationship between the CO 
and the end-diastolic volume (EDV) and the different curves depend on the 
contractility of the heart. If contractility of the heart, i.e., the strength of the 
myocardial fibers of the heart, increases, the amount of blood which is 
pumped out by the heart increases. The blue curves in the figure represent the 
relationship of the RAP as a consequence of the venous return. Both venous 
return and RAP increase as the blood volume increases [33]. The optimal 
point is therefore the point in which the venous return (i.e., the input into the 
heart) equals the CO (i.e., the output of the heart). The optimal point can be 
achieved when fluid is infused in a patient until CO stops growing in a linear 
fashion. 
17 Chapter 2 
 
 
2.6 Medical Devices Technology for Cardiac 
Output Monitoring 
Over the last years, there has been a great variety of reviews and papers 
on the available methods to measure CO [2], [25], [26], [34], [35]. Generally, 
the most ideal CO monitor should be reliable, continuous, noninvasive, 
operator-independent and cost-effective and should have a fast-response time 
[2]. This subsection includes a review of the main techniques available, which 
are classified as invasive, minimally invasive and noninvasive. 
2.6.1 Invasive Monitoring 
In the late 19th century, Adolph 
Fick described how the changes in the 
concentration of a substance dissolved 
in blood could be used as an indicator 
for determining the blood flow. This 
concept was known as the Fick 
principle but never reached the clinical 
practice. 
Today, the pulmonary artery 
catheter (PAC) or Swan-Ganz catheter 
using the thermodilution technique is 
still considered to be the gold standard. 
As Figure 2.6 shows, the catheter is 
introduced through a large vein, 
threaded though the right atrium of the heart, the right ventricle, and the 
pulmonary artery. An inflatable balloon at the tip inflates and can provide an 
indirect measurement of the pressure in the left atrium of the heart. A small 
thermistor behind the tip detects the passage of a cooler fluid and can then 
calculate the CO in the heart thanks to a thermodilution curve. 
Despite being the gold standard, the use of this method is only 
recommended in patients in extreme situations with whom the benefits of a 
higher accuracy compensate for the higher risks. Abundant complications of 
PACs have been reported: damage to carotid and subclavian artery, 
pneumothorax, dysrhythmias, perforation of heart chambers, tamponade, 
valve damage, etc. Furthermore, issues arising with its usage and related to 
Figure 2.6 Swan-Ganz catheter for 
cardiac output measurements 
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operator, indicator and patient pathologies have to be emphasized [36]. Its use 
in low-risk cardiac surgery, vascular surgery and major abdominal, orthopedic 
or neurosurgical procedures is therefore not justified and minimally invasive 
or noninvasive alternatives are recommended. 
2.6.2 Minimally Invasive Monitoring 
There are several systems to measure CO which are considered semi-
invasive or even minimally invasive. Transesophageal aortic Doppler 
ultrasound in the descending aorta can also be performed [37]–[40]. Special 
Doppler probes have been developed [ODMII (Abbott, Maidenhead, UK); 
CardioQ/Medicina TECO (Deltex Medical Ltd, Chichester, UK); 
HemoSonic100 (Arrow, Reading, Pennsylvania, USA)] although its clinical 
practice is very limited. In these devices, CO is calculated with the velocity 
time integral derived from the Doppler signal and the aortic cross-sectional 
area, which is estimated. 
Other monitoring devices are based on the concept of pulse contour 
analysis or pulse wave analysis (PWA or PCA). This is based on the relation 
between blood pressure, stroke volume, arterial compliance and systemic 
vascular resistance (SVR). Flow indices can be calculated from the arterial 
pressure waveform if the arterial compliance and the SVR are known and 
different monitors use different approaches to obtain these variables in a 
minimally invasive way. 
The PiCCO (Pulsion Medical Systems, Munich, Germany) combines 
pulse contour analysis with the transpulmonary thermodilution via femoral 
access [41]–[45]. It calculates the area under the systolic portion of the arterial 
waveform and it requires both central venous and central arterial 
catheterization. The calibration provided by the thermodilution remains 
accurate for six hours. It offers a broad range of hemodynamic parameters 
(including SVV) and is robust during hemodynamic instability. 
The LiDCO system (LiDCO Ltd, London, UK) combines pulse contour 
analysis with lithium indicator dilution for continuous SV and SVV 
monitoring [38], [46]–[50]. This indicator is used to calibrate the measurement: 
lithium is injected into a peripheral vein and does not have an effect from a 
pharmacological point of view. It requires recalibration after acute 
hemodynamic changes. It obtains multiple cardiac parameters (such as SVV 
and SVR) by calculation of the root-mean-square value of the arterial pressure 
signal. 
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The FloTrac sensor combined with the Vigileo monitor (Edwards 
Lifesciences, Irvine, California, USA) also uses pulse contour analysis but 
requires no calibration. Instead, it needs some patient demographic and 
physical characteristics and a peripheral arterial catheter only to execute an 
automated, internal calibration. It is based on the calculation of a standard 
deviation of 2,000 arterial waveform points. Its main advantage is that it is 
minimally invasive, operator independent and easy to use. Its weak points are 
that it is inaccurate especially in vasoplegic patients and does not accurately 
track changes in SV [40], [50]–[54]. 
2.6.3 Noninvasive Monitoring 
The ClearSight system (Edwards Lifesciences, Irvine, California, USA) 
provides noninvasive continuous blood pressure and CO through the method 
of the volume clamp. It involves clamping the finger artery with a cuff to a 
constant volume by dynamically providing equal pressure on either side of the 
arterial wall [42], [43], [55], [56]. This volume is measured by a photo-
plethysmograph built into the cuff. The ClearSight system inherits from the 
former Nexfin system (BMEye, Amsterdam, The Netherlands). The CNAP 
system (CNSystems Medizintechnik AG, Graz, Austria) also provides 
noninvasive continuous arterial pressure measurements by using the volume 
clamp method [57], [58]. 
The MostCare system (Vytech Health, Padova, Italy) uses pulse contour 
analysis and it calculates the area under the curve of the arterial waveform with 
no external calibration or pre-estimated data. It uses high time resolution 
(1,000 Hz) and it analyzes the entire cardiac cycle [59]. 
Pulse wave transit time (PWTT) is defined as the time between the R-
wave in the ECG and the pulse wave rise-point assessed by pulse oximetry 
[60], [61]. The esCCO technology (Nihon Kohden) uses this technology by 
analyzing the ECG, the pulse oximeter waveform and the arterial pressure and 
it is based on an inverse correlation between the PWTT and the SV. 
The partial CO2 rebreathing technique evaluates respiratory CO2 and 
applies the Fick principle to calculate CO [37], [62], [63]. Pulmonary blood 
flow can be calculated by relating the content of alveolar gas in pulmonary 
capillary blood to the quantity of gas passing to the lung. 
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The transthoracic Doppler (USCOM, Sidney, Australia) determines CO 
via flow measurements at the aortic or pulmonary valve but it requires a 
considerable level of experience for its usage and is not suitable for thoracic 
surgery [40], [63]. 
Electrical Bioimpedance 
Electrical bioimpedance is a promising method which relies on the fact 
that the impedance of the thorax is dependent on the amount of fluid in the 
thoracic compartment. Standard bioimpedance systems apply a high-
frequency electric current of known amplitude and frequency across the 
thorax and measure changes in voltage. The ratio between voltage and current 
amplitudes is a measure of transthoracic direct current resistance and varies in 
proportion to the amount of fluid in the thorax. CO is then computed based 
on mathematical equations under the assumption that thoracic impedance 
changes over time are proportional to the stroke volume. 
Drawbacks of this technique include motion artifact, arrhythmias, 
pulmonary edema, and pleural effusions among others [64]. However, the 
totally noninvasive character of this technology exceeds these limitations. 
There have been other attempts to use this technology in the past. 
Drazner and his colleagues studied patients with cardiomyopathy and found 
modest agreement between bioimpedance and thermodilution cardiac output 
monitoring [65]. Moreover, in Spiess’ work general agreement was found in 
cardiac output from bioimpedance and pulmonary artery thermodilution [66]. 
In 2009 Simon and his colleagues reported a device named ICG Monitor 
862146 (Phillips Medical System) which showed a significant statistical 
relation with the PAC. Unfortunately, the error percentage was 49% and this 
monitor ceased to exist some years ago [67]. SonoSite also discontinued its 
ICG monitor named BioZ in 2013 due to a business decision. 
Electrical velocimetry [68] is a novel algorithm of electrical impedance 
cardiography used by the AESCULON monitor (Osypka Medical, Berlin, 
Germany). This algorithm includes the maximum rate of change of impedance 
of peak aortic blood acceleration. 
Thoracic bioreactance [69] is another evolution of the electrical 
bioimpedance method which seeks to improve the signal-to-noise ratio using 
the bioreactance, which represents the phase shift in voltage across the thorax. 
The only commercially available system at present (NICOM, Cheetah Medical, 
Portland, Oregon, USA) uses 4 electrode patches each consisting of 2 
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electrodes and calculates cardiac output separately for the right and left side 
of the body with the final cardiac output being the average of these two values. 
The qCO monitor (Quantium Medical) 
A large quantity of studies 
evaluating and comparing different 
cardiac output monitors have been 
published [2], [25], [26], [34], [35], 
[39], [61], [63], [64], [67], [68], [70]–
[79]. The new qCO monitor, by 
Quantium Medical, seeks to learn 
from past experiences and introduce 
new, advanced processing 
techniques to improve the cardiac 
output calculations. The new signal 
processing techniques in artifact 
removal and in time-frequency 
characterization are some interesting 
options to obtain a cardiac output monitor which improves the fulfillment of 
current market requirements compared to previous experiences. 
The qCO monitor records the ICG and ECG signals by using 4 
electrodes, with one pair injecting a constant current (at 50 kHz), and a second 
pair of electrodes measuring the resulting voltage (Figure 2.7). The voltage is 
amplified and digitized with a sampling frequency of 1,000 Hz. The qCO 
monitor uses the information from the impedance curve to calculate different 
hemodynamic indices. 
2.7 Validation Techniques for Hemodynamic and 
Anesthesia Monitors 
During the last years, the number of available monitors which claim to 
analyze the patient’s hemodynamic situation in a noninvasive manner has 
considerably increased. Therefore, it is of outmost importance to select a 
range of techniques which permits comparing the different technological 
options which either have been launched into the market or are currently 
being developed. 
 
Figure 2.7 Location of the qCO 
electrodes. There are two exciting and two 
sensing electrodes positioned on the neck 
and on the side of the body under the ribs 
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2.7.1 Time Plot and Regression Plots 
Some authors use simple time plots in which the results from both 
methods are plotted against time (either in seconds or samples). These 
methods permit to compare visually whether the indices calculated by two or 
more methods diverge. 
Regression plots compare the values of one method versus the values of 
the other method. This plot usually includes a regression analysis with the 
Pearson’s correlation coefficient. In the example in Figure 2.8, in plot (A) 
both methods have similar results and thus data points lie along the line of 
identity. However, in plot (B) there is a discrepancy causing the regression line 
not to coincide with the line of identity, which is not detected by Pearson’s 
correlation coefficient. 
 
Figure 2.8 Regression plots for CO trending: cardiac output (CO) data 
demonstrate trending ability by lying along the line of regression, which lies along 
the line of identity (A) or with an offset (B)[80]  
2.7.2 Bland-Altman Plots 
The most popular method to evaluate cardiac output monitors is the 
Bland and Altman method [81]. This method analyzes the agreement between 
two different assays by plotting the mean of the two measurements as the 
abscissa value against the difference of the measurements as the ordinate value. 
Let S1  and S2  be the measurement given by two different methods, the 
Cartesian coordinates of a given sample S is: 
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 S(x, y) = (
S1 + S2
2
, (S1 − S2)) (6) 
The 95% limits of agreement for each comparison are usually computed 
as the average difference ± 1.96 standard deviation of the difference. This 
explains how distant measurements by the two methods are more likely to be 
for most individuals. If the differences within mean ± 1.96 standard deviation 
(SD) are not clinically significant, the two methods may be used 
interchangeably. 
Nevertheless, the Bland and Altman method only describes the 
coincidence of the evaluated method with the reference method but does not 
show whether the new method reliably detects changes in cardiac output or 
trending. Monitors can still be useful if they are capable of showing trends 
despite not providing a reliable measure of the absolute value of the cardiac 
output. 
Critchley and Critchley [79] stated that when bias and precision statistics 
were used, mean cardiac output, bias, limits of agreement, and percentage 
error should be presented. Using current reference methods, acceptance of a 
new technique should rely on limits of agreement of up to ±30%. 
 
Adjustment for Pooled Data 
Bland and Altman plots consider that data points are statistically 
independent which is not true when repeated measures are taken from the 
same patient. This coupling of data results in smaller standard deviations and 
produces limits of agreement that underestimate the true variability of the 
readings. Both Bland and Altman [82] and Myles and Cui [83] have published 
articles that provide guidance on how to correct the analysis and limits of the 
agreement in the repeated-measures model. 
2.7.3 The Four-Quadrant Plots 
The four-quadrant plot was proposed by Perrino and his colleagues in 
1994 [84]. It was presented as an analytical method based on regression 
analysis and concordance to compare a test device and a reference device. The 
figure plots the difference of the test cardiac output ΔCOtest  against the 
difference of the reference cardiac output ΔCORef. The pairs of values in the 
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center of the plot should be scattered around the four quadrants, which bring 
no statistical significance and thus are excluded in many studies. However, the 
pairs of data (ΔCOtest, ΔCORef) outside the exclusion zone tend to fall into only 
one of the quadrants on the line of identity. Concordance in these plots is 
expressed as the percentage of data points falling in only one of the quadrants. 
Figure 2.9 shows an example of the four-quadrant plot. 
These four-quadrant plots offer more information on trending than other 
methods presented before. Exclusion zones are usually taken as 0.5 L/min, 1 
L/min or < 10-15% of percentage change. Concordance rates should be > 
90% to indicate reliable trending ability. Nevertheless, it should not be 
forgotten that the four-quadrant plot obliterates information about the 
magnitude of the underlying CO change and the absolute difference between 
measures. 
 
Figure 2.9 Four-Quadrant Scattergram which illustrates the trending capability of 
the Transesophageal Doppler [84]  
 
2.7.4 The Polar Plot 
To overcome the deficiencies of the four-quadrant plot, Critchley and his 
colleagues [80] suggest to convert the pairs ( ΔCOtest, ΔCORef ) to polar 
coordinates, where agreement is shown by the angle the vector makes with 
the line of identity and the magnitude of change by length of the vector. In 
Figure 2.10, reproduced from the same work, polar plots perfectly show 
trending ability. For instance, polar plot (A) shows how most of the points lie 
within the 0.5 L/min as a sign of good trending ability, while in polar plot (C) 
many points lie outside the limits of agreement of 0.5 L/min. 
 




Figure 2.10 Polar plots used to show trending ability. The distance from the center 
of the plot represents the mean change in cardiac output (ΔCO) and the angle with 
the horizontal axis represents agreement. Data with good trending in (A) and (B) 
will lie within 0.5 L/min, or 10%, limits of agreement, compared to (C) and (D) 
[80] 
2.7.5 Prediction Probability 𝐏𝐤 
The prediction probability Pk is a performance measure recommended 
especially when comparing depth-of-anesthesia indicators with a gold 
standard. In such cases, Smith and his colleagues [85] propose to use the 
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prediction probability Pk and several authors have employed this performance 
measure [52]–[56]. 
This statistical measure is able to show the prediction probability with no 
dependence on scale units and it does not require knowing underlying 
distributions, linearizing or transforming scales. The Pk  value must be 
between 0 and 1 and these extreme values are interpreted as an exact 
prediction, negative or positive, respectively. Meanwhile, a result of 0.5 implies 




















This chapter contains the description of the databases used throughout 
the entire Doctoral Thesis. The databases have been recorded in a large variety 
of locations in Barcelona and Santiago de Compostela (Spain), Hong Kong 
and Shanghai (People’s Republic of China). A synthetic signal database is also 
explained in this chapter. 
  
3 
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3.1 Introduction to Clinical Trials 
The collaboration between private and public entities has produced a 
large quantity of clinical data. The preparation of clinical trial protocols has 
also been a relevant part of the work completed in this Doctoral Thesis. Some 
important details to be defined in protocols are as follows: 
- Rationale of the study 
- Objectives: main and secondary study parameters 
- Study design 
- Study population: inclusion and exclusion criteria, sample size 
calculation 
- Treatment of subjects 
- Investigational medical devices 
- Non-investigational medical devices 
- Methods: randomization, withdrawal of individuals, etc. 
- Safety reporting 
- Statistical analysis: primary and secondary study parameters, statistical 
tests, interim analysis (if any), etc. 
- Risk analysis 
- Ethical considerations 
- Administrative aspects: data protection, reporting, etc. 
3.2 Shanghai Database 
3.2.1 Aims of the Protocol 
The aim of this protocol was to estimate the cardiovascular and cerebral 
synchronization between cardiovascular and brain oscillators. Brain oscillators 
are the different frequencies contained in the EEG. Example of brain 
cardiovascular oscillators are the heart rate and the respiratory rate. The 
relationship between oscillators was already studied by Musizza [92]. 
Furthermore, Steriade showed that oscillators were desynchronized during the 
patient’s awake state unlike during anesthesia [93]. 
3.2.2 Recorded Data Description 
Fifteen patients undergoing major surgery under general anesthesia at the 
Zhongshan Hospital in Shanghai were assessed in this observational study. 
Details of the patients and operations are reported in Table 3.1. Age ranged 
between 43 and 67 years, with a mean age of 58.9 ± 6.7. 
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The anesthesia was induced with propofol and remifentanil or fentanyl 
and sevoflurane was also used for maintenance. Rocuronium, a non-
depolarizing agent, was administered to block neuromuscular response. In 
some cases lidocaine, morphine, atropine or ephedrine were additionally 
administered. Surface wet-get electrodes (Ambu® BlueSensor for ECG) were 
used for the qCO monitor. The pressure waveform for LiDCOrapid was 
obtained with an arterial line. The recordings were assessed simultaneously 
during the complete procedure, from 3 minutes before induction of anesthesia 
to 3 minutes after the recovery. The ICG and ECG signals were recorded by 
the qCO monitor (Quantium Medical, Spain). 
  SHANGHAI DATABASE PATIENT CHARACTERISTICS 
Gender (male:female) 9:6 
Age (years) 58.9 ± 6.7 
Height (cm) 163.7 ± 6.8 
Weight (kg) 61.1 ± 9.1 
BMI (kg m-2) 22.8 ± 2.6 
  
Operative procedure 
(No. of patients) 
Mastectomy (1) 
Carotid endarterectomy (1) 
Cytoreductive surgery (1) 
Gastrostomy (2) 
Hepatectomy (2) 
 Nephrectomy (1) 
 Ovarian cystectomy (1) 
 Thyroidectomy (1) 
 Uretescope lithotripsy (4) 
 Hysteroscopic Resection (1) 
  
Table 3.1 Patient Characteristics. Qualitative data are given as absolute 
frequencies. Age, Height, Weight and body mass index (BMI) are given as mean ± 
standard deviation 
This observational study adhered to the principles of the Declaration of 
Helsinki and it was conducted in compliance with the requirements of the 
Zhongshan Hospital Ethical Committee. Exclusion criteria were patients 
under eighteen years old and pregnant women. Different types of surgeries 
were included in this database since the objective was the direct comparison 
between cardiac output monitors in a large variety of clinical situations. 
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3.3 CMA Database 
3.3.1 Aims of the Protocol 
The objective of this protocol was to register physiological data in order 
to validate eventual indicators of anesthetic effects. It was conducted at the 
Hospital CLINIC de Barcelona (Spain) under the leadership of D. Pedro Luís 
Gambús, from the Anesthesia department. 
3.3.2 Recorded Data Description 
One hundred and fifty-three patients undergoing major surgery under 
general anesthesia were assessed in this observational study. Details of the 
patients are reported in Table 3.2. Age ranged between 18 and 88 years, with 
a mean age of 50.9 ± 16.4 years and a mean body mass index (BMI) of 25.8 
± 4.6 kg/m². 
  CMA DATABASE PATIENT CHARACTERISTICS 
Gender (male:female) 37:116 
Age (years) 50.9 ± 16.4 
Height (cm) 162.2 ± 8.2 
Weight (kg) 67.8 ± 12.7 
BSA (m2) 1.73 ± 0.21 
BMI (kg/m2) 25.8 ± 4.6  
Table 3.2 Patient Characteristics. Gender is given as an absolute frequency. Age, 
Height, Weight, body surface area (BSA) and body mass index (BMI) are given as 
mean ± standard deviation 
Patients were administered propofol and remifentanil. Anesthesia was 
induced with a target-controlled infusion system (TCI). The infusion rate of 
remifentanil was controlled by Minto’s pharmacokinetic-pharmacodynamic 
model with 3 ng/mL (range 1.5 to 5 ng/mL) as effect-site target concentration 
and the infusion rate of propofol was controlled by Schnider’s 
pharmacokinetic model with 7 μg/mL (range 6 to 10 μg/mL) as effect-site 
target concentration [94], [95]. Rocuronium, a short-to-intermediate-term 
muscle relaxant, was administered only in those cases requiring laryngoscopy 
(54 cases, 35.3%). The single bolus dose of rocuronium was 30 mg 
administered 2 minutes before laryngoscopy. In two cases, the initial dose was 
40 mg. 
After intubation, anesthesia was maintained with propofol and 
remifentanil whose target concentrations were lowered according to the 
clinician’s criteria to an average of 4 μg/mL (range 2 to 7 μg/mL) and 2 
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ng/mL (range 1.5 to 4 ng/mL), respectively. Additional maintenance doses of 
rocuronium were used in the form of 10 mg or 20 mg boluses when needed. 
In some cases, ephedrine and atropine were additionally administered, as 
Table 3.3 shows. Methadone was used at the end of surgery as an analgesic 
in 31% of patients. 
The impedance cardiography and electrocardiogram were recorded by 
the qCO monitor (Quantium Medical, Spain). The Infinity® Gamma monitor 
(Dräger, Germany) for blood pressure was also used. It offered systolic blood 
pressure (SBP: the maximum value of the arterial pressure waveform inside 
the consecutive RR interval), the diastolic blood pressure (DBP: the following 
minimum value of the pressure waveform) and mean blood pressure (MBP: 
the average arterial pressure during a single cardiac cycle). The recordings were 
assessed simultaneously during the complete procedure.  
  CMA DATABASE PATIENT CHARACTERISTICS 
Propofol 153 (100%) 
Remifentanil 153 (100%) 
Rocuronium 54 (35.3%) 
Methadone 47 (30.7%) 
Ephedrine 5 (3.3%) 
Atropine 26 (17.0%) 
Table 3.3 Medications during surgical procedures. Data are presented as absolute 
frequencies and percentages over the total sample 
This observational study was conducted in compliance with the 
requirements of the Hospital CLINIC de Barcelona. All patients gave their 
written informed consent. The protocol adhered to the principles of the 
Declaration of Helsinki and it was approved by the Institutional Review Board 
of Hospital CLINIC de Barcelona. Patients under eighteen years old or 
morbidly obese were excluded from the study. 
3.4 Other Databases 
Some other clinical trials have taken or are taking place thanks to this 
Doctoral Thesis. The institutions where these studies have taken place are as 
follows: 
- Prince of Wales Hospital (Shatin, Hong Kong Special Administrative 
Region, People’s Republic of China): fluid challenge, tilt changes and 
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bleeding challenges were applied to fifteen pigs in order to validate 
the qCO monitor ability to detect those changes. 
- Hospital Clínico Universitario de Santiago (Santiago de Compostela, 
Spain): a comparison between the qCO monitor and FloTrac monitor 
is currently taking place. 
- Universitair Medisch Centrum Groningen (Groningen, the 
Netherland): a clinical trial to study qCO monitor’s ability to track 
fluid challenges is expected to start in January 2018. 
3.5 Synthetic Signals 
Using the Shanghai database, synthetic ICG signals were generated in 
order to use them when known time-frequency characteristics are necessary. 
This synthetic signals are used for the evaluation of TFDs in Chapter 6. 
In order to construct these synthetic signals, the most typical waveform 
of a real ICG recording was recognized. In our case, a randomly chosen 
patient from the Shanghai database was chosen. This pattern was later used 
to create a Fourier-model approximation with several instantaneous 
frequencies (IFs) and synthetic signals were created including concrete 
variable time-frequency characteristics. 
3.5.1 Pattern Recognition 
A pattern recognition algorithm was designed to detect the most typical 
waveforms which are contained in the ICG signals. Each ICG beat was 
isolated and normalized for zero mean and unit standard deviation. Moreover, 
the length of all ICG beats was resampled to a constant number of samples. 
The starting and end points were defined as the QRS peaks in the ECG before 
and after an ICG maximal peak. Moreover, ICG maxima were located using 
the QRS peaks in the ECG as an initial search point. QRS peaks are easy to 
locate with a Pan-Tompkins approach [96] 
The first pattern of the database was the first ICG beat available in the 
recording. The rest of ICG beats were correlated with all the patterns in the 
database. For each ICG beat, the pattern which offered a higher Pearson 
correlation above a threshold th with the beat was then averaged with such 
beat. Two correlation thresholds were independently studies: th > 0.85 and  
th > 0.90. If the correlation threshold was not met, a new pattern was created. 
Moreover, the algorithm ensured that there will not be two patterns with a 
cross-correlation higher than 0.95. All this procedure is explained in Figure 
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3.1. In this concrete implementation, when there are 100 patterns, infrequent 
patterns (<10 repetitions) are canceled. 
 
Figure 3.1 Flowchart of the ICG pattern recognition algorithm. Each new beat is 
normalized and correlated with the rest of the pattern database. The pattern for 
which the best correlation above 0.90 is obtained is updated with the new beat. 
Infrequent patterns are also regularly canceled 
3.5.2 Template Fourier Modelling 
A periodic signal with a frequency 𝜔n = 2𝜋/Np can be represented as a 
Fourier series according to Equation (7). This Fourier series requires an 
infinite number of terms to accurately reproduce the square wave signal. 
Generally, a Fourier model for the pattern ICG signal will have a structure 
with a defined number of terms of a discrete-time Fourier series of frequency 
𝜔n = 2𝜋/Np where Np will be the length of the single pattern. 
x(t) =  ∑[an cos(n𝛺0t) + bn sin(n𝛺0t)]
∞
n=0





where an y bn are real constants and cn is a complex constant. 
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Equation (7) implies that the Fourier series requires an infinite number 
of terms to exactly reproduce the original signal. If this series is truncated, the 
accuracy of the representation decreases. 
3.5.3 Fourier Modelling with Time-Frequency Variations 
The Fourier model for the template signal allows modifying the time-
frequency characteristics of a longer signal x(n)  in a controlled, 
straightforward fashion, similar to the time-frequency dependency in chirp 
signals. 
Linear and Quadratic Variations 
The frequency sweeps considered were linear, which specifies an 
instantaneous frequency IF sweep given by 
IF(n) = f0 + Bn (8) 
B = (f1 − f0)/2n1 (9) 
In the linear sweep, B ensures that the desired frequency breakpoint f1 at 
the time n = n1 is maintained departing from an initial frequency f0 at the 
time n = 0. For ICG signals, it would be desirable to implement frequency 
variations from f0 = 50 bpm to f1 = 90 bpm in n1 = 10 seconds in order to 
test extremely variable conditions. 
Furthermore, this frequency sweep can also be quadratic by using 
Equations (10) and (11). 
IF(t) = f0 + Bt
2 (10) 




In total, 7,544 beats were analyzed for the first patient. The correlation 
threshold of 0.85 produced 92 different patterns with at least 4 appearances 
but 8 patterns covered more than 60% of beats. Figure 3.2 shows the most 
typical patterns for this correlation threshold. 
A correlation threshold of 0.90 was also studied for comparison. The 
ICG patterns obtained using either threshold were very similar. However, the 
number of patterns with at least 100 repetitions differ between both 
thresholds: it was higher with the th = 0.90 (11 patterns) compared to 10 
35 Chapter 3 
 
 
relevant patterns obtained with a th = 0.85. Moreover, the main pattern was 
appeared 699 times in the case of the th = 0.90, while in the case of the th = 
0.85, the same pattern was repeated 1,154 times. 
 
Figure 3.2 Five most frequent patterns in an ICG recording calculated with a 
correlation threshold of 0.85 
The most repetitive pattern with th = 0.85 was selected as the template 
for the Fourier modeling. However, it was necessary to slightly modify the 
endpoints of the signal with a smoothing window so that the beginning and 
the end of the templates happen to meet at the same point without creating 
noticeable transitions when concatenating several templates together to form 
a longer signal. All templates have been normalized to zero mean and adjusted 
to a length Np = 200 samples. 
Two-Term Fourier Model Approximation Results 
An approximation of two tones has been used for the Fourier series with 
a fixed frequency. The results of the model can be observed in Figure 3.3. 
Characteristic points B, C and X are marked on the ICG curve: the point B 
coincides with the opening of the aortic valve; the point C corresponds to the 
peak of the ICG signal and it coincides with the ventricular contraction; and 
the point X corresponds to the closure of the aortic valve [9]. 
The previous modelled Fourier approximation has been modified in 
order to include a linear frequency variation. Figure 3.4A presents a 
synthetized ICG with a constant IF and Figure 3.4B shows a synthetized 
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ICG signal which frequency changes in a linear fashion from f0 = 50 bpm to 
f1 = 90 bpm in 10 seconds. 
 
Figure 3.3 Fourier Model of the ICG Pattern: original ICG template (dashed blue) 
and an approximation of 2 tones of the Fourier model (red). Characteristic points 
B, C and X are marked on the ICG curve 
 
Figure 3.4 ICG signals with a constant instantaneous frequency (A) and a linear 
frequency variation (B) from f0 = 50 bpm to f1 = 90 bpm in 10 seconds 
synthetized with 2 tones 
The frequency response for the Fourier model of the ICG pattern and 
for the linearly variable time-frequency ICG in Figure 3.4B are expected to 
have a similar frequency response with some important differences in the 
shape of the frequency spectrum. The frequency response of the constant-
frequency ICG presents a set of periodically distributed peaks corresponding 
to each of the Fourier terms, as shown in Figure 3.5A. For the case of the 
two-tone synthesized ICG, the linear variation in the signal instantaneous 
frequencies makes both frequency peaks IF1 and IF2 wider (see Figure 3.5B), 
which causes them to interfere with each other as the resulting spectrum 
shows (in black). 




Figure 3.5 Periodograms of the synthetized ICG signals with no frequency 
variation (A) and with a linear frequency variation (B). Each instantaneous 
frequency is plotted individually (in color) and the total resulting spectra is also 
included (in black) 
3.5.5 Conclusions 
In this chapter, a procedure to create synthetic signals with a concrete 
exemplification of ICG signals is described. The synthetic ICG signals will be 







































4. Relationship between 
Heart Rate Variability, 
Blood Flow and Blood 







Anesthesia is known to exert an influence on the sympathetic and vagal 
tones of the autonomous central system. This leads to a modification of the 
hemodynamic state in the patient. This chapter analyses these modifications 
and relates them to the patient’s heart rate variability. 
  
4 
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4.1 Introduction 
During surgery, the effects of anesthetics in patients have been vastly 
studied. Propofol-induced hypotension is known to be mediated by an 
inhibition of the sympathetic nervous system and the impairment of 
baroreflex regulatory mechanisms [18], [19], [21]–[24]. Besides, propofol also 
reduces cardiac parasympathetic tone depending on the depth of hypnosis [20] 
although research showed that its suppression is lower than in the case of the 
sympathetic tone [17]. 
Blood pressure (BP) and cardiac output (CO) can be affected by the 
activity of the parasympathetic and sympathetic stimulations. On the one 
hand, parasympathetic stimulation decreases heart rate (HR), which in turn, 
decreases CO and thus BP. On the other hand, sympathetic stimulation 
influences the heart by increasing its heart rate and its contractile strength. 
This increases stroke volume (SV) which in combination with the increased 
HR causes the BP to augment. Besides, the sympathetic stimulation also 
increases the vasoconstriction of arterioles and veins, which can also cause an 
increase in the arterioles total peripheral resistance and venous return, 
respectively. This ultimately also increases BP [97]. Some authors have found 
some correlation between CO and BP [98]. 
CO is also related to age in a negative fashion according to different 
studies [99]–[101]. In a study [99], resting CO was measured in 151 healthy 
patients by the earpiece dye-dilution method. Cardiac index (CI, as defined in 
Equation (2)) had a significantly inverse correlation to age in volunteers older 
than 20 years old. Brandfonbrener reached the same conclusions with a 
smaller cohort [100] and Boss and his colleagues [101] reported that CO 
decreases linearly after the third decade at a rate of about 1 percent per year 
in normal subjects otherwise free of cardiac disease. 
Several authors have already studied heart rate variability (HRV) as a way 
to monitor the activity of the autonomous nervous system (ANS). Deutchman 
and colleagues [16] used the fact that high-frequency HRV reflects 
parasympathetic tone to explain that propofol anesthesia reduces 
parasympathetic tone to a lesser degree than sympathetic tone. This 
autonomic milieu predisposes the patient to developing bradycardia in 
response to parasympathetic stimuli. According to previous studies, CO, SV, 
and HR should decrease after the induction of anesthesia [102] due to the 
changes in sympathetic and parasympathetic activity, which should also be 
reflected in HRV indices. 
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However, the results have sometimes been controversial. Hidaka and 
colleagues [103] stated that after sedation with propofol, HRV high-frequency 
(HF) power (HF: 0.15-0.40 Hz) did not change, whereas low-frequency (LF) 
power (LF: 0.04-0.15 Hz) and LF/HF, an indicator of cardiac autonomic 
nervous system balance, significantly decreased with propofol. Low-frequency 
changes are more difficult to interpret since they reflect both sympathetic and 
parasympathetic activity. Nevertheless, several authors [13] consider LF 
changes to mainly reflect changes in sympathetic activity. Thus, the LF/HF 
ratio would reflect the balance between sympathetic and parasympathetic 
activity. 
Remifentanil is an anesthetic often used in combination with propofol. It 
is known to stimulate the parasympathetic nervous system, and patients with 
increased parasympathetic tone may be at greater risk of bradycardia after its 
administration [12], [13], which is reflected in the HF of the HRV [11]. 
Zaballos and colleagues [14] compared an anesthesia based on propofol with 
and without remifentanil and results showed that remifentanil depresses sinus 
node function and most parameters of atrioventricular nodal function such as 
HRV. This contributes to an explanation for clinical observations of 
remifentanil-related severe bradyarrhythmias. 
In this study, our main objective is to analyze blood flow indices (CO and 
SV), heart rate variability, and blood pressure during a propofol-remifentanil 
anesthesia in order to describe how indices are affected after the patients’ loss 
of consciousness. Moreover, the relations of the studied indices with each 
other and with the patient characteristics such as age are also analyzed. There 
are several hypothesis which are taken into account. Firstly, CO, SV, and HR 
should decrease after the induction of anesthesia due to the changes in 
sympathetic and parasympathetic activity, which should also be reflected in 
HRV indices.  Secondly, CO is to be related to age in a negative fashion 
according to the studies mentioned previously (although other patient 
characteristics will also be studied). Finally, BP should also decrease during 
anesthesia. 
4.2 Data Preparation 
In total, one hundred and fifty-three consecutive patients undergoing 
major surgery under general anesthesia at the Hospital CLINIC de Barcelona 
(Spain) were assessed in this observational study. The details of this database 
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have been explained in the Chapter 3. Data from a blood pressure monitor 
and the qCO monitor were recorded. 
The synchronization between a noninvasive blood pressure monitor and 
the qCO monitor was ensured by annotating the exact start time given by the 
two devices. The BP monitor updates the diastolic, systolic and mean blood 
pressure values (DBP, SBP, and MBP) every 120 seconds. The qCO monitor 
updates its indices (HR, CO and SV) every second. This study aimed to 
compare two anesthesia-related patient states: consciousness and 
unconsciousness. 
During the induction of anesthesia, the moment of loss of consciousness 
(LOC) was assumed to occur when patients lost response to verbal 
stimulation. To characterize each state, after checking normality, the 
registered indices HR, CO, SV and blood pressure corresponding to one-
minute length taken 4 minutes after LOC (i.e., unconscious state) were 
averaged and data corresponding to one-minute length taken 4 minutes before 
LOC (i.e., conscious state) were also averaged for comparison. Signals were 
excluded when patient movement corrupted the recorded signal or when the 
period before the induction had not been registered. For the present analysis, 
in order to avoid confounding factors, patients were discarded when 
ephedrine and atropine had been used between 4 minutes before and 4 
minutes after LOC. 
4.3 Heart Rate Variability 
The electrocardiogram (ECG) is the result of recoding the electrical 
activity of the heart over a period of time using electrodes placed on a patient’s 
body. These electrodes detect the tiny electrical changes on the skin arising 
from the depolarization of the heart muscle during each heartbeat. This is a 
noninvasive medical procedure referred to as electrocardiography. 
Regarding hemodynamics, the ECG is useful to detect the morphology, 
amplitude and duration of the cardiac cycle waves. It can also be used to derive 
other parameters such as the HR and the HRV, which are useful to describe 
the hemodynamic state of a patient. 
4.3.1 Heart Rate 
The HR is the speed of the heartbeat measured by the number of beatings 
of the heart per unit of time – typically beats per minute (bpm). The HR can 
vary according to the body's physical needs, including the need to absorb 
oxygen and excrete carbon dioxide. 
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The normal resting adult human HR ranges from 60–100 bpm. 
Tachycardia is a fast HR, defined as above 100 bpm at rest. Bradycardia is a 
slow HR, defined as below 60 bpm at rest. During sleep a slow heartbeat with 
rates around 40–50 bpm is common and considered normal. When the heart 
is not beating in a regular pattern, this is referred to as an arrhythmia. These 
abnormalities of HR sometimes indicate disease. 
The correct identification of the QRS complexes of the 
electrocardiogram signal is the first and the most important stage for analyzing 
HRV. The RR intervals represent the difference (in time) between consecutive 
QRS complexes and this is directly related to the instant heart rate (HRins) 





Heart rate can be calculated in an instantaneous way or averaged over a 
certain period of time (typically, over one minute). In Figure 4.1, the QRS 
complexes can be observed with the different RR intervals. In the lower part 
of the figure, the series of RR intervals is also plotted. 
 
4.3.2 Heart Rate Variability Calculation 
The European Society of Cardiology and the North American Society of 
Pacing and Electrophysiology [8] refers to HRV as: 
“the oscillation in the interval between consecutive heartbeats”. 
Measurements of HRV are the most widely used indirect techniques for 
assessing the autonomous nervous system function in the study of several 
physiological states and diseases. Recent studies [104] have shown that 
immune system is controlled by vagus nerve through the cholinergic anti-
inflammatory pathway. The HRV indices that reflect vagal activity are related 
to inflammatory markers [7, 8]. 
Changes in HRV may be evaluated using a variety of methods. The most 
common are the time-domain and the frequency-domain measures [8]. After 
detecting each QRS complex in an ECG, the so-called normal-to-normal (NN) 
intervals are simple to calculate. NN intervals refer to the intervals between 
normal R peaks. Simple HRV time-domain indices that can be calculated 
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include the mean NN interval, the mean heart rate, the difference between the 
longest and shortest NN interval, etc. 
 
Figure 4.1 ECG waveform and RR interval time series 
Frequency-domain parameters can also be calculated using different 
techniques. Power spectral density analysis provides the basic information of 
how power distributes as a function of the frequency. Methods for its 
calculation may be generally classified as non-parametric and parametric. In 
the real-time algorithm implemented in the qCO monitor, non-parametric 
methods are preferred due to the simplicity of the Fast Fourier Transform 
(FFT) and the high processing speed.  
Three different frequency ranges can be identified: very low frequency 
(VLF: < 0.04 Hz), low frequency (LF: 0.04-0.15 Hz) and high frequency (HF: 
0.15-0.4 Hz). However, VLF assessed from short-term recordings (< 5 min) 
is a dubious measure and should be avoided if short-term measurements are 
desired. The main indices to assess the HRV are shown in Table 4.1. Some 
of them have been implemented in the qCO monitor. 
For the calculation of the HRV indices, the beat-to-beat RR intervals 
were linearly-splined and interpolated at 2 Hz to obtain a constant sampling 
frequency. The HRV power spectral density was calculated by means of a Fast 
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HEART RATE VARIABILITY INDICES 
Index Description 
RMSSD (ms) Root mean square differences between successive RR intervals 
 
SDSD (ms) Standard deviation of differences between successive NN intervals 
pNN50 (%) Number of interval differences of successive NN intervals greater 
than 50 ms divided by the total number of NN intervals.  
HF (ms2) Power in high frequency range (0.15 – 0.4 Hz) 
HFn (n.u) HF power in normalized units, HFn = HF/(LF + HF) 
LF (ms2) Power in low frequency range (0.05 – 0.15 Hz) 
LFn (n.u) LF power in normalized units, HLn = HF/(LF + HF) 
LF/HF (n.u.) Energy balance between LF and HF. 
TP (ms2) Total Power 
Table 4.1 Heart Rate Variability Indices [8] 
The following indices for HRV were then calculated: VLF (up to 0.05 
Hz), LF, and HF. Derived indices were: normalized LF (LFn = LF/(HF+LF)), 
normalized HF (HFn = HF/(HF+LF)) and the LF/HF ratio. Three time-
derived indices were also calculated: the standard deviation of differences 
between adjacent intervals (SDSD), the square root of the mean of the sum 
of the squares of differences between adjacent intervals (RMSSD) and the rate 
of pairs of adjacent intervals differing by more than 50 ms in the recording 
(pNN50). These indices were calculated once during the pre-induction 
segment and once during the post-induction segment. HR was included as a 
default index in the qCO monitor. 
4.4 Statistical Analysis 
Normality was assessed using the Kolmogorov-Smirnov test. Normally-
distributed, quantitative data are presented as mean ± SD and qualitative data 
as frequency (percentage). Non-parametric quantitative data are presented as 
median (Inter-Quartile Range, IQR [range of maximum and minimum 
values]). 
Since some data were non-normally distributed, a non-parametric test, 
the Wilcoxon signed-rank test, was used to investigate whether the analyzed 
indices changed after induction of anesthesia. Receiver operating 
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characteristic (ROC) analysis was used to assess the ability of the studied 
indices to detect the occurrence of LOC. Another non-parametric test, the 
Mann–Whitney U-test, was applied to investigate the differences in the 
decrease of hemodynamic values between men and women. All p-values 
reported are two-sided and p-value<0.05 was considered to be statistically 
significant. 
The relationship between indices from hemodynamic, time-domain, 
frequency-domain analysis and patient characteristics was assessed using 
Spearman’s coefficient of correlation (𝜌). 
 
4.5 Variations after Loss of Consciousness 
After discarding the cases for which the period prior to the induction of 
anesthesia had not been recorded and the cases in which the recorded signals 
contained artifacts during the periods before and after the loss of 
consciousness, a total of eighty-two patients were finally included in the final 
study. The details of the patients are reported in Table 4.2. The patient 
characteristics which were analyzed during this study included age, height, 
weight, lean body mass (LBM), body surface area (BSA), body mass index 
(BMI) and gender. 
Table 4.3 shows the results comparing all the indices before and after 
patients’ LOC. There is a reduction in CO, SV, and HR and a reduction in 
DBP, SBP, and MBP. All time-derived and frequency-derived HRV indices 
also significantly decrease after LOC except from the normalized high 
frequency index (HFn) which significantly increases. The decrease in BP 
(either DBP, SBP, and MBP) is always higher than 20% (median value), 
slightly higher than the decrease in CO. The SV and HR indices decrease by 
around less than 10% (median value). Absolute frequency-derived HRV 
indices decrease by around 63% (median values for VLF, LF, HF, Total 
Power), while the ratio LF/HF decrease by 34%, HFn increases by 28% and 
LFn decreases by 8%. Time-derived HRV indices decrease by between 20% 
for pNN50 and around 33% for RMSSD and SDSD (median values). 
The Wilcoxon test shows that the variation in all indices is always 
statistically significant with the exception of the LF/HF ratio. Table 4.3 
shows the characteristics of the ROC curve for the detection of LOC. The 
ROC curves for frequency-derived HRV indices have an area under the curve 
(AUC) around 0.56-0.59 while the time-derived HRV AUCs are slightly higher 
(0.62-0.68) and hemodynamic AUCs are the highest, around 0.63-0.85. 




 Age; years 51.9 ± 14.9  
 Height; cm 162.6 ± 8.8  
 Weight; kg 69.3 ± 13.6  
 LBM; n.u. 47.6 ± 7.8  
 BSA; m2 1.75 ± 0.2   
 BMI; kg/m2 26.3 ± 5.0   
 Gender; male/female 21/61  
Table 4.2 Patient characteristics: qualitative data are presented as absolute 
frequencies; quantitative data are presented as mean ± standard deviation. LBM: 
lean body mass; BSA: body surface area; BMI: body mass index. 
4.6 Relationship between Blood Flow, Blood 
Pressure and HRV Indices 
Results showed that CO does not significantly correlate with blood 
pressure (either DBP, MBP or SBP) but SV presents certain negative 
correlation with blood pressure. The percentage variation Δ(%) between 
before and after induction in fluid indices and pressure indices does not 
correlate either. The results in Table 4.3 confirm that all HRV indices 
decrease after the induction of anesthesia except from the HFn which 
increases after loss of consciousness. 
All time-derived HRV indices in Table 4.4 (SDSD, RMSSD, and pNN50) 
are much related to each other although their correlations are higher before 
the loss of consciousness than afterwards. The same time-derived HRV 
indices are also related to the absolute frequency-derived HRV indices (VLF, 
LF, HF, and total power) in a positive fashion both before and after LOC. 
Finally, time-derived HRV indices are weakly correlated to HFn in a 
positive fashion but so are they to LFn and LF/HF in a negative fashion. 
Regarding the variations of the HRV indices, ΔSDSD and ΔTotal power, and 
ΔHF and ΔRMSSD strongly correlate with each other. No statistically-
significant correlations for HRV indices above 0.50 have been found with 
either blood flow indices (CO and SV) or blood pressure indices. 
Regarding the normalized HRV frequency indices (not included in Table 
4.3), both before and after LOC, weak correlations were found for RMSSD 
and pNN50 with LFn (negative) and with HFn (positive). All correlations for 
normalized HRV indices were similar with |𝜌| < 0.36, p-value < 0.05. 
 
RECORDED INDICES BEFORE AND AFTER LOSS OF CONSCIOUSNESS 
 Indices Pre- LOC Post-LOC Δ (%) AUC  
 Hemodynamics  
 CO (L/min) + 4.8 (1.3 [3.1–10.1]) 4.0 (0.9 [2.6–6.5]) -15.7 (12 [-60 – -2]) 0.74  
 SV (mL/beat) + 68 (15 [43–127]) 63 (11 [39–104]) -8.1 (12 [-55 – 7]) 0.63  
 SBP (mmHg) + 135 (39 [93–197]) 101 (33 [51–160]) -24 (15 [-59–9]) 0.85  
 DBP (mmHg) + 78 (16 [45–100]) 59 (23 [34–97]) -24 (21 [-47–23]) 0.84  
 MBP (mmHg) + 102 (23 [63–132]) 77 (27 [41–121]) -23 (21 [-51–17]) 0.84  
 Time-derived HRV   
 HR (bpm) * 69.4 (13 [55–117]) 62 (12 [46–104]) -9.5 (7.7 [-35 – 13.2]) 0.67  
 RMSSD (ms) + 22 (20 [0–346]) 14 (14 [0–300]) -32 (58 [-80 – 580]) 0.66  
 SDSD (ms) + 38 (27 [0–237]) 24 (21 [0–223]) -34 (62 [-87 – 306]) 0.68  
 pNN50 (%) * 1.6 (7.2 [0–45]) 0 (1.9 [0–36]) -20 (161 [-87 – 625]) 0.62  
 Frequency-derived HRV   
 VLF (ms²) * 396 (615 [0–6981]) 114 (371 [0–8441]) -60 (128 [-99 – 3804]) 0.69  
 LF (ms²) + 387 (713 [0–5401]) 98 (196 [0–17663]) -67 (104 [-100 – 2633]) 0.68  
 HF (ms²) * 110 (238 [0–13391]) 35 (112 [0–15367]) -67 (110 [-98 – 6273]) 0.66  
 T.P. (ms²) + 1105 (1529 [0–25884]) 379 (874 [0–45875]) -66 (126 [-98–2165]) 0.56  
 LF/HF (n.u.) 2.8 (5 [0–21]) 1.9 (4 [0–80]) -34 (234 [-99 – 3513]) 0.56  
 HFn (%) * 26 (28 [0–82]) 34 (41 [0–94]) 28 (192 [-90 – 1155]) 0.56  
 LFn (%) * 74 (28 [0–96]) 65 (41 [0–99]) -8 (60 [-94 – 401]) 0.56  
Table 4.3 Average values before and after loss of consciousness (pre-LOC and post-LOC) presented as median (IQR [Range]). The mean 
variation Δ(%) from pre- to post-LOC and the Area Under the Curve (AUC) of the ROC characteristics are also included. n.s. non-significant 
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4.7 Relationship between Indices and Patient 
Characteristics 
Regarding the blood flow indices (CO and SV), no index correlates with 
patients’ height. CO and SV indices weakly correlate with the remaining 
characteristics of the patients, both before (𝜌 ∈ [-0.36, -0.26], p-value < 0.05) 
and after induction of anesthesia (𝜌 ∈ [-0.47, -0.29], p-value < 0.05). Age also 
correlates with CO (before LOC) and SV. In all cases, statistically significant 
correlations are negative and rather weak (𝜌 = ∈ [-0.42, -0.28], p-value < 0.05). 
Regarding the blood pressure indices, all of them follow the same pattern: 
SBP, DBP, and MBP before induction all correlate with age (𝜌 is 0.59, 0.57 
and 0.66, respectively, p-value < 0.05), height (𝜌 is -0.40, -0.42 and -0.42, 
respectively, p-value < 0.05), and BMI (𝜌 is 0.30, 0.52 and 0.42, respectively, 
p-value < 0.05). The percentage decrease in SBP and MBP after LOC also has 
certain correlation with age in a positive way (𝜌 is 0.50 and 0.41, p-value < 
0.05). 
The relationship between patient characteristics and HRV indices has 
been quantified. HR does not correlate with patient characteristics either 
before or after induction, but its variation after induction shows a slight 
correlation with weight (𝜌 = -0.30, p-value < 0.05) and LBM (𝜌 = -0.35,           
p-value < 0.05). Age correlates positively with SDSD, RMSSD, LF, HF, HFn, 
and the LF/HF ratio. In all cases, p-values are below 0.05. No meaningful 
differences have been found for the remaining patient characteristics. 
Finally, in regard to gender, statistically significant differences have been 
found for the percentage decrease in heart rate and cardiac output. The 
ΔHR(%) was -5.4±7.2 for men and -10.7±8.2 for women (p-value = 0.011). 
The ΔCO(%) was -13.8±6.5 for men and -19.2±10.2 for women (p-value = 
0.033). Statistically significant differences have been found for the CO at pre-
LOC according to gender (COpre = 4.47±0.86 for men and COpre = 
5.13±1.16 for women, p-value = 0.016). No statistically significant differences 




CORRELATION P BETWEEN HRV INDICES. 
SDSD 
Pre-LOC   
                    
Post-LOC 0.54   
                   
Δ(%) -0.24 0.61   
                  
RMSSD 
Pre-LOC 0.92 0.65 -   
                 
Post-LOC 0.65 0.81 0.31 0.79   
                
Δ(%) - 0.24 0.65 - 0.35   
               
pNN50 
Pre-LOC 0.84 0.53  - 0.88 0.67  -   
              
Post-LOC 0.61 0.63 0.22 0.70 0.86 0.36 0.63   
             
Δ(%) - - - - - 0.68 - 0.49    
            
VLF 
Pre-LOC 0.65 0.27 - 0.48 0.32 - 0.42 0.42 -   
           
Post-LOC 0.35 0.88 0.62 0.42 0.55 - 0.36 0.29 - -   
          
Δ(%) - 0.37 0.45 - - - - - - - 0.54   
         
LF 
Pre-LOC 0.85 0.36 -0.24 0.73 0.46 - 0.67 0.42 - 0.53 0.22 -   
        
Post-LOC 0.42 0.74 0.37 0.51 0.75 0.29 0.47 0.43 -  - 0.74 0.39 0.31   
       
Δ(%) - 0.30 0.50 - 0.26 0.54 - - - - 0.33 0.27 - 0.50   
      
HF 
Pre-LOC 0.82 0.65 - 0.96 0.79 - 0.77 0.65 - 0.37 0.43 - 0.62 0.53 -   
     
Post-LOC 0.52 0.75 0.33 0.63 0.83 0.27 0.58 0.58 - - 0.69 0.34 0.39 0.92 0.38 0.61   
    
Δ(%) - - 0.58 - 0.23 0.87 - - - - - - - 0.31 0.47 - 0.28   
   
Total 
Power 
Pre-LOC 0.95 0.57 - 0.93 0.70 - 0.78 0.64 - 0.71 0.37 - 0.84 0.45 - 0.88 0.54 -   
  




0.56 0.77   0.43 0.62   
 
































  SDSD RMSSD pNN50 VLF LF HF Total Power 
Table 4.4 Correlation 𝜌 between HRV indices. The values presented correspond to the Spearman’s coefficient when p-value < 0.05 (*) or p-
value < 0.01 (**). Otherwise, non-significant values are obtained 
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4.8 Discussion of Results 
Results show that after LOC, there was a decrease in blood pressure 
indices, blood flow indices, and HRV indices (p-value < 0.05). The decrease 
in LF band indexes can be directly related with an increase in high-frequency 
HRV (p-value < 0.05). However, no significant differences were observed in 
the LF/HF ratio of the HRV between before and after LOC. 
This work has obtained similar results as former studies with much larger 
cohorts. In previous studies, Gabarrón et al. [102] showed that the decrease 
in CO after induction was 23% and Momota [107] showed that blood 
pressures at loss of response to stimulation and 5 to 15 minutes after 
intubation were significantly lower than those before induction. 
In our study, SV was inversely-correlated with any BP but these indices 
decreased after LOC. These facts are compatible since the decrease in BP was 
much larger than the decrease in SV. No correlation was found between BP 
and CO. Guyton [108] explained that the pumping action of the heart is 
ultimately responsible for BP. Increases or decreases in CO can result in 
increases or decreases respectively in BP. Several studies [98], [109] have 
reported a positive correlation between CO and BP and in our study only SV 
has shown a statistically significant relationship with BP. Theoretically, MBP 
is related to systemic vascular resistance and CO, which in turn is related to 
HR and SV. In our study, the correlations between MBP and the HR and 
between MBP and SV are similar with opposite sign, which makes 
interpretation non-trivial. 
In the HRV spectral decomposition, the HF band (0.15–0.4 Hz) is 
claimed to reflect the parasympathetic autonomic modulations [8], [110], 
while the LF band (0.04–0.15 Hz) has been suggested to primarily represent 
sympathetic cardiac activation [111]. Nevertheless, evidence supporting the 
cardiac sympathetic origin of the LF component is not very strong, and recent 
work suggests that the LF band does not reflect cardiac sympathetic outflow 
per se but simply modulation of cardiac autonomic drive via the baroreflex. 
This is a rapid negative feedback loop in which an elevated BP reflexively 
causes the HR to decrease and the BP to decrease, and which has been 
explained by several research groups [111]–[113]. 
During anesthesia, remifentanil is known to cause hypotension and 
bradycardia either by parasympathetic activation (HF) and/or by other 
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negative chronotropic effects [11]–[14]. Remifentanil also decreases 
sympathetic action [15]. Propofol during anesthesia reduces parasympathetic 
tone to a lesser degree than sympathetic tone [16]–[24]. The combination of 
remifentanil and propofol could therefore imply a maintained or slightly-
reduced vagal tone and a reduced sympathetic tone. 
In our case, the total power decreased after the loss of consciousness, 
which is in line with the previous statements and is an index of sympathetic 
nerve predominance [114]. In fact, the LF/HF ratio had an increased 
tendency and LF remained higher than HF (vagal tone) after the induction of 
anesthesia. This could be in line with the before-mentioned assumptions by 
some authors regarding the sympathetic character or the modulation of 
cardiac autonomic drive via the baroreflexes of the low-frequency HRV. 
Most time-derived HRV indices positively correlate to each other as 
suggested in previous studies [8] since all these measurements of short-term 
variation are estimates of high frequency variations in heart rate. Moreover, 
time-derived HRV indices decrease as frequency-derived HRV indices 
decrease although, as already discussed, the variation in HF is larger than the 
variation in LF and therefore time-frequency indices correlate in a positive 
way with HFn and in a negative way with LFn. 
Confounders like age, gender, height, weight, and BMI that might have 
possible influences on hemodynamics and HRV have been considered. Our 
results show that BP (SBP, DBP, and MBP) both before and after LOC is 
higher when age and BMI also are. The BP before LOC is inversely 
proportional to height. Nonetheless, several articles reported a decrease in 
blood fluid indices with age [99]–[101]. CO and SV indices correlated in a 
negative fashion with age, weight, LBM, BSA, and BMI while HR showed no 
correlation. In a study by Park and colleagues, there was no significant 
decrease in HR with increasing age [115] but some other studies have found 
evidence of such a decrease [116]. Regarding HRV, Fagard [117] and Piccirillo 
[118] found an age-related decrease in nearly all spectral components in 
healthy subjects: SDSD, LF and HF were significantly decreased with age. In 
our case, we have found that almost all spectral components after loss of 
consciousness and the percentage variation of HRV indices correlated in a 
positive way with age. Since most HRV variations were negative, the previous 
statement suggests that HRV indices changed in a lesser degree as their age 
increased.  
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Our study presents some limitations which must be considered. First, the 
qCO monitor is not a gold standard method for cardiac output monitoring. 
All noninvasive methods for the detection of the cardiac output are known to 
exhibit a certain error. Furthermore, the pharmacological effects of the drugs 
infused in the patients may vary depending on the target concentrations. This 
is especially true when analyzing the modifications in the vagal and 
sympathetic tones caused by propofol and remifentanil. Therefore, the 
hemodynamic and HRV measurements might also be affected by the different 
concentrations used in every case. In fact, Kanaya [20] and colleagues showed 
that propofol reduces cardiac parasympathetic tone depending on the depth 
of hypnosis. These facts do not reduce the validity of results but should be 
taken into account especially in future works for which information from 
depth-of-anesthesia monitors should be included. Subsequent studies in this 
Doctoral Thesis have taken into account the depth of anesthesia in the 
analysis. 
4.9 Conclusions 
In conclusion, this work has provided extensive results regarding the 
changes in blood flow, blood pressure, and HRV during surgical operations 
with remifentanil and propofol and has validated previous results found in the 
literature. There was a decrease in CO and all BP indices after LOC. HRV 
indices except HFn have also decreased after LOC indicating a decrease in 
both sympathetic and vagal activity. Finally, gender differences in HR and CO, 














































5. Time Distance between 









Several studies have concluded that the time difference between the R 
peak in the electrocardiogram and the C point in the impedance cardiogram 
is a measure for the time delay between the electrical and mechanical activity 
of the heart. This chapter investigates the RC segment and compares it with 
other hemodynamic measures.  
5 
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5.1 Introduction 
The organization of this chapter is as follows. The basic calculations for 
the ECG and the ICG signals by the qCO monitor are presented. Then, the 
RC segment which relates ECG and ICG is discussed and analyzed on a large 
set of cases from the CMA database described in Chapter 3. Results are finally 
presented and discussed. 
5.2 ECG Calculations 
The qCO implementation is based on the well-known algorithm of Pan 
and Tompkins [96] for the real-time QRS complexes detection. This algorithm 
takes into account information about slope, amplitude and width of the QRS 
complexes in order to detect a large number of QRS morphologies. The set 
of filters and methods enhances QRS complexes while suppressing noise and 
artifacts (Figure 5.1). We have partially modified some of its stages to adapt 
it to our sampling rate (250 Hz). 
 
Figure 5.1 Block diagram of the implemented QRS-detection algorithm. The 
output is the position within the QRS complex where the R peak is situated 
The main goal of the band-pass filter is to improve signal-to-noise ratio 
to achieve good detection performance. The filter is a band-pass 4th-order IIR 
Butterworth filter with unitary gain between 10 and 30 Hz.  It therefore 
attenuates influence of noise due to EMG, 50/60Hz interference, baseline 
wander, and P and T waves interferences whilst preserving the spectral 
contents of the QRS complex. 
The differentiation is based on a high-pass filter. The general aim is to 
find the slope information in the QRS complexes, which is essentially 
different from the other waves in the ECG.  With this procedure, higher 
frequencies that are characteristic for the QRS complex are emphasized and 
lower frequencies that are characteristic for P and T waves and baseline 
wander are attenuated. However, differentiation also amplifies higher 
frequencies due to noise, thus a low-pass 2nd-order Butterworth filter with 
 fc = 15 Hz  is used for smoothing the output. 
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Squaring is a nonlinear operation which turns all samples positive. This 
is better suited for the threshold detection and it is also important since: 
- it enhances QRS complex attenuating the remaining background 
noise, and 
- it emphasizes the QRS complex (emphasizing large differences 
arising from QRS complex whereas small differences from P and T 
waves are suppressed). 
The final processing stage is a moving window integrator whose main 
goal is to obtain a signal which includes information about both the slope and 
the width of the QRS complex. The result is a smoothing version of the 
output from the preceding operations. It is very important to choose a proper 
width of the window. If it is excessively wide, the resulting integration 
waveform will contain the QRS complexes and T waves together; if it is 
excessively narrow, the resulting waveform will contain several peaks caused 
by the same QRS complex. The transfer function of this block is given by 
Equation (13). 
H(z) =
1 + z−1 + z−2 + ⋯ + z−(N−1)
N
 (13) 
where N is the window length. In the qCO monitor, N = 38. 
After the processing stage, the decision block locates the QRS complexes 
in an adaptive manner taking into account refractory periods of the QRS 
complex, eventual high T waves and abnormally high QRS complexes which 
might distort thresholds. In the qCO monitor, R peaks will be necessary for 
the calculation of the heart rate, the heart rate variability and the search of 
characteristic points in the impedance cardiogram. 
5.3 ICG Calculations 
The impedance cardiograph signal (ICG) represents the changes of the 
thoracic impedance due to variations in the blood flow. In practice, the raw 
impedance signal Z (in Ω) is transformed into the ICG waveform (in Ω/s) by 
using the first derivative to remark inflection points of the raw Z signal. The 
most important characteristics points of the ICG waveform are points B, C 
and X (Figure 2.3). All these points are associated to distinct physiological 
events within the systolic part of the cardiac cycle. In that sense, R wave from 
ECG signal can be an important reference for detecting such events. 
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ICG signal is extremely sensitive to artifacts due to movements and 
respiration. Baseline variations can considerably alter hemodynamic 
parameters obtained with the ICG characteristic points. High frequency 
interferences can also affect accuracy in estimating some characteristics points, 
essentially the B point. Therefore, a combination of low pass filters is applied 
after the derivative as it can be seen in Figure 5.2. 
 
Figure 5.2 Blocks diagram of the algorithm for calculation of ICG signal from the 
impedance signal (Z) 
The goal of the first derivative procedure is to remark inflection points 
on Z signal. These inflection points are indeed the characteristic points of 
interest. Derivative procedure also amplifies the high frequency noise so a 
block to attenuate this adverse effect is crucial. The derivative operation is 
indeed a high-pass filtering which attenuates the baseline drifts (due to 
movement or respiration) and low-pass filtering stage attenuates the high-
frequency noise improving accuracy when detecting the characteristic points. 
Finally, the middle block in Figure 5.2 provides the negated version of the 
ICG signal, according to a typical medical representation. 
The last step in the initial ICG process is to find the C and B points of 
each ICG beat taking the R peak in the ECG as a reference. These points are 
located by searching the minimum and maximum points within a window 
before and after the R peak as shown in Figure 2.3. 
5.3.1 Basic Artifact Rejection and Correction Criteria 
There are several criteria which have been implemented in order to 
improve the quality of the detection of characteristic points of ECG and ICG. 
Some of them are as follows: 
- Out of range of the raw ECG and ICG signals: segments are 
discarded if any sample is out of range according to some amplitude 
thresholds. 
- Adjustment of RR in the ECG and C and B in the ICG according to 
moving exponential averages (MAEs). MAEs are stored for the RR 
segment and the amplitude values of C and B points. Thresholds 
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In addition, in this chapter, the relationship between ECG and ICG 
periods (i.e., RR and CC segments) is investigated in order to set a new artifact 
rejection criterion. 
5.3.2 Indices extracted from ICG signals 
In addition to the heart rate variability indices described in the Chapter 4, 
the qCO monitor also displays the patient’s cardiac output and stroke volume, 
which are calculated by using the ICG signal. 
When determining stroke volume from thoracic impedance changes, 
Kubicek and his colleagues [119]  made some assumptions concerning the 
relationship between stroke volume and the net change in the thorax blood 
volume. In a very simple model, the impedance of the thorax can be 
considered to be divided into two parts: the impedance of tissues and the 
impedance of fluids. When the patient does not breath, the impedance is 
constant, except the amount and distribution of blood. 
The amount of blood in a patient’s thorax changes as a function of the 
heart cycle [120]. During systole, the right ventricle ejects an amount of blood 
into the lungs which equals the stroke volume. This can be determined by 
means of the impedance cardiography. Several formulation has been 









· te (14) 
where 𝜌b is the resistivity of the blood (Ω·cm), l is the mean distance between 
the inner electrodes (cm), Z is the mean impedance of the thorax (Ω), te is 
the ejection time and |dZ/dt|min is the absolute maximum deviation of the 
first derivative signal during systole (Ω/s), which is written as ICG in the rest 
of this text. 
 
5.4 The RC Segment 
Electrical impedance on the thorax varies in a synchronous manner with 
the heart activity. Several applications have been found using the derivative of 
this variation, which is called Impedance Cardiogram (ICG). A major 
application is the work developed by Kubicek [121] on the cardiac output 
characterization of patients through ICG signals. 
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According to the work developed by Meijer [122], the comparison of the 
time relationships between ICG and the ECG can be of special interest to 
evaluate the hemodynamic behavior of a patient. Regardless of the multiple 
sources of the signal, the ICG reflects the mechanical and hydrodynamical 
aspects of the cardiac cycle, while the ECG reflects the electrical aspect of the 
cardiac activity. Therefore, the time difference between ECG and ICG can be 
regarded as the time difference between the electrical and the mechanical 
aspects of the heart. 
The advantage of this perspective is that both ECG and ICG signals are 
easily recorded: ECG and ICG systems are noninvasive, simple to apply and 
do not require sophisticated hospital environment. ECG and ICG signals 
have proven to be useful even in complicated setting such as during functional 
magnetic resonance [123]. The time difference between the ECG and ICG 
can be estimated using the cardiac pre-ejection period (PEP). Several authors 
[124], [125] have studied the PEP, which has been found to relate to the 
sympathetic autonomous nervous activation, but not to the parasympathetic 
activity. 
The autonomic nervous system controls mainly automatic body 
functions that are engaged in homeostasis, such as heart rate, respiratory rate 
and renal function. The sympathetic nervous system prepares the human body 
when danger and stress occur while the parasympathetic nervous system 
regulates resting states. This activity can be measured using ICG and ECG 
signals through the PEP [126]. A large variety of applications of the PEP has 
been developed during the last years. For instance, since an increased pre-
ejection period is an indication of decreased contractility [127], Ashouri 
proposed to measure PEP and stroke volume changes outside the clinic to 
provide insight into the severity of their condition [128]. Other recent works 
relate PEP to stress assessment [129] or hypotension [130], [131]. 
PEP is measured between the Q wave onset of the ECG signal and the 
C point or upstroke in the ICG signal. Nevertheless, these points are not easy 
to locate and can be greatly distorted in some cases. In fact, from a 
mathematical point of view, it would be more efficient to calculate the 
difference between the R peak in the ECG and the C point in the ICG, the 
RC interval, since these are local maxima. Meijer and colleagues [122], [132] 
have already worked on this RC interval, which they called the initial systolic 
time interval. In their study, the PEP and the initial systolic time interval were 
analyzed under different conditions and behaved largely similarly in all cases 
and maintained a significant correlation. Besides that, this interval has also 
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been studied against other intervals such as the RR [133] and under different 
perturbations such as a Valsalva maneuver [134]. During exercise, the RC 
interval decreased with increasing heart rate (amount of heart beats per minute, 
HR) and the relative proportion of RC, RC/RR, was found to also decrease 
with increasing HR [133]. During a Valsalva maneuver, the influence of the 
Frank-Starling mechanism (explained in Chapter 2) was definitely observed, 
which is to some extent consistent with reports on the time course of 
sympathetic activation [134]. 
Theoretically, the initial systolic time interval or RC interval depends on 
three factors: the preload of the heart by way of the Frank-Starling mechanism, 
the afterload of the heart caused by the peripheral resistance, and the 
autonomic nervous control. Smorenberg et al. [135], [136] studied the RC 
interval and PEP in patients during fluid infusion. Preliminary results showed 
significant relationships between the initial systolic time interval and cardiac 
output (CO) and between changes in both of these indices before and after 
fluid administration. This indicated that the initial systolic time interval is 
dependent upon preload via the Frank-Starling mechanism, and that the initial 
systolic time interval has the potential to be used as a clinical parameter 
assessing preload. 
Nevertheless, the conclusions of one of the last works published about 
this interval highlighted the need to further analyze these parameters in 
different settings [134]. Several studies have compared the RC interval with 
several time markers of the heart cycle but databases are always comparatively 
small. For instance, van Eijnatten [137] and colleagues used a database of 16 
healthy patients to show that the shortening of the RC interval with increasing 
heart rate in response to an exercise stimulus was caused by a shortening of 
the PEP. To the best of our knowledge, all studies have been conducted in 
laboratory settings. 
The present study uses a large database to characterize the RC interval 
and its relationship with the RR and CC intervals during surgery in operating 
rooms. Furthermore, the RC interval has also been compared with the 
patients’ blood pressure during the whole surgical procedures. The 
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5.5 Data Preparation 
The synchronization between both the qCO monitor and the 
noninvasive blood flow monitor (Dräger Infinity® Gamma monitor) was 
ensured by annotating the exact start time given by the two devices. The blood 
pressure monitor updates its blood pressure values (diastolic, systolic and 
mean) every 120 seconds. The ECG and ICG signals registered by the qCO 
monitor were processed to detect the R peaks in the ECG and the C peaks 
and B points in the ICG. Figure 2.3 shows the position of these characteristic 
points. 
Once R and C peaks were found, for each consecutive heart beat the 
intervals RR, RC and CC were calculated. Since RR, RC and CC intervals 
occurred in every heart beat but the blood pressure was measured less often, 
there were more RR, RC and CC intervals detected than blood pressure points. 
Thus, the nearest RR, RC and CC intervals were chosen for each blood 
pressure measurement point in order to create pairs of data points to compare. 
This study also aims to compare two anesthesia-related patient states: 
consciousness and unconsciousness. During the induction of anesthesia, the 
moment of loss of consciousness was considered to occur when patients lost 
response to verbal stimulus. To characterize each state, data corresponding to 
one-minute length taken 4 minutes before LOC (i.e., conscious state) were 
averaged and data corresponding to one-minute length taken 4 minutes after 
LOC (i.e., unconscious state) were also averaged for comparison. Signals were 
excluded when patient movement corrupted the recorded signal. 
 
5.6 Statistical Analysis 
Normality of distributions was assessed using a Kolmogorov-Smirnov 
test. Relationships between time intervals, blood pressure indices, and patient 
characteristics were assessed using Spearman’s coefficient of correlation (). 
A non-parametric test, the Mann–Whitney U-test, was applied with the 
significance level set at p-value < 0.05 to investigate the differences in gender. 
Since some indices were normally distributed, the t-Student test was used to 
investigate whether those hemodynamic indices changed after LOC. 
Quantitative data are presented as mean ± standard deviation (SD) and 
qualitative data are presented as frequency (percentage). 
 
63 Chapter 5 
 
 
The RR, RC, CC and RC/RR intervals were statistically described and so 
were SBP, DBP and MBP. The relation between all those indices was analyzed 
using correlation and regression techniques. Moreover, the correlation 
between time-shifted versions of RR and RC was studied and the 
decorrelation velocity, the negative slope of the linear regression of the 
Spearman’s coefficients once the decrease in the correlation is linear, was 
calculated. Finally, the relationship between the mean of all indices before and 
after LOC was investigated. 
5.7 Description of the Time Segments and Pressure 
Indices 
A total of 502,343 RR, RC and CC intervals have been extracted and a 
total of 4,456 sets of RR, RC, CC and blood pressure values have been formed 
from 149 patients (from 8 to 108 points per patient). The mean and standard 
deviation values (mean ± SD) of the time segments RR, RC, and CC and the 
ratio RC/RR are reported in Table 5.1, where the blood pressure indices as 
systolic blood pressure (SBP, mmHg), diastolic blood pressure (DBP, mmHg) 
and mean blood pressure (MBP, mmHg) are also presented. It can be 
observed that the value of the ratio between RC and RR intervals is of 21.6 ± 
3.8 % and the mean value of RR and CC intervals is coincident. 
MEASURED HEMODYNAMIC INDICES 
 Indices Mean ± SD  
 RR 959.8 ± 155.2 ms  
 RC 202.0 ± 20.4 ms  
 CC 959.8 ± 155.2 ms  
 RC/RR 21.6 ± 3.8 %  
 SBP 110.1 ± 23.5 mmHg  
 DBP 63.9 ± 15.7 mmHg  
 MBP 83.2 ± 18.5 mmHg  
Table 5.1 Mean and standard deviation of measured hemodynamic indices in 
the sample of patients undergoing surgery. SBP: systolic blood pressure; DBP: 
diastolic blood pressure; MBP: mean blood pressure 
The relationship between pressure indices (systolic, diastolic and mean 
blood pressure) and time segments (RR, CC and RC intervals) was studied. 
The ratio RC/RR was also included. Table 5.2 reports the values of this 
relationship. The highest correlation was observed between RR intervals (or 
CC intervals) and the DBP index with  = -0.341 (p-value < 0.01) and RR 
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intervals with the MBP index,  = -0.317 (p-value < 0.01). A lower correlation 
was obtained between CC and SBP,  = -0.259 (p-value < 0.01). However, all 
of these are considered as weak correlations. 
Figure 5.3 includes a graphical representation of the relationships between 
the time segments (RR, CC and RC) with their correlations. Figure 5.3A 
shows that there exists a very strong, positive correlation between RR and CC 
with  = 0.998 (p-value < 0.0005). In order to study the relation between the 
electrical and mechanical activity of the heart provided by the RR and RC 
intervals taking into account that the RC interval is in fact a portion of the RR 
interval the dispersion plot between RR and the ratio RC/RR has been 
evaluated in Figure 5.3B. It proved to be inversely proportional according to 
Equation (15). 
RC/RR(%)  =  a + b/RR (15) 
where a = 3.94 (no units); b = 16.47 s, with  = 0.662 (p-value < 0.01). RR 
intervals between 700 and 1000 ms correspond with RC/RR ratios lower than 
30%. 
 
Figure 5.3 Regression plots between RR, RC and CC of patients undergoing 
surgery. (A) CC (ms) = 0.999·RR (ms) + 0.704,  = 0.998, with a 
significance of p-value < 0.0005; (B) RC/RR (%) = 3.94+16.47/RR, being 
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MEASURED HEMODYNAMIC INDICES 
 Indices SBP DBP MBP 
 RR -0.260 -0.341 -0.317 
 CC -0.259 -0.341 -0.316 
 RC -0.218 -0.127 -0.179 
 RC/RR +0.116 +0.249 +0.195 
Table 5.2 Spearman’s coefficients between time segments and blood pressure 
indices. All correlations are statistically significant with p-value < 0.01. 
 
Furthermore, the linear relationships between the current RC with the 
previous RR or RC intervals, and also between the current RR with the 
previous RR or RC have also been analyzed. A maximum time lag of 40 beats 
was considered for this study. 
In order to describe these relationships, the decorrelation velocity (Dv) 
for each pair of measurements was calculated as the negative slope of the 
linear regression of the Spearman’s coefficients once the decrease in  is linear 
and it is measured in percentage decrease per time lag difference. The variation 
of  between RC[n] and RC[n-1] was -17.1%, much higher than the variation 
presented between RR[n] and RR[n-1] ( = -4.5%) as can be seen inTable 
5.3. The variation of  between RC[n] and RR[n-1] was +0.9% while it was 
 = +0.6% in the case of RR[n] vs RC[n-1]. In all cases, Dv was very low. 
RR AND CC CORRELATION AND DECORRELATION VELOCITY 
    Dv 
 RR[n] vs RR[n-1] -4.5% 0.14% 
 RC[n] vs RC[n-1] -17.1% 0.12% 
 RR[n] vs RC[n-1] +0.6% 0.04% 
 RC[n] vs RR[n-1] +0.9% 0.02% 
Table 5.3 Variation of Spearman’s coefficient () and decorrelation velocity 
(Dv), considering n = 502,343 samples 
 
5.8 Effect of Induction of Anesthesia on Time 
Segments and Blood Pressure Indices 
Taking into consideration both the time segments (RR and RC) and the 
blood pressure values, the t-Student test has shown that the variation in these 
values before and after LOC is statistically significant (p-value < 0.0005) as 
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reported in Table 5.4. An increase in the value of the RR intervals and in the 
value of RC intervals (p-value < 0.0005) can be observed. However, the values 
of the blood pressure indices significantly decreased from after LOC during 
surgery (p-value < 0.0005). Figure 5.4 shows the evolution of the relationship 
between instant RR and RC intervals in a patient undergoing anesthesia. The 
reduction of RC/RR between before and after LOC can be clearly noted. 
CHANGES IN HEMODYNAMIC INDICES WITH ANESTHESIA 
   Pre-LOC Post-LOC p-value 
 RR (ms) 872.1 ± 121.7 959.7 ± 142.7 < 0.0005 
 RC (ms) 186.4 ± 13.6 205.0 ± 15.8 < 0.0005 
 SBP (mmHg) 135.2 ± 24.4 102.3 ± 21.1 < 0.0005 
 DBP (mmHg) 78.5 ± 11.3 61.3 ± 11.3 < 0.0005 
 MBP (mmHg) 102.2 ± 15.8 79.1 ± 16.9 < 0.0005 




Figure 5.4 RC/RR ratio in a patient undergoing anesthesia. The vertical line marks 
the instant of LOC 
The relationships between the mean of the time segments RR, RC and 
CC before and after LOC have also been analyzed using 83 available 
comparisons. The RR intervals presented a higher correlation between before 
and after LOC ( = 0.764, p-value < 0.01) than the correlation RC intervals 
before and after LOC ( = 0.601, p-value < 0.01), as it can be seen in Table 
5.6. Before LOC, RC intervals were correlated with RR intervals ( = 0.427, 
p-value < 0.0005), also RC and RR intervals were correlated after LOC, ( = 
0.488, p-value < 0.0005) as seen in Table 5.5. However, the RC intervals both 
before and after LOC are more dependent on the RR values before LOC than 
those after LOC. Non-significant differences were observed when the 
influence of age and gender in all analyzed indices was measured. 
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CORRELATION COEFFICIENTS FOR HEMODYNAMIC INDICES 
BEFORE AND AFTER LOSS OF CONSCIOUSNESS 




Pre-LOC 0.427  < 0.0005 
Post-LOC 0.252 0.029 
SBP 
Pre-LOC -0.290 0.039 
Post-LOC -0.181 n.s. 
DBP 
Pre-LOC -0.093 n.s. 
Post-LOC -0.181 n.s. 
Post-LOC 
RR 
Pre-LOC 0.488  < 0.0005 
Post-LOC 0.252 0.021 
SBP 
Pre-LOC -0.206 n.s. 
Post-LOC -0.452 0.001 
DBP 
Pre-LOC -0.103 n.s. 




Pre-LOC -0.290 0.039 
Post-LOC -0.240 n.s. 
DBP 
Pre-LOC -0.173 n.s. 
Post-LOC -0.283 0.044 
Post-LOC 
SBP 
Pre-LOC -0.229 n.s. 
Post-LOC -0.270 n.s. 
DBP 
Pre-LOC -0.258 n.s. 
Post-LOC -0.361 0.009 
Table 5.5 Spearman’s correlation coefficients between variables A and B before 
(Pre) and after LOC (Post). n.s.: statistically non-significant 
AUTOCORRELATION COEFFICIENTS FOR HEMODYNAMIC INDICES 
  Pre vs. Post-LOC  p-value 
 RR (ms) 0.764  < 0.0005 
 RC (ms) 0.601  < 0.0005 
 SBP (mmHg) 0.463  < 0.001 
 DBP (mmHg) 0.478  < 0.0005 
Table 5.6 Spearman’s auto-correlation coefficients for RR and RC before (Pre) 
and after LOC (Post) 
Table 5.7 contains the results according to variation responsiveness of 
the studied indices between pre and post-LOC. If VAR is any of the studied 
indices in this chapter, the variation responsiveness was defined as ΔVAR = 
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(VARpost-VARpre)/VARpost. It is observed that an increase of RC intervals 
with anesthetic drug infusion negatively correlated with a decrease in SBP ( 
= -0.445, p-value = 0.001). In addition, RC and SBP correlate after LOC ( 
= -0.452, p-value = 0.001) as seen in Table 5.5. No correlation was found 
between the increase in RR and the increase in RC ( = 0.113, p-value = 
0.310). 
CORRELATION COEFFICIENTS BETWEEN HEMODYNAMIC INDICES 
  Variable A Variable B  p-value  
 
ΔRR 
ΔSBP -0.200 n.s.  
 ΔDBP -0.051 n.s.  
 
ΔRC 
ΔSBP -0.445 0.001  
 ΔDBP -0.277 0.01  
Table 5.7 Spearman’s correlation coefficients between variables A and B. n.s.: 
statistically non-significant 
5.9 Discussion of Results 
In the present study, the use of a noninvasive method based on an 
approximation of the pre-ejection period to study the response of induced 
anesthesia was investigated. In this way, RR, RC, CC cardiac intervals obtained 
from ECG and ICG signals, and systolic, diastolic and mean blood pressures 
responses were compared. The use of these signals for any pharmacologic 
effect related to anesthetic depth detection is attractive: recordings can be 
obtained entirely noninvasively, rapidly, and easily. 
Both RR and CC intervals have been found to be almost identical with a 
Spearman’s coefficient of 0.998 (p-value < 0.01). This coincidence can be used 
in order to detect artifacts in the ICG and ECG signals. The RC interval 
correlates in a positive way with both RR and CC, as several studies also 
showed [133], [137].  
Regarding the RC/RR rate, the relationship with the RR interval is 
relevant. In fact, the RC/RR clearly decreases with the increase of the RR 
interval. The inversely proportional Equation (15) has a regression coefficient 
of 0.66 and the behavior shown in Figure 5.3 is very similar to the relation 
between the RR interval and the RC/RR ratio found by Hoekstra [133] where 
exercise stimulus effects were studied. In those studies, highly trained subjects 
had an RC interval and a RC/RR interval higher than the control group, 
indicating that the time delay between electrical and mechanical activity was 
longer in such group. This could eventually lead to sports applications. 
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The positive linear relationship between the RC and RR intervals 
demonstrates that with a decrease in the RR interval, the RC is also shortened. 
The inversely proportional relationship between the RC/RR and RR interval 
shows that when RR decreases, the RC interval phase decreases less than the 
total cardiac cycle. This goes in line with the conclusions by Eijnatten [137] 
when he states that the shortening of the initial systolic time interval with 
increasing HR in response to an exercise stimulus can be attributed to a 
shortening of the pre-ejection period in every individual: when the HR 
increases, the time interval between the R peak and the opening of the aortic 
valves decreases while the time between the opening of the aortic valves and 
the C point remains constant. It is important to note that van Lien [138] 
already concluded that despite the RC interval being an important tool, it 
should not be used to estimate PEP with only a single regression equation. 
The present study also analyzed how the RC interval depends on its 
previous values, obtaining correlations varying from 0.641 (consecutive beats) 
to 0.333 (between two beats delayed 8 beats). The dependence between the 
RC interval and RR also decreased in time but was always lower than such of 
the RC with itself, as it can be seen in Table 5.3. 
Our study has also found a negative relationship between the RC interval 
and blood pressure (systolic, diastolic and mean) but a positive relationship 
between the RC/RR proportion and blood pressure. Biesheuvel [139] also 
found a negative relationship between the RC interval and the systolic blood 
pressure and so did Muehlsteff [140] and Wong [141]. The latter also claimed 
that PEP had some potential to predict systolic blood pressure. However, it 
is necessary to highlight the complicated nature of the relationships between 
HR, BP and PEP. Whitsett [142] conducted a study comparing these 
measurements in patients with Parkinson’s disease using different drugs 
looking for the mechanisms responsible of varying and control these 
parameters. 
Both RR and RC have shown to decrease after LOC, which is consistent 
with previous studies [102], [136]. This response was similarly observed in 
predicting fluid responsiveness after cardiac surgery [136]. In addition, systolic 
and diastolic pressures presented a statistically decreasing difference. This 
decrease is compensated by an increase in RR, and as well RC, that is 
secondary to vagal withdrawal and increased cardiac sympathetic activity [143], 
[144]. However, it is know that SBP is affected by the pulse pressure and 
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vascular dimensions [145], whereas the RC is a more direct measure of 
electromechanical coupling of the heart. The RC interval has shown no 
relationship to most variables such as age and gender. An increase of RC 
intervals with anesthetic drug infusion negatively correlated with a decrease in 
SBP ( = -0.445, p-value = 0.001, as can be seen in Table 5.7). Also, RC and 
SBP correlate after induction ( = -0.452, p-value = 0.001) as seen in Table 
5.5. 
Some limitations may arise when comparing the results against previous 
studies found in the literature. Each ICG monitor has different properties 
concerning the positioning of electrodes and number of electrodes. For 
instance, in the method used in [133], [139], [146], the four electrodes are 
completely separated while qCO has two groups of two electrodes which are 
close to each other. Furthermore, the applied AC currents are different. Also 
the monitor device in [133], [137], [146] uses 0.3 mA at 64 kHz while the qCO 
monitor applied an AC current of 0.4 mA at 50 kHz. Finally, the 
pharmacological effects of the drugs infused in the patients may vary 
depending on the target concentrations. Therefore, the hemodynamic 
measurements might also be affected by the different concentrations used in 
every case. These facts do not reduce the validity of results but should be 
taken into account when analyzing the values of RC intervals. 
5.10 Conclusions 
This study has further characterized the relationship between ICG and 
ECG. Some previous results found in the literature have been validated using 
a new database and some new results have been reached. The relationship 
between the different time intervals in ICG and ECG and the blood pressure 
has been described. According to our analysis, the RC interval could have an 
important impact in describing the state of a patient and further studies are 
required to identify further possible applications. Finally, the coincidence of 
the CC and RR segments are key to develop new artefact detection algorithms 











6. Performance of Time-
Frequency Distributions 






Time-frequency distributions show how the spectral content in a signal 
changes with time. It is a powerful tool which, however, requires the selection 
of an appropriate kernel for each type of signal. In order to describe ICG 
signals, this chapter analyses the performance of several kernels which have 
been applied to ICG signals. Finally, the proposed kernels are tested for noise 
resistance and on a clinical database of real ICG signals. The results of this 
chapter have been accepted for publication in the journal “Medical & 
Biological Engineering & Computing”.  
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6.1 Introduction 
Advanced techniques for the analysis of biomedical signals such as the 
ICG signals and process automatization techniques are increasingly important 
for diagnosis. The visual inspection of biomedical signals may be a tedious 
task and subjective judgements and errors can occur even when skilled 
interpreters are involved. 
In order to improve the calculation of the indices derived from the 
analysis of impedance cardiography, several authors have exploited the 
periodic or quasi-periodic behavior of the ICG signals for denoising or for 
locating their characteristic points [147], [148]. The study of these signals in 
the frequency domain can shed light on the quasi-periodical behavior of ICG 
signals and also on ICG features which cannot be directly observed in the 
time domain. Some features could be related to HRV, for which ECG analysis 
would be more effective, but other features could be related to the patient’s 
hemodynamic state. However, the ICG behavior in the frequency domain 
varies with time and, therefore, it is convenient to analyze how the frequency 
distribution of a biomedical signal changes with time [149]. 
Time-frequency distributions is a technique which is often used in the 
case of analyzing electroencephalogram (EEG) [150]–[156], heart rate 
variability [157]–[162], respiration signals for apnea detection [163], and 
pathological speech signals [164]–[166], amongst others. There are several 
different ways to formulate valid TFDs [167] but any application would ideally 
require high definition in spectral components, no interferences between the 
spectral components which can cause cross-terms to appear (in order to avoid 
confusing real components from artifacts or noise), a low computational 
complexity and some mathematical properties [168]. However, these 
properties do not normally occur together and the selection of an appropriate 
TFD depends on the characteristics of the signal to analyze. 
When it comes to selecting the best TFD for synthetic signals, several 
quantitative measurements can be used based on geometrical properties [169], 
[170], error and entropy properties [156], [171]–[175] of the TFDs. These 
measurements can be applied when the time-frequency characteristics of real 
signals are known. Nevertheless, these characteristics are usually unknown in 
the case of real physiological signals. 
In this chapter, in order to test the goodness of TFDs for real biological 
signals such as the ICG, we propose the usage of synthetic signals modeling 
the real ICG signals. The TFDs can then be optimized for its usage with real 
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ICG signals by means of using ICG synthetic signals fulfilling the following 
requirements: synthetic signals should resemble very much to the original 
signals from a time and frequency perspectives, and time-frequency 
parameters should be easily modifiable. To the best of our knowledge, the 
application of TFDs to ICG signals has not been extensively published. 
In order to accomplish these requirements, the synthetic signals explained 
in Chapter 3 were used to evaluate different TFDs based on geometric criteria. 
An exemplary signal can be found in Figure 3.4. The most common TF 
distributions available were tested: the Wigner-Ville Distribution (WVD), the 
Born-Jordan distribution (BJD), the spectrogram, the S-method (SM), the 
Choi-Williams distribution (CWD), the Zhao-Atlas-Marks distribution 
(ZAM), the Modified B-Distribution (MBD) and the Extended Modified B-
Distribution (EMBD) [167]. 
The instantaneous frequency of the different spectral components on the 
TFDs was determined and its errors with the theoretical IFs were measured. 
The robustness against low signal-to-noise ratios has also been tested. In 
addition, optimized TFDs were used on synthetic ICG signals derived from 
patterns of the rest of patients in the ICG database obtained from the 
Shanghai Study and described in Chapter 3. 
6.2 Time-Frequency Distributions 
This subsection explains the basic theory of the time-frequency 
distributions. Concepts such as the analytic associate, the variety of available 
kernels and the detection of the instantaneous frequency are described. 
6.2.1 Analytic Associate 
In TFDs, the usage of the analytic associate of a given real signal, rather 
than the signal itself, is useful for reducing the required sampling rate, and 
essential for obtaining an unambiguous instantaneous frequency. The analytic 
associate is obtained via the Hilbert transform: 
ℋ{s(t)} = ℱt←f 
−1 {(−j sgn(f))ℱt←f {s(t)}} (16) 
where ℱt←f {… } is the Fourier transform. 
The detail process to obtain the Hilbert transform of s(t) is as follows: 
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1. Take the Fourier transform S(f) of s(t). 
2. Multiply S(f) by –j for positive, by +j for negative, and by zero for 
f=0. 
3. Take the inverse Fourier transform. 
This procedure creates an analytic signal containing no negative 
frequencies. This does not produce any loss of information in the case of real 
signals and it introduces two beneficial effects: it halves the total bandwidth 
and avoid the appearance of interference terms generated by the interaction 
of positive and negative components in quadratic TFDs which are a 
consequence of the bilinear nature of the TFD formulation. 
6.2.2 TFD Formulation 
High-resolution time-frequency analysis is useful for signals which are 
nonstationary and/or multicomponent. Quadratic TFDs are based on 
estimating the instantaneous power spectrum of the signal by using a bilinear 
operator [167]. The Wigner-Ville distribution is the basic quadratic TFD and 
is defined by taking the Fourier transform of an instantaneous auto-
correlation function Kz(t, 𝜏). 





where Kz(t, 𝜏) is defined as 
Kz(t, 𝜏) = z(t + 𝜏/2)z
∗(t − 𝜏/2) (18) 
and where z(t) is the analytic associate of a real signal s(t) obtained with the 
Hilbert transform z(t) = s(t) + jℋ{s(t)} as explained before. 
6.2.3 Kernels for TFDs 
The WVD provides a high-resolution representation of the signal x(t) in 
time and frequency but the presence of cross-terms in multicomponent 
signals is deleterious for biomedical signal processing. Cross-terms can be 
reduced by convolving the WVD with a two-dimensional kernel 𝛾(t, f) to 
obtain the general formulation of quadratic TFDs in Equation (19). 
𝜌z(t, f) = 𝛾(t, f) ∗∗
(t,f)
Wz(t, f) (19) 
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The two-dimensional kernel 𝛾(t, f)  reduces cross-terms – the terms 
created by the interaction of different time-frequency components in a signal 
– but it also blurs auto-terms – the terms in the TFD which really represent 
the different time-frequency components in a signal. Therefore, kernels need 
to be designed to obtain the best tradeoff between minimizing cross-terms 
and maintaining the auto-terms’ resolution. 
The general formulation in Equation (21) of the kernels 𝛾(t, f) (19) in the 
time-frequency domain is usually formulated in a so-called ambiguity domain 
such as g(𝜈, 𝜏), where 𝜈 and 𝜏 are Doppler and lag, respectively, as indicated 
in Equation (20). This is because the convolution operation in the time-
frequency domain becomes a multiplication in this ambiguity domain, which 
reduces its complexity. 








where Az(𝜈, 𝜏) is the ambiguity function of the analytic associate z(t) of the 
real signal s(t). Separable kernels are a special case when g(𝜈, 𝜏) = G1(𝜈)g2(𝜏). 
If G1(𝜈) = 1, the kernel is Doppler independent. If g2(𝜏) = 1, the kernel is lag 
independent. Table 6.1 shows the TFDs tested along with the corresponding 
kernels. The spectrogram is calculated using four different windows: 
rectangular, Hamming, Hanning and Bartlett. 
The S-Method is based on the relation of the Short-Time Fourier 
Transform (STFT) and the WVD: the STFT is a linear operation and does not 
suffer from any cross-terms [176]. Cross-terms in TFDs appear due to the 
interaction of the STFTs of different signal components, which can be 
avoided using a window frequency function P(𝜈) = 0, |𝜈| > LP. By changing 
LP, a gradual transition can be obtained ranging from the spectrogram (LP →
0, P(𝜈) = δ(𝜈)/2)  to the WVD (LP → signal length, P(𝜈) = 1) . The best 
choice of LP would be the value when P(𝜈) is wide enough to enable complete 
integration over the auto-terms, but narrower than the distance between the 
auto-terms, in order to avoid the cross-terms. Equation (21) describes how 
the SM is based on the STFT and the window frequency function P(𝜈). 
SMZ(t, f) = 2 ∫ P(𝜈) STFTz(t, f + 𝜈) STFTz





6 TFD Performance for ICG 76 
 
KERNELS FOR TIME-FREQUENCY DISTRIBUTION 
TFD Kernel Type Kernel g(𝜈, 𝜏) 
WVD  1 
BJD Non-separable sinc(2𝛼𝜈𝜏) 
S-Method Non-separable Aw(𝜈, 𝜏) ∗
𝜈
P(−𝜈/2) 











MBD Lag-independent |𝛤(𝛽 + j𝜋𝜈)|2
𝛤2(𝛽)
 





Table 6.1 Kernels for the TFDs [167] used in this work. The parameters a, 𝛼, β 
and σ and the window w define the kernel shape and are estimated taking into 
account the characteristics of the signal, where ν and τ are Doppler and lag, 
respectively 
6.2.4 Identification of Instantaneous Frequency 
The evaluation of different kernels by using synthetized ICG signals with 
known time-frequency properties can lead to the most adequate TFD for real 
ICG signals. To validate this extent, the IF can be calculated in the TFDs with 
the optimized kernels. 
There are several techniques to spot the different IF. One of the 
approaches used an iterative estimate of the first moment of the spectrogram 
as the IF in order to also construct a matched spectrogram estimate. This 
approach is stopped when convergence between two consecutive 
spectrograms was reached and produces a match spectrogram concentrated 
along the IF of monocomponent signals [177]. IF estimation from the maxima 
of the TFDs has a variance and bias highly influenced by the lag window 
length. Therefore, Stanković and Katkovnik [178], [179] proposed an adaptive 
algorithm for determining the optimal lag width based on the intersection of 
upper and lower confidence intervals of the IF estimates for each time instant.  
The IF estimation methods of multicomponent signals are highly 
dependent on the selected TFR and presence of cross-terms which could be 
mistaken for the IF estimate. A simple approach is to use time-frequency 
filtering methods to retrieve individual IFs [167]. Other approaches require 
77 Chapter 6 
 
 
extending algorithms for estimation of monocomponent IF to the case of 
signals with various IF [180]. 
In general, concrete properties are required for the TFDs when detecting 
the IF of multicomponent signals: high time-frequency resolution and 
efficient suppression of cross-terms; direct amplitude estimation for the 
individual components, and minimum bias of the IF from the true IF laws. 
TFDs such as the MBD satisfy these requirements and the work by Stanković 
and Katkovnik in [178], [179] can also be extended for the case of 
multicomponent signals. 
This work proposes an algorithm to search the IF without setting the 
total number of existing IFs and their approximate frequencies. The steps are 
as follows: 
1. Find the local maximum peaks for every time instant in the TFD 
higher. 
2. Group these peaks so that they form a continuum along time. This is 
the expected behavior of IF laws since the synthetic TFDs are created 
as a Fourier series of tones whose frequency varies in a determined 
manner along time. 
It is important to note that the first and last 10% of time of the TFD is 
not to be taken into consideration in order to detect the IF, since the starting 
and final instants of the TFD are blurry and can introduce errors in 
calculations. 
6.3 Performance Calculation 
Choosing the best kernel for a signal requires a concrete strategy. In some 
studies, the kernel is selected in a visual way. However, this method is highly 
unpredictable and biased and therefore quantification methods have been 
proposed. Since the characteristics of the synthetic ICG signal to analyze are 
well known, it is possible to quantify which kernel produces the quadratic 
TFD with characteristics most similar to those of the ICG signal. Boashash 
and Sucic [169] proposed to measure the difference between the 
instantaneous frequency IF̂(n)  that a TFD produced and the theoretical 
instantaneous frequency IF(n). For this purpose, two statistical measures are 
used in order to quantify these differences: the mean square error (MSE) in 
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Equation (22) and the percentile root mean square difference (PRD) in 
Equation (23).  
MSE =






√∑ [IF(n) − IF̂(n)]
2
 Nn=1
√∑ [IF(n)]2 Nn=1  
 (23) 
where n is the time instant. 
Furthermore, Boashash and Sucic [169], [170], [181] also proposed a 
method to measure the performance of a TFD with an objective quantitative 
criterion expressed in Equation (24). 


















where for a pair of signal components at time n (in the total interval of N time 
instants), AM is the average of the components main lobes amplitudes, As is 
the average of the components sidelobes, AX is the in-between components 
cross-terms amplitude, E is the average of the components mainlobes 
bandwidths, and Δf is the frequency separation between the IF components. 
A low P indicates poor performance while values close to one indicate good 
performance. Both performance P and the different statistical measures are 
used to select the best TFD and its parameters. 
A new performance P calculation is proposed. It is based on a 
modification to Equation (24) to take into account that the tones in a 
synthetized ICG signal will not have the same amplitude. Equation (25) shows 
the adaptation of the performance for a two-tone synthetized ICG signal. 






















where, As1(n)  and As2(n) are the sidelobe amplitudes of tones 1 and 2, 
A1(n) and A2(n)  are the tone amplitudes of tones 1 and 2, Ax(n) is the 
amplitude of the cross-term between both tones, and D(n)  is defined in 
Equation (26). 
D(n) = (V1(n)/2 + V2(n)/2)/(f2(n) − f1(n)) (26) 
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where V1(n) and V2(n) are the bandwidths, and the instantaneous frequencies 
of the first and second tones are f1(n) and f2(n), respectively. 
A new approach has also been used in order to validate the performance 
of the studied distributions. Taking into account that the WVD of a linear 
frequency-modulated signal gives an unbiased estimate of the IF of such 
frequency, the performance of a TFD can also be studied as the likelihood 
between such TFD and the addition of the WVDs of every single tone in a 
test signal such as the synthetic ICG signal. This likelihood can be quantified 
by means of the cross-correlation (CC) between the studied TFD of the 
synthetized ICG signal, and the addition of the WVDs of every single tone in 
the synthetized ICG signal. 
Finally, the previously mentioned measurements (P, MSE, PRD and CC) 
have been applied to synthetic ICG signals with and without noise. To test 
the behavior of the different TFDs, noise tests have been conducted by 
corrupting the synthetic ICG signals with white noise in signal-to-noise ratios 
(SNR) decreasing from 20 dB to -5 dB in steps of 1 dB. 
According to the literature [167], [182]–[184], the sources of error in the 
estimation when detecting the IFs by using the TFD maximal positions are 
the estimate bias, the random deviation of the maxima in the auto-term due 
to small noise and the large random deviations due to false detection of 
maximal points outside the auto-terms. In [184], an adaptive IF estimator with 
a time-varying and data-driven window length is presented and the results are 
similar to the quality obtained if the IF information was known in advance. 
The work in [183] shows that the estimator of the polynomial WVD for 
signals with additive white Gaussian noise can be improved by the adequate 
selection of the kernel coefficients in the distribution. These works are 
expanded in [185] and it explains that the crucial parameter is the ratio of auto-
term magnitude and the standard deviation of the distribution. 
Once the initial synthetic signals have been designed and the optimized 
TFDs have been selected, these results have been applied to the complete 
database of 15 patients. Synthetic ICG signals have been designed using ICG 
patterns extracted from the real ICG signals in every patient. The synthetic 
ICG signals have been used to test the performance P, cross-correlation, and 
IF errors for the optimized TFDs. 
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6.4 Results of TFD Performance for Synthetic ICG 
Signals 
To test the performance of different TFDs, the previous synthetized two-
tone ICG signal with a linear frequency variation has been used. The 
performance has been calculated for each type of TFD kernel with the 
different characteristic parameters for each type of kernel. For each TFD, the 
values of the parameters for the best performance have been obtained 
through an optimization procedure to find the combination of parameters for 
which the performance P is maximal according to Equation (25). 
The results of the optimization process are plotted in Figure 6.1 and the 
specifications are included in Table 6.2. Figure 6.1 shows how the 
performance changes for each type of TFD depending on the values of several 
parameters such as window length 𝑤 for the spectrogram (Figure 6.1A), σ for 
the CWD (Figure 6.1B), a for the ZAM distribution (Figure 6.1C), β for the 
MBD (Figure 6.1D), LP and window length 𝑤 for the SM for all window 
types (Figure 6.1E), and α and β for the EMBD (Figure 6.1F). As the figure 
shows, the highest P performances are obtained for the spectrograms (except 
when the rectangular window is used) and the EMBD, and the lowest P 
performances are for the CWD. The S-Method provides results very similar 
to those offered by the spectrogram for all cases although slightly inferior. 
The blank spaces in Figure 6.1E represent the combination of values for 
which the performance calculation algorithm has not been able to identify the 
IF tones. Table 6.2 presents the values for these parameters for the best-
performance distributions, where the maximum performances are for the 
spectrogram when the Hamming (P = 0.781), Hanning and Bartlett (P = 0.780 
for both windows) windows are used, and for the EMBD (P = 0.778). 
In addition, the CC correlation between the studied TFDs of the 
synthetized ICG real-based signal, and the addition of the WVDs of the two 
single tone in the synthetized ICG signal is included in the same table. The 
CC correlation is best for the MBD and worst for some of the spectrograms 
and S-Method reaching even less than 0.5. Finally, a comparison between the 
expected and the resulting instantaneous frequencies has been performed 
using Equations (22)  and (23), whose results are also included in Table 6.2. 
 




Figure 6.1 TFD Performance optimization results: the resulting performance P of 
the spectrograms (A), ZAM distribution (B), CWD (C), MBD (D), SM (E) and 
EMBD (F) for varying parameters is plotted. The SM is optimized for a rectangular 
(E1), Hamming (E2), Hanning (E3) and Bartlett (E4) windows 
Table 6.3 includes all the numerical values of the characteristic points 
for the central slice, corresponding to the instant 5s: the sidelobe amplitudes 
of tones 1 and 2 (As1 and As2), the tone amplitudes of tones 1 and 2 (A1 and 
A2), the amplitude of the cross-term between both tones Ax, the bandwidths, 
V1 and V2 and the instantaneous frequencies of the first and second tones 
are f1(n) and f2(n), respectively. Figure 6.2A contains the plot of the time 
slice at t = 5s with the characteristic points used to calculate the performance 
P according to Equation (25) for the spectrogram with a Barlett window 
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(column 1), CWD (column 2), and EMBD (column 3). Figure 6.2B shows 
the resulting TFDs for the kernels spectrogram with Hanning window, CWD 
and EMBD, and Figure 6.2C shows the theoretical IFs and the resulting IFs 
located on the TFDs. Some features of these kernels can be easily seen in 
Figure 6.2. The non-negativity characteristic of the spectrogram provides 
zero-valued cross-term and secondary term amplitudes easy to locate. 
  TFD OPTIMIZATION RESULTS 
  
Parameters 
 MSE (%) PRD (%) 
  P CC IF1 IF2 IF1 IF2 
WVD  0.698 - 0.013 0.029 0.952 0.727 
BJD  0.698 0.557 0.117 0.286 2.907 2.274 
SM Rect. w=929, LP=1 0.769 0.588 0.000 0.000 1.092 0.902 
 Ham. w=999, LP=2 0.764 0.492 0.000 0.000 0.763 0.409 
 Han. w=999, LP=1 0.757 0.471 0.000 0.000 0.775 0.424 
 Bart. w=999, LP=2 0.765 0.498 0.000 0.000 0.804 0.461 
Spect. Rect. w=919 0.764 0.506 0.019 0.060 1.176 1.043 
  Ham. w=1569 0.781 0.495 0.048 0.139 1.870 1.584 
  Han. w=1779 0.780 0.501 0.020 0.066 1.194 1.092 
  Bart. w=999 0.780 0.448 0.009 0.021 0.795 0.617 
CWD 𝜎=4.12 0.715 0.600 0.077 0.149 2.359 1.638 
ZAM a=2.3 0.618 0.603 0.023 0.086 1.290 1.248 
MBD 𝛽=0.0026 0.765 0.686 0.072 0.107 2.272 1.392 
EMBD 𝛼=0.002, 𝛽=0.988 0.778 0.577 0.077 0.114 2.362 1.432 
Table 6.2 Best-performance P and correlation CC of TFDs with their parameter 
values; MSE and PRD for the resulting and theoretical IFs for the first (IF1) and 
second (IF2) tones. 
In Figure 6.2, the frequency width of the IFs is larger for the 
spectrogram than for other kernels such as the EMBD and the CWD. It is 
also noticeable how the spectrogram and the EMBD kernels provide a softer 
TFD with fewer cross-terms between the two frequencies, which are 
prominent in the case of the CWD. A large number of undulations appear in 
addition to the two main ridges which represent the sum of the two frequency-
modulated signals. In the theoretical WVD, the cross-terms are located 
midway between the interacting components, oscillate proportionally to the 
distance between the auto-terms and in a direction orthogonal to the line 
connecting these auto-terms. 
Quadratic TFDs in which cross-terms are attenuated relative to the auto-
terms in often named a reduced-interference distribution and it is a well-
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studied topic in the literature [167], [186]. In general, since auto-terms in the 
(t,f) plane are usually smooth, their corresponding version in the (𝜈, 𝜏) plane 
tends to be concentrated in the origin. On the contrary, Figure 6.2B shows 
that cross-terms tend to be oscillatory in the (t,f) plane which lead to terms 
far away from the origin in the (𝜈, 𝜏) plane. Choosing the right kernel in the 
(𝜈, 𝜏)  plane can filter out information far from the center and can thus 
attenuate cross-terms. In addition, the starting and final seconds of the TFD 
seem fuzzier than the rest of the TFD. This fact is to be taken into account 
when calculating the IFs of the distributions. 
SLICE OPTIMIZATION RESULTS 
   Characteristic Points in TF Slice 
  Pt=5s As1 IF1 V1 Ax V2 IF2 A2 As2 
WVD 0.668 -0.229 1.19 39.4 0.358 46.4 2.35 0.420 -0.076 
BJD 0.522 -0.172 1.22 198.4 0.074 247.8 2.29 0.374 -0.103 
SM Rect. 0.770 0.028 1.19 56.1 -0.003 59.7 2.35 0.384 0.022 
SM Ham. 0.763 0.000 1.19 75.8 0.000 82.7 2.35 0.395 0.000 
SM Han. 0.754 0.000 1.19 85.6 0.000 87.5 2.35 0.420 0.000 
SM Bart. 0.767 0.000 1.19 74.5 0.000 80.0 2.35 0.408 0.000 
Spect.Rect. 0.757 0.022 1.19 166.0 0.030 178.8 2.38 0.346 0.059 
Spect. Ham. 0.776 0.000 1.19 159.3 0.000 286.9 2.35 0.263 0.000 
Spect. Han. 0.781 0.000 1.19 174.6 0.000 217.3 2.35 0.333 0.000 
Spect. Bart. 0.768 0.000 1.19 228.0 0.000 246.9 2.35 0.402 0.000 
CWD 0.716 -0.072 1.19 176.1 0.094 243.8 2.35 0.338 -0.051 
ZAM 0.605 -0.456 1.19 86.1 -0.109 109.3 2.35 0.285 -0.167 
MBD 0.753 -0.014 1.19 65.00 0.173 83.0 2.35 0.244 0.016 
EMBD 0.782 0.004 1.19 119.6 0.037 177.0 2.35 0.267 -0.003 
Table 6.3 Slice optimization results: amplitudes As1 , Ax, A2, As2, frequency bands 
V1 and V2 (in mHz) of the IF1 and IF2 (in Hz) for the calculation of the instant 
performance Pt=5s. Amplitudes A1 are always the unit 
Finally, the analysis of the robustness of the different kernels in relation to the 
signal-to-noise ratio (SNR) is summarized in Figure 6.3. Noise in TFDs has 
been previous analyzed in depth and the bias and variance for different types 
of additive and multiplicative noise have been determined [187]. The study of 
the additive Gaussian noise influence on TFDs has led to the design of robust 
TF distribution using the robust minimax Huber M-estimates [186], [188]. 
 




















Figure 6.2 Optimized TFD Results: (1) A time slice at t = 5s of the TFD with 
the characteristics points As1 , Ax, A2, As2, and frequency bands V1 and V2 in red of 
the two tones and the cross tones for the calculation of the performance P. (2) The 
resulting optimized TFD. (3) Location of the resulting first (in blue) and second (in 
red) IFs, IF1 and IF2 against the theoretical results (in black), for each type of 
analyzed TFD: Spectrogram with a Bartlett window (A), CWD (B), and EMBD (C) 
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In this study, all kernels except ZAM, CWD and BJD present similar 
performance P between 0.76 and 0.78 when SNR = 20 dB and such 
performance decreases at a similar speed for all cases until reaching a 
performance P between 0.73 and 0.76 when SNR = -5 dB although the case 
at which the P decreases is slightly higher for EMBD and MBD Figure 6.3A 
and B. Regarding Figure 6.3C, the MSE values are not similar for all kernels 
and vary from 0.01 to 0.12 for SNR = 20 dB and from 0.02 to 0.22 for SNR 
= -5 dB. However, the evolution of the decrease in MSE with decreasing SNR 
is similar for all kernels and the MSE values remain constant after 10 dB. 
 
 
Figure 6.3 TFD results to noise tests. (A) and (B) show the performance P of 
several TFDs to different SNR rates; (C) shows the root mean square error (MSE) 
in the detection of the first instantaneous frequency 
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6.5 Results of TFD Performance for Real ICG 
Signals 
According to the procedure of creation of the synthetic ICG signals 
explained in Chapter 3, the most frequent pattern has been extracted from 
every patient with a correlation coefficient of th = 0.85 between ICG beats, 
as in the case for the synthetized ICG signal described in Chapter 3. All 
patterns are included in Figure 6.4. These patterns have been used to create 
synthetic ICG signals with known linear time-frequency variations in order to 
calculate their TFDs with different kernels and test their performances. Table 
6.4 includes the performance P, cross-correlation performance CC, MSE of 
IF, and PRD of IF. The performance at a single slice in the central time Pt=5s 
has also been included. The performance P is maximum for the spectrogram 
when either Hanning or Hamming windows are used, and for the EMBD, 
while the WVD and the ZAM offer the worst results. However, the WVD 
also offers some of the best results for the location of the instantaneous 
frequency since MSE and PRD are minimum. 
 
Figure 6.4 Main ICG pattern for all patients in the data base. X-axis is 
normalized time and y-axis is normalized ICG. Patterns have been normalized to 
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TFD RESULTS FOR THE COMPLETE DATABASE 
  Performance MSE (%) PRD (%) 
  P Pt=5s CC IF1 IF2 IF1 IF2 
WVD 0.601 ± 0.011 0.610 ± 0.010 - 0.016 ± 0.003 0.017 ± 0.006 1.081 ± 0.099 0.542 ± 0.087 
BJD 0.686 ± 0.003 0.684 ± 0.004 0.603 ± 0.027 0.095 ± 0.005 0.196 ± 0.041 2.617 ± 0.074 1.871 ± 0.181 
SM Rect. 0.762 ± 0.002 0.762 ± 0.002 0.577 ± 0.004 0.027 ± 0.009 0.030 ± 0.017 1.380 ± 0.230 0.715 ± 0.168 
SM Ham. 0.780 ± 0.000 0.780 ± 0.000 0.465 ± 0.002 0.008 ± 0.000 0.009 ± 0.001 0.781 ± 0.013 0.396 ± 0.016 
SM Han. 0.780 ± 0.000 0.780 ± 0.001 0.483 ± 0.003 0.008 ± 0.000 0.009 ± 0.000 0.785 ± 0.014 0.415 ± 0.006 
SM Bart. 0.765 ± 0.000 0.765 ± 0.000 0.490 ± 0.003 0.009 ± 0.001 0.011 ± 0.001 0.824 ± 0.033 0.446 ± 0.012 
Spec. Rect. 0.710 ± 0.003 0.714 ± 0.004 0.657 ± 0.005 0.022 ± 0.009 0.046 ± 0.018 1.244 ± 0.236 0.896 ± 0.153 
Spec. Ham. 0.614 ± 0.003 0.620 ± 0.001 0.634 ± 0.014 0.038 ± 0.003 0.145 ± 0.006 1.655 ± 0.067 1.616 ± 0.035 
Spec. Han. 0.764 ± 0.002 0.767 ± 0.002 0.621 ± 0.028 0.013 ± 0.001 0.068 ± 0.003 0.964 ± 0.043 1.103 ± 0.028 
Spec. Bart. 0.776 ± 0.001 0.782 ± 0.001 0.587 ± 0.003 0.010 ± 0.001 0.020 ± 0.001 0.832 ± 0.037 0.596 ± 0.023 
CWD 0.766 ± 0.001 0.767 ± 0.001 0.640 ± 0.027 0.064 ± 0.003 0.121 ± 0.017 2.145 ± 0.052 1.476 ± 0.097 
ZAM 0.764 ± 0.000 0.765 ± 0.000 0.692 ± 0.030 0.018 ± 0.001 0.073 ± 0.014 1.154 ± 0.039 1.143 ± 0.102 
MBD 0.757 ± 0.000 0.758 ± 0.000 0.798 ± 0.031 0.048 ± 0.003 0.107 ± 0.006 1.863 ± 0.065 1.387 ± 0.042 
EMBD 0.765 ± 0.000 0.766 ± 0.000 0.699 ± 0.026 0.054 ± 0.005 0.116 ± 0.005 1.978 ± 0.099 1.445 ± 0.031 
Table 6.4 Average of performance measures: performance P, performance 
Pt=5sof the time slice at t = 5s, and cross-correlation performance CC, and 
instantaneous frequency in MSE and PRD errors for all cases using several TFDs 
6.6 Discussion of Results 
In this work, the primary key finding is the proposal of an innovative 
methodology for choosing a suitable TFD for a real biomedical signal. On the 
one hand, several authors have previously addressed the complexity of 
selecting kernels for TFDs by using visual methods or characteristics of the 
signals to analyze [167]. Nevertheless, this work takes into account that such 
characteristics are often partially unknown and the proposed methodology has 
been applied to ICG signals. On the other hand, some authors have used 
wavelet transforms for denoising ICG signals and for locating the 
characteristics points of the ICG curve [147], [148], [189], [190]. The main 
difference is that wavelet analysis uses some given analyzing wavelets (such as 
the so-called Mexican hat or Morlet wavelets) while the objective of this work 
was to investigate the overall time-frequency content of the ICG signals.  
Taking the most characteristic pattern of a patient’s ICG signal, a signal 
with a pre-defined linearly-variant time-frequency characteristics has been 
constructed and used to calculate the goodness of several TFDs. The 
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goodness has been calculated using the geometrical characteristics of the TFD 
according to formulation adapted from prior publications [169], [170], [181], 
and the MSE and the PRD between the expected and the theoretical IFs of 
the TFDs. Furthermore, a new performance measure has been introduced 
taking into account the fact that the IF detected in a WVD for a frequency 
linearly-variant signal is the best approximation of the instantaneous 
frequency of the signal.  
The second key finding relates to the different TFDs analyzed. In our 
results, neither the spectrogram nor the newer MBD and EMBD are clearly 
superior to each other. According to the results in Table 6.2, the kernels with 
largest P performances are the EMBD and the spectrogram when used with 
Hamming, Hanning or Bartlett windows (P ∈[0.768,0.782]). The S-Method 
provides results similar to the spectrogram although slightly inferior. The 
MBD and the spectrogram with the rectangular windows also present high P 
performance but it should be noted that the spectrogram is more sensitive to 
the length of the rectangular window than to the length of the rest of windows, 
as it can be seen in Figure 6.1A. Figure 6.1F also shows that the EMBD 
provides a stable performance P for a large variety of values for the parameters 
α and β. 
The correlation CC is best for MBD and worst for the spectrogram and 
the S-Method. However, this seems not to define the ability to detect the IF 
as predicted since the best MSE for both IF1 and IF2 is for the spectrogram 
with the Bartlett window. The MSE and PRD for the WVD is also very low, 
which is in line with the theoretical description of the WVD having a perfect 
IF when the signal tone changes in a linear fashion. 
Regarding the performance P in the central time slice of the TFDs, the 
best performance P is such of EMBD followed by the Hanning spectrogram. 
It is important to note that there are almost no secondary and cross lobes. 
Nevertheless, the thinnest tone is detected by MBD (after the WVD for the 
reasons explained above). In fact, the spectrogram provides the widest tones 
irrespective of the window in use. This is detrimental for the location of 
instant tones such as the ones used in this work. Moreover, the cross-
correlation performance CC has offered poor results for the spectrograms 
while the resulting CC is best for MBD. 
In general, the robustness of the spectrogram is related to the lack of 
undesirable artifacts present in other TFDs since the non-linearity is 
introduced in the final step of the spectrogram computation (when taking the 
squared magnitude). Nonetheless, the spectrogram does not satisfy the 
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instantaneous frequency criterion of the quadratic class of TFDs and hence it 
does not allow the exact extraction of the signal IFs from its dominant peaks 
[167]. 
Regarding the noise test, the results have shown that no TFD stands out 
for its resistance to noise. The performance of the spectrogram seems to 
decrease at a slower speed than the performance of other TFDs with similar 
performance such as MBD and EMBD. The root mean square errors between 
the expected IF and the calculated IF follow the same pattern for all TFDs 
and start to rise for SNR less than 2 dB. Finally, the tests on the whole 
database of patients confirm the above-mentioned discussion, since the 
results have been very similar, according to Table 6.4. 
6.7 Conclusions 
The technique explained in this chapter sheds light on the methodological 
aspects of the selection of the best kernel to analyze ICG signals and the 
robustness of these kernels to noise has been analyzed. In the case of the ICG 
signals, some traditional kernels such as BJD could be discarded due to the 
results of this work. As a result, the final choice of the kernel to use must 
follow a thorough evaluation of the measurements described in this chapter 















































This chapter explores different TFD-derived features in order to 
characterize the time-frequency content of ICG signals with a reduced 
number of information. The features derived by using several kernels are also 
compared and discriminant analyses were conducted to differentiate between 
the TFD features from the ICG signals registered before and after the 
patient’s loss of consciousness during anesthesia procedures. The results of 
this chapter have been accepted for publication in the journal “Methods of 
Information in Medicine”.  
7 
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7.1 Introduction 
TFDs offer a useful insight in the time-frequency content of signals but 
they contain considerably large amounts of data. Therefore, features are to be 
extracted from the TFDs in order to improve its characterization. Several 
authors have proposed different features applied to TFD in order to describe 
non-stationary signals or to locate events based on the signal entropy, energy 
concentration measures or singular values decomposition [191]–[194]. This 
chapter compiles some of those features in order to apply them to the ICG 
signals from the CMA database explained in Chapter 3. Several kernels are 
also compared and discriminant analyses were conducted to differentiate 
between the TFD features from the ICG signals registered before and after 
the patient’s loss of consciousness during anesthesia procedures, as it has been 
also presented in Chapter 4 and 5. 
7.2 TFD-Derived Features 
The time variation in the spectrum of a signal can be characterized with 
several features extracted from its TFDs. This paper analyses a collection of 
TFD measures based on singular value decomposition (SVD), entropy 
characteristics, energy concentration and time and frequency characteristics of 
the ICG signal. 
7.2.1 SVD-Based TFD-Derived Features 
A TFD of NxM (time samples x frequency samples) can be decomposed 
using its singular values in the form 𝜌 = USVH, where U is an NxN matrix, S 
is an NxM diagonal matrix with positive real singular values 𝜎i, and V
H is an 
MxM real unitary matrix. Following previous works [191]–[193], in this 
investigation several features are extracted from the singular values  𝜎i of the 
TFD, such as: FSVD1, the maximum  𝜎i ; FSVD2, standard deviation of  𝜎i ; and 
FSVD3, the number of non-zero 𝜎i . 
7.2.2 Entropy-Based TFD-Derived Features 
The concept of Shannon Entropy [195] has been applied to both the 
design of new TFDs with minimum entropy [194] and the quantification of 
TFD complexity in TFDs. If the TFD is interpreted as a quasi-probability 
distribution, a highly-concentrated TFD with a small number of components 
has a lower entropy than a signal with a large number of components. The 
TFD complexity (TFCM) in Equation (27) uses both SVD and Shannon 
entropy concepts and it represents the magnitude and the number of the non-
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zero singular values of the TFD [191], [192]. It is a useful feature as their 
magnitudes have a strong relationship with the information content in the 
TFD. 
TFCM =  − ∑ 𝜎i̅ log 𝜎i̅
N
i=1
, 𝜎i̅ > 0 (27) 
where 𝜎i̅ are the N normalized singular values, i.e.: 𝜎i̅ = 𝜎i/ ∑ 𝜎i
N
i=1 . 
If the entropy of a TFD is to be calculated without using its singular 
values, the Time-Frequency Rényi entropy (TFRE)  in Equation (28) is used 
in substitution of the Shannon entropy [196]. The latter cannot be used for 
the majority of TFDs as these are not non-negative. TFRE is a statistical tool 
sensitive to the number of signal components, their time duration and 










, q > 2 (28) 
 
The TFRE for odd values of q causes zero-mean cross-terms to diminish 
due to the summation operation. Thus, the TFRE cannot discriminate a high-
resolution TFD with significantly reduced cross-terms from a high-resolution 
TFD without any suppression of cross-terms. The TFD normalized Rényi 
entropy (TFNRE) in Equation (29) solves this issue so that cross-terms have 
an overall effect of reducing the TFNRE. 
TFNREq =  −
1
2
log2 ∑ ∑ [
𝜌[n, m]








+ log2 δtδf (29) 
where δt  and δf  are the time and frequency sampling steps, respectively. 
Baranjiuk et al. [197], [198] analyzed the influence of the parameter q when 
calculating both TFRE and TFNRE and concluded that non-integer orders 
are yield complex values and so appeared of limited utility. In this study, a 
large range of q values (q = {3, 4, …, 14, 15, 18, 21, 24, 27, 30, 35, 40, 45, 50}) 
have been selected for TFRE and TFNRE in order to analyze its influence. 
7.2.3 Extended Time-Domain TFD Features 
In order to use statistical time-domain features, such as mean and 
variance, the one-dimensional time-domain moments have been replaced with 
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the corresponding two-dimensional TF characteristics according to [199]. 
Table 7.1 includes all extended time-domain features. 
 
TIME-FREQUENCY EXTENSION OF TIME-DOMAIN FEATURES 

















































TFD Coef. of variation 
cTF = 𝜎TF/mTF (34) 
 
Table 7.1 Time-frequency extension of time-domain features 
7.2.4 Extended Frequency-Domain TFD Features 
The energy concentration measure (ECOME) determines the 
concentration of the dominant component at each location in the TF domain. 
Signals with TFD distributed in the TF plane will have a larger ECOME, while 
concentrated TFDs will have a smaller ECOME. 









, r > 1  (35) 
 
Sub-band energy-based features represent the energy of the ICG signal 
in different frequency sub-bands. To the best of the authors’ knowledge, no 
previous studies have been published regarding the spectral content of the 
ICG signals. Therefore, the frequency plane of the TFDs has been divided by 
visual inspection and by using pairs of logarithmically spaced values. In total, 
138 frequency bands have been analyzed and their corresponding features 
have been calculated using Equation (36). 





, i = 1 … 138 (36) 
where Mi0 and Mi1 delimit the starting and end frequencies of the i-th band. 
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7.3 Selected Features and Statistical Analysis 
For the work in this chapter, several TFD kernels have been used: the 
spectrogram with Hanning window, the Choi-Williams Distribution (CWD), 
the Zhao-Atlas-Marks distribution (ZAM), the Modified B-Distribution 
(MBD) and the Extended Modified B-Distribution (EMBD). Their 
parameters have been selected by using the synthetic signals explained in 
Chapter 3 and using the methodology presented in Chapter 6. The details of 
the kernels are included in Table 6.2. 
In order to characterize signals corresponding to the segment previous 
to LOC and that after LOC, a range of features were selected in our study. 
These features are listed in Table 7.2. 
SELECTED TIME-FREQUENCY FEATURES 
Class Feature Name Formulation 
SVD-based Maximum SV FSVD1 
 SV Standard Deviation FSVD2 
 SV Range FSVD3 
Entropy-based TF Complexity TFCM 
 TF Rényi Entropy TFREq 
 TF Normalized Rényi Entropy TFNREq 
Extended time-domain Mean mTF 
 Variance 𝜎TF
2  
 Kurtosis kTF 
 Skewness 𝛾TF 
 Coefficient of variation cTF 
Concentration-based Energy Concentration ECOME 
Sub-bands energy-based Energy in i-th band FBandi, i = 1 … 138 
Table 7.2 Selected features to distinguish between pre-LOC and post-LOC ICG 
segments. All features are n.u. 
Quantitative data are presented as mean ± standard deviation and 
qualitative data as frequency (percentage). A non-parametric test, the 
Wilcoxon signed-rank test, was used to investigate whether the analyzed 
features changed after induction of anesthesia. 
Features that satisfy this condition were considered for building a linear 
discriminant function. The leave-one-out method was used for validation. 
Sensitivity (Sen), specificity (Spe) and the area under the curve (AUC) of the 
receiver operating characteristic (ROC) curve were calculated to assess the 
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ability of the studied features to predict the occurrence of LOC. Sen 
represents the proportion of pre-LOC ICG segments correctly classified as 
pre-LOC and Spe represents the proportion of post-LOC ICG segments 
correctly classified as post-LOC. 
Grouped sensitivities and specificities are presented as mean [95% 
confidence interval (CI)]. In the classification, the cut-off values are always 
the main of the centroids of the groups. Predicted membership is calculated 
by first producing a discriminant score for each case using a linear 
discriminant function. Then cases are classified in a concrete group depending 
on whether their discriminant score is smaller or larger than the cut-off value. 
Relationship between time-frequency derived indices and patient 
characteristics was assessed using Pearson’s coefficient of correlation (𝜌). 
Significance level was always set at p-value<0.05. 
 
7.4 Results of TFD-Derived Features 
After isolating ten-second segments from before and after LOC, TFDs 
were calculated with different kernels and, then, the features were extracted 
and analyzed. Figure 7.1 displays an example of a case analyzed using an 
EMBD. Figure 7.1A shows the pre-LOC TFD and Figure 7.1B shows the 
post-LOC TFD. The main differences between the two states are the content 
below 1Hz and the instantaneous frequencies, which seem to be lower in 
Figure 7.1B. The subsequent results aim to show tables and figures how the 
several TFD-derived features reported in Table 7.2 are related to the patient’s 
state. 
  
Figure 7.1 EMBD of an ICG segment before LOC (A) and after LOC (B) 
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7.4.1 SVD-based TFD-derived Features 
SVD-based TFD features change from before to after LOC in a 
statistically significant manner in the case of FSVD1, FSVD2 and FSVD3 values. 
Table 7.3 shows the average values for these features for all the TFD kernels.  
It can be seen that the defined SVD features are higher before LOC than after 
LOC. These results have been obtained with values of Sen, Spe and AUC very 
similar for all kernels and all SVD-based TFD features. In this way, over the 
different kernels used, Sen(%) is 76.4 [1.1] for FSVD1, 78.0 [0.6] for FSVD2 and 
65.0 [3.2] for FSVD3. In addition, Spe(%) is 49.2 [0.4] for FSVD1, 51.0 [0.4] for 
FSVD2 and 57.0 [2.5] for FSVD3; AUC is 0.69 [0.01] for FSVD1, 0.70 [0.00] for 
FSVD2 and 0.65 [0.01] for FSVD3. The best SVD-based TFD feature is FSVD3 
calculated with an EMBD kernel, which presents an AUC = 0.63, Sen = 67.7% 
and Spe = 60.3%. 
  SVD-BASED TFD FEATURES 
  FSVD1 FSVD2 FSVD3 
  pre-LOC post-LOC pre-LOC post-LOC pre-LOC post-LOC 
CWD (4.0 ± 3.0)·104 (2.4 ± 1.6)·104 (9.8 ± 7.1)·102 (5.6 ± 3.7)·102 (8.1 ± 1.4)·101 (7.4 ± 1.3)·101 
MBD (1.5 ± 1.1)·105 (9.2 ± 6.4)·104 (3.6 ± 2.6)·103 (2.0 ± 1.4)·103 (1.3 ± 0.1)·102  (1.2 ± 0.2)·102 
EMBD (1.4 ± 1.1)·107 (8.4 ± 5.8)·106 (3.2 ± 2.3)·105 (1.8 ± 1.2)·105 (2.4 ± 0.6)·102 * (2.1 ± 0.5)·102 
Spec. (Han.) (1.5 ± 1.1)·107 (8.3 ± 5.6)·106 (3.1 ± 2.3)·105 (1.7 ± 1.1)·105 (1.0 ± 0.1)·102 (9.7 ± 1.2)·101 
ZAM (6.3 ± 4.7)·106 (3.8 ± 2.7)·106 (1.6 ± 1.2)·105 (9.1 ± 6.0)·104 (5.4 ± 1.9)·102 (4.6 ± 1.4)·102 
Table 7.3 Mean and standard deviation of the SVD-based TFD features. All changes 
between pre-LOC and post-LOC are statistically significant. * indicates that Sen > 60%, Spe 
> 60% and AUC > 60%. 
 
7.4.2 Entropy-based TFD-derived Features 
Regarding the entropy-based TF features, several results have been 
obtained. The TFCM presents statistically significant differences between pre-
LOC and post-LOC for all kernels (see Figure 7.2). In average for all kernels, 
Sen(%) is 65.4 [4.5], Spe(%) is 51.6 [1.6] and AUC is 0.62 [0.03]. The 
complexity of the TFD responses is greater during pre-LOC than during post-
LOC. 
TFREq  always shows statistically significant differences between pre-
LOC and post-LOC for all kernels and for all q values. Furthermore, Sen, Spe 
and AUC are similar for all q values as seen in Figure 7.3 and also for all 
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kernels as Table 7.4 shows. Figure 7.3A shows the TFREq for an exemplary 
kernel such as the EMBD for all the different q values. TFREq emphasizes 
high probabilities when q > 1. This figures shows how the values converge as 
the q increases and the values are always higher for the pre-LOC signals than 
for the post-LOC signals. 
 
 
Figure 7.2 TFCM values for different kernels before (blue) and after (red) LOC. 
All changes are statistically significant 
 
AREA UNDER THE CURVE FOR TIME-FREQUENCY RÉNYI ENTROPY 
 





CWD 61.52 [0.16] 68.90 [0.24] 0.69 [0.00] -9.26 ± 1.18 -8.51 ± 1.13 
MBD 61.07 [0.19] 67.19 [0.48] 0.69 [0.00] -11.38 ± 1.25 -10.59 ± 1.21 
EMBD 63.01 [0.09] 69.33 [0.27] 0.71 [0.00] -17.64 ± 1.24 -16.77 ± 1.20 
Spec. (Han) 62.29 [0.36] 69.92 [0.21] 0.72 [0.00] -17.15 ± 1.23 -16.22 ± 1.13 
ZAM 62.44 [0.27] 69.41 [0.46] 0.70 [0.01] -16.73 ± 1.22 -15.91 ± 1.15 
Table 7.4 Values for Time-Frequency Rényi Entropy: Mean [95% CI] of area under the 
curve (AUC) of the receiving operating curve (ROC), sensitivity (Sen) and specificity (Spe) 
of the TFREq feature for all the studied distributions and all q values. TFRE50 values for 
before and after LOC have also been included 
TFNRE also shows statistically significant differences between pre and 
post-LOC for all q values in the case of the spectrogram and in the case of 
the EMBD for q ≥ 6. Compared to the TFRE values, the normalization has 
decreased the AUC below 0.6 in all cases and Sen and Spe are below 60%. 
Figure 7.3B also shows the TFNRE for an exemplary kernel such as the 
EMBD for all the different q values. 




Figure 7.3 Pre (blue) and post-LOC (red) median values for TFRE (A) and 
TFNRE (B) for the EMBD. Changes between pre-LOC and post-LOC values are 
always statistically significant (p-value<0.05) 
7.4.3 Extended Time-Domain TFD-derived Features 
The time-extended TF features show statistically significant differences 
between the pre-LOC and post-LOC values of mTF  and  𝜎TF
2 , for all TFD 
kernels. In addition, there are also statistically significant differences in the 
case of kTF for all TFD kernels except for the CWD and in the case of the 
𝛾TF for all TFD kernels except for CWD and ZAM. The difference between 
the pre-LOC and post-LOC values of cTF is only statistically significant for 
the spectrogram. For all TFD kernels, the AUC for these features is 0.70 
for  mTF  and  𝜎TF
2 , and between 0.51 and 0.63 for kTF, 𝛾TF  and cTF . Spe is 
always lower than 60% (between 38.2 and 54.2) for all time-extended TF 
features and for all kernels but Sen(%) is in average 75.5 [0.3] for mTF and 
85.8 [0.3] for 𝜎TF
2 . Table 7.5 shows that all the time-extended TF features 
decrease after LOC for the spectrogram. This also occurs for the rest of 
kernels. 
EXTENDED TIME-DOMAIN TFD-DERIVED FEATURES 
 pre-LOC post-LOC 
mTF 486.5 ± 340.5 275.0 ± 168.4 
𝜎TF
2  (3.6 ± 5.3)·107 (1.0 ± 1.5)·107 
kTF 16.1 ± 2.8 15.0 ± 2.4 
𝛾TF 319.0 ± 100.9 278.0 ± 87.1 
cTF 9.8 ± 1.5 9.5 ± 1.3 
Table 7.5 Time-extended TF features of the ICG signals before and after 
LOC using the spectrogram kernel with a Hanning window. All changes are 
statistically significant. Features have arbitrary units. 
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7.4.5 Energy Concentration 
ECOME values for all TFD kernels before and after LOC are plotted in 
Figure 7.4 and these are higher after LOC than before it. All changes have 
proven to be statistically significant. In average, Sen(%) is 75.3 [2.1], Spe(%) 
is 51.6 [1.7] and AUC is 0.72 for all kernels. 
 
 
Figure 7.4 Pre and post-LOC ECOME values for the CWD (A), the EMBD (B), 
the MBD (C), the spectrogram with a Hamming window (D) and the ZAM 
distribution (E). Changes between pre and post LOC values are always statistically 
significant (p-value<0.05) 
7.4.6 Sub-Bands Energy-based Features 
The spectrum of the TFDs has been divided into 138 different frequency 
bands. The MBD and the ZAM distribution are the ones with the largest 
number of statistically significant frequency bands, with 114 and 116, 
respectively. The rest of kernels provide less significant bands: EMBD with 
106 bands, CWD with 100 band and the spectrogram with a Hanning window 
with 91 bands. The spectral content of the TFD bands is always greater before 
LOC than after LOC. AUC is in almost all cases above 0.6 but both Sen and 
Spe are not larger than 60% at the same time. Figure 7.5 shows how the 
energy in some of the frequency bands changes between before and after LOC. 
Moreover, this figure also shows how most energy is concentrated between 1 
and 4 Hz. The very low frequency from 0 to 0.05 Hz is also prominent, due 
to the non-zero signal mean. 




Figure 7.5 Mean and standard deviation of the energy of some bands for the pre-
LOC (blue) and post-LOC (red) periods. The kernel used for this figure is the 
MBD. * indicates that the change is statistically significant (p-value<0.05) 
7.5 Discussion of Results 
TFDs have been analyzed using five different kernels and information 
has been extracted using several features based on SVD decomposition, 
entropy, extended time-domain, concentration and sub-bands energy. All 
features decreased after LOC. The EMBD kernel offered the largest quantity 
of features with statistically significant differences with 156 features. There 
were found 129 features for CWD, 129 for MBD, 147 for the spectrogram 
and 146 for ZAM distribution. As it can be seen in Table 7.3, Table 7.4, and 
Table 7.5, after EMBD kernels such as the spectrogram and the ZAM 
distribution also offer a large amount of significant features but ZAM usually 
introduces more cross-terms than other distributions. 
The robustness of the spectrogram is generally related to the lack of 
undesirable artifacts present in other TFDs since the non-linearity is 
introduced in the final step of the spectrogram computation. Nonetheless, the 
spectrogram does not satisfy the instantaneous frequency criterion of the 
quadratic class of TFDs and hence it does not allow the exact extraction of 
the signal IFs from its dominant peaks. 
Among all the features which have been analyzed, TFRE is the most 
successful. For all kernel types and for any q value, TFRE values decrease 
after the loss of consciousness and both their sensitivity and specificity are 
always above 60%. Moreover, the AUC is always above 0.6. The increase in 
the TFRE is theoretically related to the decrease of predictability or the 
increase of disorder. From a biological point of view, this would imply that 
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the ICG signals are more deterministic after LOC, which could be related to 
the mechanical ventilation of the patient during anesthesia. Regarding the sub-
bands energy-based features, these show that most of the ICG energy is 
concentrated between 1 and 4 Hz, since their values are higher than in the rest 
of frequency band. Nevertheless, sensitivity and specificity of the features 
should be improved in the future for such features to be adequate for clinical 
applications. 
Our study presents some limitations which must be considered. The 
pharmacological effects of the drugs infused in the patients may induce 
different depth of anesthesia states depending on the target concentrations. 
This is especially true when analyzing signals after LOC. This fact does not 
reduce the validity of results but should be taken into account especially in 
future works for which information from depth-of-anesthesia monitors 
should be included. 
7.6 Conclusions 
In conclusion, this chapter presents a collection of various features which 
can be obtained from TFDs. Different kernel TFDs have been calculated and 
their results have been compared. When analyzing signals representing 
different anesthetic states, the TF Rényi entropy is the most prominent feature. 
Regarding the various kernels which have been analyzed, the EMBD is the 
most successful for the extraction of features showing statistically significant 











8. TFDs and 
Recurrence Plots for 





This chapter extends the work in the previous chapter by analyzing the 
behavior of features derived from the TFDs during anesthesia. In addition, 
features from Recurrent Plots – a methodology to analyze periodicities in non-
stationary signals – are also included in the analysis. Relationships between all 
the presented features with hemodynamic parameters and depth of anesthesia 
are calculated. Finally, several prediction models for CO and depth-of-
anesthesia state are discussed. 
  
8 
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8.1 Introduction 
In the previous chapters, an analysis of TFDs for ICG signals has been 
presented and some results regarding TFD-derived features have also been 
analyzed. Nevertheless, the study in Chapter 7 has only considered two 
different patient states: consciousness and unconsciousness. Therefore, the 
study presented in the present chapter completes the previous analyses by 
including complete surgery procedures. 
The main objective is to analyze the changes in TFD-derived features in 
ICG signals during the whole surgeries. This chapter first describes the 
relationship between TFD-derived features and the depth of anesthesia. It 
also describes the relationships between TFD-derived features and the 
hemodynamic state of the patient, defined by the HR, CO, SV, and blood 
pressure. Finally, the relationship between TFD-derived features and heart 
rate variability indices described in Chapter 4 is also analyzed. Furthermore, 
features extracted from recurrence plots of ICG signals are also studied along 
with TFD-derived features. As a secondary objective, several system such as 
classification trees and adaptive neuro-fuzzy inference systems (ANFIS) are 
designed to predict cardiac output and depth of anesthesia by using TFD-
derived features. 
8.2 Recurrence Plots Features 
The Recurrence Plot (RP) graphically displays distance correlations and 
non-stationarity in time series. No mathematical assumptions regarding the 
system generating the time series are required and thus this tool is suitable for 
the analysis of physiological signals such as the ICG [200]. 
RPs are calculated using an embedding dimension m, a time delay t and 
a threshold value 𝜀. First, the time series to analyze is embedded to a high-
dimensional space with the time-delay embedding technique and a trajectory 
matrix is obtained [201], [202]. The trajectory matrix X for a time series si  of 







s1 s1+t … s1−(m−1)t










Each of the M = N − t(m − 1) row vectors xj in the matrix represents 
an m-dimensional trajectory point in the reconstructed state-space. The RP of 
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a signal can be obtained with the state-space reconstruction. The RP is an 
MxM matrix whose elements can be calculated using Equation (38). 
Ri,j = Θ(𝜀 − ‖xi − xj‖)     i, j = 1,2, … , M (38) 
where Θ is the Heaviside function and the ‖·‖ is the Euclidean norm, defined 
in Equation (39) and Equation (40), respectively. This means that if the 
distance between xi and xj is less than a threshold 𝜀, then Ri,j = 1. 
Θ(z) =  {
0, z ≤ 0
1, z > 0
    (39) 
∀z = {z1, … , zM}, ‖z‖ = √|z1
2| + ⋯ + |zM
2 | (40) 
 
The RPs are quantified with the recurrence rate RRrec  (percentage of 
recurrence points in a RP, which corresponds to the correlation sum), the 
determinism DET (the percentage of recurrence points which form diagonal 
lines), the entropy ENTR (the Shannon entropy of the probability distribution 
of the line lengths) and the average diagonal line length L. The more periodic 
a signal is, the higher RRrec  is. It reflects the longest duration of a stable 
interaction and the average duration of these interactions. DET offers 
information about the duration of a stable interaction. In our study, ℓmin is 2 
samples. Finally, the more different the length of the diagonals are, the more 
complex the deterministic structure of the RP is and the larger the ENTR 
value is.  
In Table 8.1, these measures are explained. In addition, P(ℓ) is the 
number of diagonal structures whose length is ℓ and p(ℓ) is the probability 
density of the diagonal structure whose length is ℓ  and it is defined as 
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Table 8.1 Features derived from Recurrence Plots 
 
8.3 TFD-Derived Features 
For this study of the time-frequency characteristics of the ICG signals, a 
spectrogram with a rectangular window was constructed for every second of 
signal. In Chapter 7, spectrograms showed a considerable performance and 
its Fourier Transform implementation is simple. This was accomplished by 
using the last 10 seconds of available signal. ICG signal segments for which 
the associated Signal Quality Index (SQI) was decreasing were discarded. SQI 
is given by the qCO monitor and it reflects the quality of the signal. All signal 
segments with an increasing SQI were accepted. TFD-Derived features from 
Chapter 7 were calculated for those spectrograms: extended time-domain 
TFD features (mean mTF, variance 𝜎TF
2 , skewness 𝛾TF, kurtosis kTF, coefficient 
of variation cTF), extended frequency-domain TFD features (ECOME), and 
entropy-based TFD-derived features (Rényi Entropy TFREq and normalized 
Rényi Entropy TFNREq). Rényi entropies were calculated with q = 3 since the 
literature research [196]–[198]and results in Chapter 7 showed that this 
parameter provides efficient results. Furthermore, three additional extended 
frequency-domain TFD features are calculated [203]: 
- TF flux: provides an assessment of the rate of signal energy in the TF 
domain. 
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where 𝜌z[n, k] is the discretization of the NxM TFD, and ℓ and q 
determine the direction along which the rate of change of the signal 
energy is estimated. Three TF flux directions are calculated: the time 
axis using (ℓ = 0, q = 1), the frequency axis using (ℓ = 1, q = 0), 
and the diagonal axis (ℓ = 1, q = 1). 
- TF flatness: is defined as the ratio of the geometric mean of a TFD 
divided by its arithmetic mean. It is a useful tool to classify signals 
whose energy is concentrated in the time-frequency plane from 
signals whose energy is spread in this same domain. 
𝒮ℱ = MN












- Minkowski distance: is a distance measure, which is not sensitive to 
small values in the TFD. Signals with power distributed over the 
whole time-frequency plane will have a larger M2. 











The TFD total energy Etot , the five first Instantaneous Frequencies 
IFi, i = 1 … 5, its energies Ei, i = 1 … 5, and the decay of such energies were also 
calculated. 
8.4 Statistical Analysis 
Recurrence Plots are calculated varying the embedding dimension m={2, 
3, 4, 5, 6}, the time delay t={1, 33, 62} and a threshold value 𝜀={0.3, 0.5, 0.7}. 
The first objective of this Chapter was to choose the best combination of 
parameters t, m and 𝜀 to enhance the difference between RPs of ICG signals 
taken from before and after LOC. Therefore, mean and average of the RP-
derived features from before and after LOC were calculated and a 
discriminant analysis was conducted. The final selection was made based on 
the best specificity Spe(%), sensitivity Sen(%), and area under the ROC (AUC). 
A total of 131 patients from the CMA database explained in Chapter 3 were 
analyzed for selecting the best combination of RP parameters. 
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As explained in Chapter 2, the index of depth of anesthesia qCON was 
divided into four different patient states: awakeness (qCON > 80), sedation 
(qCON ∈  [60, 80]), general anesthesia (qCON ∈  [40, 60]) and deep 
anesthesia (qCON < 40). The probability of prediction of the patient states 
Pk has been calculated for all TFD-derived and RP-derived features. In this 
case, both TFD-derived and RP-derived features have been calculated for 
every second of signal using the last 10 seconds of available signal. The 
prediction probability Pk  has been explained in Chapter 2. Correlations 
between all TFD-derived and RP-derived features with HRV indices, blood 
pressure, CO, SV and depth-of-anesthesia index qCON have also been 
calculated. 
In addition, decision trees have been trained to predict the patient state 
(awakeness, sedation, general anesthesia, and deep anesthesia) by using several 
TFD-derived features and RP-derived features. Finally, adaptive neuro-fuzzy 
inference systems (ANFIS) were also trained to predict cardiac output. 
Decision trees are a type of training systems useful to predict categorical 
variables (such as the patient’s anesthetic state). ANFIS are useful to model a 
continuous output variable when one or more continuous input variables are 
available. 
8.5 Selection of RP Parameters 
An initial RP was calculated as t = 1 sample, m = 3, 𝜀 = 0.5. Figure 8.1A 
and Figure 8.1B show the trajectory matrix of a pre-LOC ICG signal and a 
post-LOC ICG signal, respectively. Using the m-dimensional trajectory matrix 
and Equations (37) and (38), the RPs can be constructed. Figure 8.2A shows 
the RP before the LOC and Figure 8.2B shows the RP after LOC. Figure 
8.2C and Figure 8.2D show the recurrence plot with no threshold 𝜀. 
Table 8.2 and Figure 8.3 show the results of the four features extracted 
from the previous RPs. All RP-derived features show statistically significant 
difference in the two cases studied (before and after LOC). Sen and AUC are 
especially high for DET while Spe is higher for L than the rest of features. 
Both the plots and the table show how all RP-derived features increase after 
LOC. In general, ENTR is the best parameter in AUC, Spe and Sen. 
 




Figure 8.1 Three-dimensional trajectory matrix of a pre-LOC (A) and post-LOC 
(B) ICG signals. ICG(n-t), ICG(n-2t) and ICG(n-3t) are delayed versions of the 
ICG signal with m=3 and t=1 
 
Figure 8.2 Recurrence plots with m=3 and t=1 samples above a threshold 𝜀 = 0.5 
before (A) and after LOC (B) and recurrence plots with no threshold before (C) 
and after LOC (D) 
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DESCRIPTION OF RP-DERIVED FEATURES 
 Both Pre-LOC Post-LOC AUC Sen Spe 
RRrec 0.206 ± 0.036 0.201 ± 0.034 0.212 ± 0.037 0.605 50% 66% 
DET 0.997 ± 0.003 0.996 ± 0.004 0.998 ± 0.002 0.718 84% 53% 
ENTR 3.120 ± 0.293 3.010 ± 0.289 3.230 ± 0.255 0.716 70% 63% 
L 11.6 ± 2.9 10.7 ± 2.5 12.6 ± 2.9 0.700 59% 69% 
Table 8.2 Mean, standard deviation and discriminant analysis of the RP-derived 
features with t = 1 samples, m = 3, and 𝜀 = 0.5. All differences have p-value < 
0.05, rejecting the hypothesis that the distribution of the difference of the paired 
values of before and after LOC of a feature comes from a zero-median distribution 
 
Figure 8.3 Boxplots of the quantification features of the recurrence plots for t = 1 
samples, m = 3, and 𝜀 = 0.5. On each box, the central mark indicates the median, 
and the bottom and top edges of the box indicate the 25th and 75th percentiles, 
respectively. The whiskers extend to the most extreme data points not considered 
outliers, and the outliers are plotted individually using the '+' symbol 
Other combinations of parameters were tested: 𝜀 was set to {0.3, 0.5,  
0.7}; t was set to {1, 3, 33, 62} samples; m was set to {1, 2, 3, 4, 5, 6}. The 
delays t = {1, 3} samples were proposed as an initial exercise and t = {33, 62} 
samples were proposed since they are a multiple of the dominant period 
(which here is supposed to be a heart rate of 60 bpm). This ensures an accurate 
reconstruction of a system’s underlying attractor [204]. Other studies [205] 
also propose to use the minimum lag which minimizes the autocorrelation 
function of the signals since this value maximizes the linear independence of 
the coordinates of the embedding vector. 
Figure 8.4 shows the evolution of the AUC of DET, ENTR, L and RR 
with t, m and 𝜀 . As it can be seen in Figure 8.4A, AUC of RP-features 
decrease with m. Figure 8.4B shows that AUC is maximum for t = 33 and 
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Figure 8.4C shows that AUC is approximately constant with 𝜀 for DET and 
RRRec. The AUC of L increases with 𝜀 while AUC of ENTR decreases. RPs 
calculated with t = 33 samples, m = 2 and 𝜀 = 0.5 were used for the rest of 
this chapter due to its high AUC, Sen and Spe. Table 8.3 shows the results 
for this combination. Other combinations which provided similar results were 
t = 33, m = 3 and 𝜀 = 0.5, and t = 1, m = 4 and 𝜀 = 0.5. 
 
Figure 8.4 Evolution of AUC of the RP-derived features with the RP parameters: 
dimension m (A), lag t (B) and error 𝜀 (C) 
DESCRIPTION OF RP-DERIVED FEATURES 
 Both Pre-LOC Post-LOC AUC Sen Spe 
𝑅𝑅𝑟𝑒𝑐 0.114 ± 0.036 0.108 ± 0.033 0.120 ± 0.038 0.623 46% 68% 
DET 0.998 ± 0.002 0.997 ± 0.002 0.998 ± 0.001 0.760 81% 53% 
ENTR 3.211 ± 0.347 3.074 ± 0.330 3.348 ± 0.309 0.724 67% 65% 
L 13.2 ± 4.0 11.8 ± 3.3 14.7 ± 4.1 0.719 63% 70% 
Table 8.3 Mean, standard deviation and discriminant analysis of the RP-derived 
features with t =33, m = 2, ε = 0.5. All differences have p-value < 0.05, rejecting 
the hypothesis that the distribution of the difference of the pairs of before and 
after LOC of a feature comes from a zero-median distribution 
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8.6 Changes in Features with Depth of 
Consciousness 
For this analysis, a total of 83 cases from the CMA database explained in 
Chapter 3 were analyzed and both TFD-derived and RP-derived features were 
extracted. The rest of cases were discarded since the SQI was decreasing 
excessively often (>33% of the case) so that features could not be extracted. 
The index for depth of consciousness, qCON, was grouped into two different 
ways. First, the prediction probability Pk for awake/asleep was analyzed. Then, 
the prediction probability Pk  was calculated for the four different states: 
awakeness, sedation, anesthesia, deep anesthesia. During surgical operations, 
patients are usually longer in the anesthesia or deep anesthesia states. 
Therefore, the largest equal amount of data points were selected for every 
state before calculating Pk values. Table 8.4 compiles these Pk values. The Pk 
values have been reassigned according to Equation (48) to avoid directional 
information. Both TFD-derived and RP-derived features are included. 
Pk′ = |Pk − 0.5| + 0.5 (48) 
PREDICTION PROBABILITY PK OF FEATURES 
 
 4 states 2 states    4 states 2 states 
IFs 





Etot 0.582 0.715 
IF2mean 0.538 0.604  TFREq 0.541 0.683 
IF3mean 0.531 0.637  TFNREq 0.658 0.798 
IF4mean 0.533 0.650  ℱℒ(0,1) 0.549 0.704 
IF5mean 0.560 0.570  ℱℒ(1,0) 0.625 0.806 
IF1STD 0.615 0.688  ℱℒ(1,1) 0.609 0.791 
IF2STD 0.647 0.741  𝒮ℱ 0.549 0.628 
IF3STD 0.678 0.751  M2 0.568 0.719 





mTF 0.578 0.759 
IF5STD 0.593 0.650  𝜎TF
2  0.539 0.678 
Energy 
of IFs 
E1 0.594 0.676  𝛾TF 0.585 0.701 
E2 0.511 0.723  kTF 0.566 0.701 
E3 0.584 0.722  cTF 0.658 0.798 




RRrec 0.534 0.579 
E5 0.578 0.759  DET 0.623 0.687 
Decay 0.570 0.532  ENTR 0.616 0.650 
    L 0.628 0.676 
Table 8.4 Prediction Probability Pk of calculated TFD-derived and RP-derived features 
for 2 and 4 patient states. Values above 0.65 are in bold and all values have p-
value<0.005 
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8.7 Studied Correlations 
Table 8.5 reports the correlations between CO, SV and HR and several 
TFD-derived features. All values included are statistically significant (p-
value<0.05) and those which are not have been omitted. On the one side, no 
statistically significant correlations have been found between TFD-derived 
with blood pressure, HRV or depth of anesthesia. On the other side, no 
statistically significant correlations have been found between RP-derived with 
blood pressure, HRV or depth of anesthesia. It can be observed that HR is 
correlated with the mean of the IFs but CO is correlated with the rest of TFD-
derived features. The SV is correlated with both groups of TFD-derived 
features. 
CORRELATION BETWEEN FEATURES AND BLOOD FLOW INDICES 
  CO SV HR  
IFs 
IF1mean -- -0.42 0.60  
IF2mean -- -0.40 0.55  
IF3mean -- -0.41 0.59  
IF4mean -- -0.43 0.64  
IF5mean -- -0.43 0.77  
TF Ext. 
Time Feat. 
mTF 0.85 0.66 --  
𝜎TF





Etot 0.82 0.64 --  
TFREq -0.87 -0.67 --  
ℱℒ(0,1) 0.90 0.70 --  
ℱℒ(1,0) 0.72 0.54 --  
ℱℒ(1,1) 0.80 0.61 --  
M2 0.77 0.58 --  
Energy of 
IFs 
E1 0.80 0.51 --  
E2 0.49 0.48 --  
E3 0.50 0.35 --  
E4 0.35 -- --  
E5 0.85 0.66 --  
Table 8.5 Pearson’s Correlation values for CO, SV and HR with the studied TFD-
derived. Only features with correlations above 0.30 which are statistically significant 
values have been included. In all cases, p-value<0.05 
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8.8 Prediction of Depth of Anesthesia using TFD-
Derived and RP-derived Features 
A fitted binary classification tree has been trained to predict patient 
depth-of-anesthesia states. Fitted binary classification trees develops 
predictive models based on both input and output data. First, data has been 
randomly divided into two sets of training and testing and the same amount 
of data points from every state were selected for the training and testing sets 
of data. A decision tree consists of branching conditions where the value of 
an input variable (also known as predictors, features, or attributes) is 
compared to a trained weight. The number of branches and the values of 
weights are determined in the training process. 
In this case, the predictors for the patient state have been chosen from 
among the TFD-derived and RP-derived features with a higher prediction 
probability Pk. Two classifications for the patient depth-of-anesthesia states 
have been employed: two states (awake and asleep states) and four states 
(awakeness, sedation, general anesthesia and deep anesthesia). Performance 
of the classification trees is calculated as the percentage of correctly predicted 
data divided the total amount of data in the testing set. Results are included in 
Table 8.6. In such table, if more features are used to train the classification 
tree, the performance continues decreasing. 
For two states, several decision trees provide prediction performance 
higher to 80%. In this case, the decision tree including IF3STD ,TFNREq ,cTF , 
ℱℒ(0,1), ℱℒ(1,1), E5, and the Minkowski distance M2 provides a performance 
of 82% for the two-state case. In the case of decision trees with four states, 
performances are much inferior. 
8.9 Prediction of Cardiac Output using TFD-
Derived and RP-derived Features 
Several ANFIS have been trained to predict cardiac output during the 
whole anesthesia procedures. Neuro-fuzzy systems combine two intelligent 
technologies [206], [207]. Neural networks are low-level computational 
structures which perform well with raw data but are opaque to the user. Fuzzy 
logic deals with reasoning at a higher level, using linguistic information 
acquired from domain experts but it lacks the ability to learn and cannot adjust 
itself to new environments. The integration of both technologies can combine 
the parallel computation and learning abilities of neural networks with the 
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human-like knowledge representation and explanation abilities of fuzzy 
systems. These systems can thus be trained to develop if-then fuzzy rules and 
determine membership functions for input and output variables of the system. 
PERFORMANCE OF DECISION TREES 
  4 states 2 states  
 IF3STD 39% 63%  
 TFNREq 33% 67%  
 cTF 33% 67%  
 ℱℒ(0,1) 37% 74%  
 ℱℒ(1,1) 38% 76%  
 E5 39% 76%  
 M2 38% 82%  
 IF4STD 35% 81%  
 IF2STD 38% 80%  
 E2 37% 75%  
 E3 37% 72%  
Table 8.6 Prediction performance calculated for each of the decision trees for two 
and four patient states. Note: each new decision trees includes the previous features 
The trained system for the prediction of cardiac output consists of six 
layers (represented in Figure 8.5) and it employs a hybrid learning algorithm 
combining the least-squares estimator and the gradient descent method: 
neural connection weights are modified in order to progressively reduce an 
error measure. Rule consequent parameters are identified on the layer 5 by the 
least-square estimator and error is back-propagated to update the antecedent 
parameters which describe the membership function in layer 2 by gradient 
descent. Both antecedent and consequent parameters are optimized using a 
combination of the least-squares and backpropagation gradient descent 
methods. No prior knowledge of rule consequent parameters is required. In 
the example of Figure 8.5, x1 and x2 are any two input indices which enter 
the model in layer 1. Layer 2 is the fuzzification layer which is followed by 
layer 3 which is composed by Sugeno-type rules. In a Takagi and Sugeno’s 
fuzzy if-then rule, the output of the rule is a linear combination of input 
variables plus a constant term, and the final output is the weighted average of 
each rule’s outputs [208]. 
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Figure 8.5 ANFIS with four rules: layer 1 is the input layer; layer 2 is the 
fuzzification layer; in layer 3, the rule layer, each neuron receives an fuzzy input and 
calculates the firing strength of the single Sugeno-type fuzzy rule it represents; layer 
4 normalizes the received firing strength to the sum of firing strengths of all rules; 
layer 5 also receives the inputs x1 and x2 to calculate the weighted consequent value 
of a rule; layer 6 sums the outputs of all defuzzification neurons and produces the 
overall ANFIS output. 
In total, one to five features (ℱℒ(0,1), 𝜎TF
2 , TFREq, E5, Etot) are used to 
train an ANFIS system which tries to imitate Cardiac Output through the 
whole surgery. These features have been chosen according to their correlation 
with CO and no more features were chosen because the ANFIS error started 
to increase as the number of features increased. Data were equally divided into 
the training and testing sets of data (132,200 data points for each set). The 
error was calculated as the mean RMS difference between the real output and 








ℱℒ(0,1) 0.310 0.392 
ℱℒ(0,1), 𝜎TF
2  0.297 0.376 
ℱℒ(0,1), 𝜎TF
2 , TFREq 0.288 0.387 
ℱℒ(0,1), 𝜎TF
2 , TFREq, E5 0.283 0.390 
ℱℒ(0,1), 𝜎TF
2 , TFREq, E5, Etot 0.280 0.401 
Table 8.7 Trained and predicted RMS for different ANFIS models trained to 
predict CO with TFD-derived features 
As the predicted RMS error shows in Table 8.7, a prediction error of 
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Finally, taking into account that CO = SV·HR, the HR index has been also 
introduced in some of the previous ANFIS to test whether results could be 
improved. Results are included in Table 8.8. The Bland-Altman error has 
been calculated according to indications in Chapter 2. The ANFIS model with 
three TFD-derived features (ℱℒ(0,1), 𝜎TF
2 , and TFREq) and HR shows a Bland-
Altman error of 14% and predicted RMS error of 0.44 L/min. 









2 , HR 0.248 0.392 15% 
ℱℒ(0,1), 𝜎TF
2 , TFREq, HR 0.233 0.438 14% 
Table 8.8 Trained and predicted RMS for different ANFIS models trained to 
predict CO with TFD-derived features and HR 
 
The Bland-Altman analysis has been included along with the regression 
analysis in Figure 8.6. The regression analysis includes de regression line of 
determination coefficient R2=0.86 calculated with n=132,200 data points (the 
testing set). The Bland-Altman analysis shows the limits of agreement (LOA) 
of the comparison between the predicted CO (COPred) and the reference CO 
(CORef) in absolute and percentual value. 
 
 
Figure 8.6 Regression analysis (A) and Bland-Altman analysis (B) for the ANFIS 
model with ℱℒ(0,1), 𝜎TF
2 , TFREq, and  HR as predictors. 
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In Figure 8.7, a complete surgery is plotted as a reference. The figure 
shows how the predicted CO and the reference CO are very similar. 
Calculations for this concrete case show a total RMS error of 0.191 L/min 
and a Bland-Altman error of 7.30%. In this concrete case, it is noticeable how 
the error seems proportional to the magnitude of cardiac output and thus is 
inferior at the end of the surgery. 
 
Figure 8.7 Reference and Predicted Cardiac Output for a full surgery 
8.10 Discussion and Conclusion 
In this analysis, all four RP-derived features decrease after LOC with a 
statistically significant difference. Moreover, both ENTR and L have an AUC, 
Sen and Spe above 60% when distinguishing between ICG pre-LOC and 
post-LOC signals for different combinations of RP parameters, such as 
referred in Table 8.2 and Table 8.3. Nevertheless, the analysis of the 
prediction probability shows a low Pk for the RP-derived features, especially 
when 4 different states are considered, and the correlation of such features 
with HRV, BP, CO, HR and SV is not statistically significant. Nevertheless, 
previous studies had used RPs to analyze HRV [209]. 
Regarding the correlation of the blood flow indices and features, IF 
energy and TF extended frequency features are related to CO and SV. The 
highest correlations are with CO for ℱℒ(1,0) (𝜌 = 0.90), 𝜎TF
2  (𝜌 = 0.89), TFREq 
(𝜌 = -0.87). The mean of the IFs are directly correlated to SV (𝜌 ∈ [-0.43, -
0.40]) and inversely correlated to HR (𝜌 ∈ [0.55, 0.77]). No other correlations 
have been found. 
When two patient states are considered (awake and asleep states), some 
of the TFD-derived features provide a good Pk above or around 0.75 (below 
or around 0.25). This is the case of the TFNREq, ℱℒ(1,0), ℱℒ(1,0), cTF, STD of 
IF2, IF3, IF4, and E5. Nevertheless, when considering four different states, the 
features with the best prediction probability Pk are only IF3STD  (Pk = 0.678),  
TFNREq  ( Pk = 0.658), cTF  ( Pk  = 0.342). These are promising results but 
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further analysis is required to improve them. Some of the options for this 
would be to use more complex TFD kernels such as the ones described in the 
previous chapters despite requiring a higher computational complexity, to 
consider 3 patient states instead of four (awakeness, sedation, anesthesia – 
both general and deep), to use a TFD with a higher time resolution. Currently, 
the time resolution is 1 Hz but it increase to 250 Hz. These suggestions will 
be taken into consideration in a future work. 
Regarding the prediction models, TFD-derived and RP-derived features 
do not seem to be good predictors for the patient depth-of-anesthesia state. 
In the best case, a total of seven features (IF3STD, TFNREq, cTF, ℱℒ(0,1), ℱℒ(1,1), 
E5, M2, IF4STD , IF2STD , E2, and E3) can be used to train a classification tree to 
predict patient state with a resulting performance of 82% calculated as the 
ratio of correctly predicted data when only two states are considered and of 
38% when four states are considered. 
Furthermore, ANFIS models trained to predict CO seem to provide 
promising results. The ANFIS model trained with three TFD-derived features 
(ℱℒ(0,1), 𝜎TF
2 , TFREq) and the patient’s heart rate provides LOA = 14%, which 
is far below the 30% acceptable for the interchangeability of indices, according 
to explanations in Chapter 2 [79] . 
As explained before, no statistically significant correlations have been 
found between TFD-derived or RP-derived features with blood pressure, 
HRV. Nevertheless, as Table 8.5 shows, TFD-derived features of the ICG 
seem to be related to the HR and to CO (which is also ultimately related to 
HR). In addition, ANFIS models with TFD-derived features have proved to 
predict CO with good results. TFD-derived features of the ICG could provide 
further information for the calculation of cardiac output. This hypothesis 













































This chapter is based on an excerpt of an article published during the 
present Doctoral Thesis [210]. A comparison between the LiDCOrapid 
monitor and the qCO monitor is presented. The Bland-Altman method is 
used for such comparison.  
9 
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9.1 Introduction 
The aim of this last chapter is to report a performance test of the qCO 
using the LiDCOrapid as a reference. The two devices can monitor the CO 
continuously, but with different methods. The qCO detects variations in the 
impedance, while LiDCOrapid processes the pressure waveform to estimate 
the CO [47]. 
Several studies report an improved outcome with the usage of 
LiDCOrapid to guide goal-directed fluid therapy after emergency laparotomy 
[211], a reduced length of hospital stay in colorectal surgery [212], and in high-
risk abdominal and bariatric surgery [213]. Therefore, the aim of this study 
was to compare the behaviors of LiDCOrapid and the new qCO device during 
anesthesia procedures in the operatory room. 
9.2 Methods 
Fifteen patients undergoing major surgery under general anesthesia at the 
Zhongshan Hospital in Shanghai were assessed in this observational study. 
Details of the patients and operations were reported in Table 3.1. 
The synchronization between both devices was ensured by annotating 
the exact start time given by the two devices. Data values of cardiac output 
were not taken into consideration when there was an instantaneous variation 
of either HR, CO or SV greater than 25% which was not justified from a 
clinical point of view. This led to a total rejection rate of < 2% for 
LiDCOrapid and < 1% for qCO. Two patients (one for gastrostomy and 
another one for cytoreductive surgery) were excluded due to excessive noise, 
and thus a total of thirteen patients remained to be considered for this study. 
To create the pairs of cardiac output values, each CO point from qCO was 
paired with the closest CO point by LiDCOrapid within a time difference of 
one second between both points. 
9.2.1 Statistical Analysis  
The qCO agreement with the LiDCOrapid’s signal was assessed using 
different statistical techniques: regression and Bland-Altman analysis. The 
Bland-Altman analysis is explained in Chapter 2. 
A regression analysis was conducted to estimate the relationship between 
the cardiac outputs calculated by the LiDCOrapid and qCO monitors. 
Regression can show whether pairs of indices are related but a high correlation 
does not imply a good agreement between two methods. Bland-Altman 
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analysis for repeated measurements per patient were used for the pool of 
patients to assess the agreement between qCO and LiDCOrapid. The Bland-
Altman plot, also known as difference plot, is a method to compare two 
techniques (usually one of them as a reference) for the measurement of the 
same parameter. The correlation is shown by plotting the differences between 
the measurements produced by both methods against the mean value of such 
measurements. 
A linear mixed model with random effects was used to adjust for the 
interaction between the two methods and the time replicates of patients, 
resulting in a common standard deviation (SD) to calculate the limits of 
agreement (LOA) with its upper and lower limits determined by the mean 
difference between data from the reference and studied method ± 1.96 SD 
[82], [214], [215]. The percentage error was calculated as the ratio of 2 SD of 
the bias to the mean CO and was considered clinically acceptable when it was 
30% or less, as proposed by Critchley and Critchley [79], [80]. Before 
computing the Bland-Altman plot, according to Squara et al. [216], each 
recording should be divided into unchanging, increasing and decreasing 
periods and the description of a device can only be estimated on unchanging, 
stable periods. 
9.3 Results 
Data from 13 patients, 8 males and 5 females were included into final 
analysis. Not a single patient suffered from any complication in the context of 
the present study. Blood loss, fluid administration and hypotension periods 
after induction were not included into our analysis. Figure 9.1 displays one of 
the cases. In this figure, it is visible that qCO and LiDCOrapid share a 
common overall trend. However, LiDCOrapid shows several sudden drops 
in cardiac output for which there is no reported clinical evidence and which 
are not followed by the qCO monitor. 
Patient hemodynamic data are reported in Table 3.1. According to qCO, 
cardiac output ranged 4.5 ± 0.5 L/min, stroke volume 69.6 ± 8.8 mL/beat. 
According to LiDCOrapid, these values were 4.5 ± 0.7 L/min and 69.8 ± 10.9 
mL/beat, respectively. Heart rate was the same for both devices: 64.8 ± 7.5 
bpm. Non-significant differences were observed between qCO and 
LiDCOrapid regarding those values.  
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Figure 9.1 The cardiac output assessed by the qCO and the LiDCOrapid. The 
figure shows an example of a recording obtained with qCO and LiDCOrapid 
HEMODYNAMIC CHARACTERISTICS 
Surgery duration (min) 135.1 ± 59.63 
Cardiac Output (L/min) 4.5 ± 0.5 (qCO); 4.5 ± 0.7 (LiDCOrapid) 
Stroke Volume (mL/beat) 69.6 ± 8.8 (qCO); 69.8 ± 10.9 (LiDCOrapid) 
Heart Rate (bpm) 64.8 ± 7.5 (qCO and LiDCOrapid) 
Table 9.1 Hemodynamic characteristics. All values are presented as mean ± 
standard deviation 
The operative procedures, whose type is also reported in Table 9.1, lasted 
113 [88 200] minutes (median and 25, 75-percentiles). A median of 3,557 
[2,407 6,996] points (median and 25, 75-percentiles) were paired from qCO 
and LiDCO cardiac output. 
Regression analysis showed no good indication of proportional bias 
(r²=0.3987, p-value<0.05). This analysis and the Bland-Altman plot are 
included in Figure 9.2 and Figure 9.3, respectively. The Bland-Altman plot 
compares the differences in CO values against the mean of the total measures 
of both methods, qCO and LiDCOrapid. In Figure 9.3, the black solid line 
represents the mean difference and the dotted lines represent the accepted 
limits of agreement (mean difference ± 2 SD). The standard deviation has 
been corrected for the pooled data using two variances: that for repeated 
differences between the two methods on the same subject and that for the 
differences between the averages of the two methods across subjects. 




Figure 9.2 Regression analysis of the pool data 
In this case, the Bland-Altman analysis shows a mean bias of -0.03 ± 0.71 
L/min. Upper and lower limits of agreement are 1.4 and -1.4, respectively. 
Percentage error was 29%, which is just below the recommended 30% [79], 
[80]. The color bar ranges from a 0 to 1043 in logarithmic units, so the areas 
outside the limits of agreement are not relevant compared to the rest of the 
figure. 
9.4 Discussion 
There is a reasonable amount of studies on the LiDCOrapid technology. 
In a study by Phan and colleagues [217], LiDCOrapid showed an increase of 
41% after a fluid bolus measurement. When comparing the test device to 
thermodilution, the Kappa statistic (a statistic which measures inter-rater 
agreement for categorical data) showed fair agreement of 0.28. After 
vasopressor administration, there was also significant variation in the change 
in cardiac output. Using Bland-Altman analysis, the precision of LiDCOrapid 
in comparison to thermodilution showed minimal bias, but wide limits of 
agreement with percentage errors of 54.2%. In this study, other instruments 
were also tested against thermodilution with similar results. These findings 
indicated that LiDCOrapid, VigileoFlotrac and Oesophageal Doppler 
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Monitor (ODM) differ in their responses, do not always provide the same 
information as thermodilution and should not be used interchangeably to 
track cardiac output changes. 
 
Figure 9.3 Bland-Altman plot of comparing the differences in CO values against 
the mean of the total measures of qCO and LiDCOrapid. The color column 
indicates the number of points in each square 
Nordström and colleagues [38] compared ODM and LiDCOrapid for 
stroke volume (SV) optimization during colorectal surgery using fluid 
challenges. For 172 paired SV values, the overall correlation was 𝜌 = 0.39, and 
bias (limits of agreement) -28 [-91 35] mL, percentage error 70%. The ability 
of LiDCOrapid to track changes in SV compared to ODM was weak with a 
concordance rate of 80%, and a sensitivity and specificity of 48% and 81%, 
respectively, to detect a positive fluid challenge. 
Davies and colleagues [54] conducted a study where simultaneous reading 
of SV, stroke volume variation (SVV) and pulse pressure variation (PPV) from 
LiDCOrapid and FloTrac were taken in 20 patients and compared with ODM. 
The main conclusion was that SV measured by the FloTrac and LiDCOrapid 
systems does not correlate with the ODM, has poor concordance and a 
clinically unacceptable percentage error. However, SVV measured by the 
LiDCOrapid has clinical utility. 
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Costa and colleagues [49] studied the level of agreement between cardiac 
output obtained by LiDCOrapid and continuous cardiac output (CCO) and 
intermittent cardiac output (ICC) obtained by the pulmonary artery catheter 
(PAC) in patients after liver transplantation. The performance of LiDCOrapid 
was moderate in detecting changes in ICO. 
The current study statistically describes the new qCO monitor. It 
therefore constitutes an initial validation of this new monitor. Today, 
clinicians can choose amongst a wide variety of less-invasive or noninvasive 
devices to calculate cardiac output. Each device consists on a proprietary 
software algorithm which processes different types of signals. However, 
several studies have demonstrated a lack of accuracy in these monitors [38], 
[49], [54], [79], [217]–[219]. Quantium Medical qCO monitors is born from 
the intention of applying advanced signal processing techniques to 
bioimpedance signals in order to offer a totally noninvasive device to measure 
cardiac output. 
Our main finding is the acceptable percentage error of the qCO monitor 
compared to the LiDCOrapid system. It should be mentioned that several 
studies have previously demonstrated the validity of monitors using a 
technology similar to qCO in comparison to gold standards. The NICOM 
monitor (Cheetah Medical) [220] compared to thermodilution showed a mean 
bias of -0.81 with 95% limits of agreement of [-3.54, +1.92]. Cardiac output 
by NICOM was also more precise than by thermodilution (precision of 
3.5±0.3% for NICOM versus 9.6±6.1% for thermodilution, p-value<0.001). 
In our study, the Bland-Altman plot between qCO and LiDCO shows 
that the majority of values adjusted to the agreement limits and the hot spots 
are distributed near zero (represented with the hottest colors in Figure 9.3). 
The mean bias is -0.03 and the limits of agreement are +1.4 and -1.4. Given 
the large sample size (56,456 total samples), this distribution of the points 
demonstrates a very low bias.  
In a similar study performed for the validation of electrical velocimetry 
(EV) with cardiac magnetic resonance imaging (CMR) as referenced in [68], 
the authors admitted an insufficient agreement and referred to a Bland-
Altman plot with a mean bias of 1.2 ± 1.4 L/min. This represents a higher 
mean bias and wider limits of agreement compared to the data published in 
the present article. Consequently, it is possible to affirm that nearly identical 
results can be provided from qCO and LiDCOrapid. 
9 Validation of qCO monitor 128 
 
Our study presents a number of limitations which must be considered. 
First, the observational protocol included a variety of surgical operations and 
did not include exact measuring points. It is especially important to note that 
this variety of surgical operations can imply different requirements in fluid 
management. Although this introduces a higher variability in our findings, it 
was useful to characterize the general behavior of the qCO monitor. 
Nonetheless, one should recognize that this methodology might not provide 
sufficiently clean data to make perfect comparisons between technologies. 
This is also linked with the fact that segmentation into unchanged, 
increasing and decreasing periods was not possible. Some authors [216] have 
stated that the comparison and analysis of medical devices must be conducted 
during stable periods. However, the analysis of the trends in our recordings 
showed a lack of many unchanged periods and, therefore, the analysis of the 
bias was performed on all data and not only on the data with unchanging trend. 
At the same time, this implies an important limitation although it should also 
be noted that the purpose of this work was to compare the behavior of both 
instruments under the same varying conditions. 
As previously mentioned, LiDCOrapid is not a gold standard. Further 
studies against gold standards, such as the pulmonary artery catheter, will be 
required in order to complete the validation of the new qCO monitor. 
Moreover, in future studies, more protocol-based procedures would be highly 
recommended. Outcome studies are also a powerful tool to take into account 
in order to validate the benefits of the usage of the qCO monitor. 
Furthermore, the implementation of more detailed protocols will also allow 
determination of the trending ability of changes between qCO and other gold 
standard technologies.  
Finally, future studies will need to include the analysis of the precision of 
the qCO device as reported in [73]. Precision is a major issue in clinical 
monitoring which has also been cited for other devices during the discussion 
but not analyzed for the case of the qCO. 
9.5 Conclusions 
In conclusion, the results indicate that cardiac output calculated with the 
qCO monitor is comparable to the values calculated by the LiDCOrapid 
monitor. In line with this and previous studies [102], [221],  the qCO has 
demonstrated a very low bias with the LiDCOrapid monitor in a variety of 
different situations. 
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Future studies need to be performed to compare the qCO with a gold 
standard in order to ensure a complete validation. Certainly, the availability 
and reliability of noninvasive cardiac output devices make cardiac output 
monitoring an attractive option for all clinical situations.  
  


































In this final chapter the most important findings and contributions of the 
present dissertation are summarized, from the concept of the devices used in 
this research to the application and possible uses of the fast impedance 
measurements performed. In addition, several guidelines for further work in 
the topic are proposed. 
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10.1 Conclusions 
As it was stated in the Introduction, the main objective of this Doctoral 
Thesis was «the development of signal treatment techniques for the thoracic 
bioimpedance signals in order to create an innovative hemodynamic monitor». 
This main objective was also divided into several minor objectives. 
The present Doctoral Thesis incorporates a presentation on the available 
cardiac output monitoring technologies. Regarding the different options, 
patient risk is related to invasiveness, which is, in turn, inversely related to 
accuracy. Thus, the invasive Swan-Ganz catheter continues to be the gold 
standard of the technique but its invasiveness – and associated risk for the 
patient – implies that this measurement device is only used in critically ill 
patients in which the improved accuracy compensates for the increased risk. 
In the rest of cases, minimally invasive and noninvasive monitors are preferred 
and the competition lies on the accuracy of such techniques. 
This Doctoral Thesis has produced a considerable amount of clinical data 
grouped in different databases. The clinical trials conducted in Barcelona, 
Hong Kong, Santiago and Shanghai are valuable resources which have been 
used to validate the methodologies discussed in this text. In Barcelona, 
Santiago and Shanghai, the anesthesia were induced with propofol and 
remifentanil or fentanyl. Sevoflurane was also used for maintenance in some 
cases.  
The previous databases have also permitted to test different relationships 
between blood flow, blood pressure and heart rate variability in this concrete 
anesthetic context. During anesthesia, there was a decrease in cardiac output 
and blood pressure after loss of consciousness. Except from the index 
reflecting the normalized high-frequency spectral power of the HRV, the rest 
of HRV indices also decreased after LOC indicating a decrease in both 
sympathetic and vagal activity. Such exception indicates that although both 
high-frequency and low-frequency components of the HRV decrease after the 
onset of anesthesia, the high-frequency power decreases less than the low-
frequency power does. Gender differences in HR and CO, and age differences 
in HRV measurements were also found after LOC. In addition to these results, 
a new method to create synthetic signals with known time-frequency 
characteristics has been designed and implemented using the ICG signals. 
Concerning the relationship between ICG and ECG signals, RR and CC 
segments are very much comparable ( = 0.998, p-value < 0.0005). In fact, 
this can be used in cardiac output monitors in order to check that the R and 
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C points are properly located on the ECG and ICG signals. The time delay 
between the electrical activity of the heart (represented by the ECG) and its 
mechanical activity (represented by the ICG) can be measured with the RC 
segment or the ratio RC/RR. The ratio RC/RR is inversely proportional to 
RR and is lower than 30% for RR intervals between 700 and 1000 ms, which 
would correspond to a heart rate of 86 and 60 bpm, respectively. 
Time-Frequency Distributions (TFD) have been widely studied in this 
Doctoral Thesis. The basic knowledge of TFD has been reviewed and a new 
method to test TFD kernels with multi-tone synthetic signals based on real 
biomedical signals has been designed and implemented. It consists on using 
well-known, synthetic signals to check how different kernels can locate the 
instantaneous frequencies of the synthetic signals. In the case of the ICG 
signals, some traditional kernels such as Born-Jordan Distribution (BJD) 
could be discarded due to the results of this work. A new performance 
parameter has also been designed as the correlation between the studied TFDs 
of the synthetized ICG real-based signal and the addition of the Wigner-Ville 
Distributions (WVD) of the two single tone in the synthetized ICG signal. 
Nevertheless, the final choice of the kernel to use must follow a thorough 
evaluation of the performance measurements described in chapter 6 and it 
also depends on the available knowledge of the type of signals to analyze. 
A wide range of TFD features has been presented and calculated on ICG 
signals. These features were based on different characteristics of the signals: 
single-value decomposition, entropy, concentration, time or frequency 
characteristics. Feature values from before and after the loss of consciousness 
during anesthesia have been compared and several TFD features have proven 
to be significantly different in these two situations. These features have also 
been calculated on TFDs with different kernels.  When analyzing different 
anesthetic states, the TF Rényi entropy was the most prominent feature. 
Regarding the various kernels which were analyzed, the Extended Modified 
Beta Distribution (EMBD) was the most successful for the extraction of 
features showing statistically significant differences in different anesthesia 
points. 
Many of the different TFD features used in this Doctoral Thesis also 
correlate with the patients’ cardiac output, stroke volume and heart rate. 
Furthermore, the prediction probability Pk  of many of the TFD-derived 
features to detect two anesthesia states (awake/asleep) is also acceptable, 
10 Conclusions  134 
 
reaching up to 0.798 for the normalized Rényi Entropy. Nevertheless, results 
are less promising for the ability of those TFD-derived features to 
differentiate between four patient states (awakeness, sedation, general 
anesthesia and deep anesthesia) and the prediction probability was always less 
than 0.68.  
Decision trees have been trained to differentiate between two and four 
states. For two states, several decision trees provided prediction performance 
(ratio of correctly predicted results over the total of decisions) higher to 80%, 
although for four states, results were much inferior. Finally, several ANFIS 
systems have also been trained to predict cardiac output by using TFD-
derived features and Heart Rate with excellent results. The best results have 
been obtained with an ANFIS system which combines three TFD-derived 
features (Rényi Entropy, Flux, and TF signal variance) and heart rate. This 
provided a Bland-Altman error of 14% and predicted RMS error of 0.44 
L/min, which is considered satisfactory. 
The qCO monitor includes several algorithms developed in this Doctoral 
Thesis and a comparison against one of its main competitors, the LiDCO 
monitor, has been included at the end of this work. This work has in 
conclusion enabled the qCO monitor to improve its resistance to noise and 
its calculation methods of cardiac output. 
From a business perspective, the success of this Doctoral Thesis relies on 
three main points: 
- the filing of a patent containing the algorithms discussed in this 
Doctoral Thesis; 
- the CE mark of the qCO monitor; 
- and the business decision to engage in new clinical trials to continue 
developing this monitor based on the results of this Doctoral Thesis. 
 
10.2 Ongoing and Future Work 
As explained in the previous section, Quantium Medical continues to 
develop and improve the qCO monitor for noninvasive cardiac output 
monitoring. The TFD-derived and RP-derived features explained in Chapter 
8 continue to be developed and tested over the CMA database explained in 
Chapter 3. Several approaches have already been mentioned in Chapter 8. 
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Future steps will also be based on the consecution of a new database 
comparing the qCO with a gold standard monitor (or similar). Further 
techniques explained in this Doctoral Thesis will be then added to new 
impedance cardiography signals recorded by the qCO monitor and the cardiac 
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